<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/stylesheet.xsl" type="text/xsl"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:podcast="https://podcastindex.org/namespace/1.0">
  <channel>
    <atom:link rel="self" type="application/rss+xml" href="https://feeds.transistor.fm/the-ngbideas-podcast" title="MP3 Audio"/>
    <atom:link rel="hub" href="https://pubsubhubbub.appspot.com/"/>
    <podcast:podping usesPodping="true"/>
    <title>NGBideas</title>
    <generator>Transistor (https://transistor.fm)</generator>
    <itunes:new-feed-url>https://feeds.transistor.fm/the-ngbideas-podcast</itunes:new-feed-url>
    <description>Join Jim Wilson as he sits down with today's leaders in Canadian Life Sciences to talk about their personal journey and what they have learned along the way.</description>
    <copyright>Copyright 2022 All rights reserved.</copyright>
    <podcast:guid>c0b8f394-b267-529b-8f11-fe75e6767385</podcast:guid>
    <podcast:locked>yes</podcast:locked>
    <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    <podcast:trailer pubdate="Mon, 28 Jul 2025 14:53:49 -0400" url="https://media.transistor.fm/3a6f8b8e/3380c25d.mp3" length="2021783" type="audio/mpeg" season="3">NGBi25 Podcasts Coming Soon</podcast:trailer>
    <podcast:trailer pubdate="Fri, 23 Dec 2022 10:10:33 -0500" url="https://media.transistor.fm/254a96b9/24ce2615.mp3" length="594510" type="audio/mpeg" season="1">S1: NGBideas Trailer</podcast:trailer>
    <language>en</language>
    <pubDate>Tue, 21 Apr 2026 05:27:12 -0400</pubDate>
    <lastBuildDate>Tue, 21 Apr 2026 05:27:16 -0400</lastBuildDate>
    <link>http://ngbideas.transistor.fm</link>
    <image>
      <url>https://img.transistorcdn.com/GAJjxVnf_WOheuWjq0hiyggwEzHir6nYiuQ_rz07UbE/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81OWNi/ZGQwMDBjZGJkMTVk/OGE0NzQ2NWY1Y2Uw/OTAxNi5wbmc.jpg</url>
      <title>NGBideas</title>
      <link>http://ngbideas.transistor.fm</link>
    </image>
    <itunes:category text="Science">
      <itunes:category text="Life Sciences"/>
    </itunes:category>
    <itunes:category text="Business"/>
    <itunes:type>episodic</itunes:type>
    <itunes:author>Jim Wilson</itunes:author>
    <itunes:image href="https://img.transistorcdn.com/GAJjxVnf_WOheuWjq0hiyggwEzHir6nYiuQ_rz07UbE/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81OWNi/ZGQwMDBjZGJkMTVk/OGE0NzQ2NWY1Y2Uw/OTAxNi5wbmc.jpg"/>
    <itunes:summary>Join Jim Wilson as he sits down with today's leaders in Canadian Life Sciences to talk about their personal journey and what they have learned along the way.</itunes:summary>
    <itunes:subtitle>Join Jim Wilson as he sits down with today's leaders in Canadian Life Sciences to talk about their personal journey and what they have learned along the way..</itunes:subtitle>
    <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
    <itunes:owner>
      <itunes:name>Jim Wilson</itunes:name>
      <itunes:email>ngbicanada@gmail.com</itunes:email>
    </itunes:owner>
    <itunes:complete>No</itunes:complete>
    <itunes:explicit>No</itunes:explicit>
    <item>
      <title>NGBideas S4.E4 - BlueRock Therapeutics LP</title>
      <itunes:title>NGBideas S4.E4 - BlueRock Therapeutics LP</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">8955addf-7ec7-4436-8c1b-81ac927c34f9</guid>
      <link>https://ngbideas.transistor.fm/bluerock</link>
      <description>
        <![CDATA[<p>In the next episode of NGBideas Jim Wilson sits down with Gerald Prince who is Senior Director of GMP Manufacturing Gerald Prince at Bluerock Therapeutics.  Gerald's professional journey has wound through some of North America's largest food, consumer goods, and pharmaceutical companies and ultimately landed him at MaRS Discovery District in Toronto.  Gerald's story began in Stockton, California where his childhood home was unfortunately touched by gun violence but teachers and coaches believed in him before he believed in himself and their encouragement helped set Gerald on a career path defined by leadership, ambition and perseverence.  His journey eventually brought him to Canada and the forefront of cell and gene therapy where he and his team are helping change the future of medicine.  It is an inspiring story and we know you will enjoy learning about it.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In the next episode of NGBideas Jim Wilson sits down with Gerald Prince who is Senior Director of GMP Manufacturing Gerald Prince at Bluerock Therapeutics.  Gerald's professional journey has wound through some of North America's largest food, consumer goods, and pharmaceutical companies and ultimately landed him at MaRS Discovery District in Toronto.  Gerald's story began in Stockton, California where his childhood home was unfortunately touched by gun violence but teachers and coaches believed in him before he believed in himself and their encouragement helped set Gerald on a career path defined by leadership, ambition and perseverence.  His journey eventually brought him to Canada and the forefront of cell and gene therapy where he and his team are helping change the future of medicine.  It is an inspiring story and we know you will enjoy learning about it.</p>]]>
      </content:encoded>
      <pubDate>Tue, 21 Apr 2026 03:30:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/e87a474d/194f3e03.mp3" length="35816821" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/mhZpJbPQVvUscnE8ZPFvmjZekxw4ncjHEIsFbs3rKcY/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yNjZk/NTA4ODhiZjQ2MDAx/MGEzOTMzZWNmN2Y4/MTliMy5wbmc.jpg"/>
      <itunes:duration>4478</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In the next episode of NGBideas Jim Wilson sits down with Gerald Prince who is Senior Director of GMP Manufacturing Gerald Prince at Bluerock Therapeutics.  Gerald's professional journey has wound through some of North America's largest food, consumer goods, and pharmaceutical companies and ultimately landed him at MaRS Discovery District in Toronto.  Gerald's story began in Stockton, California where his childhood home was unfortunately touched by gun violence but teachers and coaches believed in him before he believed in himself and their encouragement helped set Gerald on a career path defined by leadership, ambition and perseverence.  His journey eventually brought him to Canada and the forefront of cell and gene therapy where he and his team are helping change the future of medicine.  It is an inspiring story and we know you will enjoy learning about it.</p>]]>
      </itunes:summary>
      <itunes:keywords>Gerald Prince, Life Sciences, Regenerative Medicine, Cell and Gene Therapy, Leadership, Biotechnology, Personal Journey, Mentorship, Innovation, Diversity Equity and Inclusion, Toronto, MaRS, Startups, Innovators, Canadian Business, Jim Wilson, Life Sciences Summit, Health Sciences, Biopharma, MedTech</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBiLab S3.E8: Targa Biomedical</title>
      <itunes:title>NGBiLab S3.E8: Targa Biomedical</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">a470fbb8-375f-4b08-aad4-358c96e41937</guid>
      <link>https://ngbideas.transistor.fm/ngbilab-targa-biomedical</link>
      <description>
        <![CDATA[<p>Based in Montreal, Quebec, Targa Biomedical is developing pharmacological solutions designed to improve the quality of cells, tissues, and organs for transplantation and regenerative medicine. Their technology has the potential to rescue damaged donor organs that would otherwise be discarded, making more transplants possible for patients in need.</p><p>In this episode, host Jim Wilson speaks with co-founder and CEO Shant Der Sarkissian about how a chance observation in the lab, combined with a conversation with a cardiac surgeon next door, became the foundation for a company seven years in the making. Shant walks through the science behind conditioning damaged organs outside the body and why Targa believes it is first to market with this specific approach.</p><p>Shant also reflects on the unique challenges of being an academic entrepreneur, and why he believes the confusion of having too many career options in front of you is actually a blessing in disguise.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Based in Montreal, Quebec, Targa Biomedical is developing pharmacological solutions designed to improve the quality of cells, tissues, and organs for transplantation and regenerative medicine. Their technology has the potential to rescue damaged donor organs that would otherwise be discarded, making more transplants possible for patients in need.</p><p>In this episode, host Jim Wilson speaks with co-founder and CEO Shant Der Sarkissian about how a chance observation in the lab, combined with a conversation with a cardiac surgeon next door, became the foundation for a company seven years in the making. Shant walks through the science behind conditioning damaged organs outside the body and why Targa believes it is first to market with this specific approach.</p><p>Shant also reflects on the unique challenges of being an academic entrepreneur, and why he believes the confusion of having too many career options in front of you is actually a blessing in disguise.</p>]]>
      </content:encoded>
      <pubDate>Thu, 16 Apr 2026 03:30:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/287b48d8/b3e7bb5f.mp3" length="11857311" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/ZMnMM9tr2lUYs6Gj5pIV3FdTesEsY5RMzsV4v4ihngY/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hZDli/ZGMxNWE2MDhkOTU0/MDYzZWVmOTkyMjg0/MTI2Mi5wbmc.jpg"/>
      <itunes:duration>1483</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Based in Montreal, Quebec, Targa Biomedical is developing pharmacological solutions designed to improve the quality of cells, tissues, and organs for transplantation and regenerative medicine. Their technology has the potential to rescue damaged donor organs that would otherwise be discarded, making more transplants possible for patients in need.</p><p>In this episode, host Jim Wilson speaks with co-founder and CEO Shant Der Sarkissian about how a chance observation in the lab, combined with a conversation with a cardiac surgeon next door, became the foundation for a company seven years in the making. Shant walks through the science behind conditioning damaged organs outside the body and why Targa believes it is first to market with this specific approach.</p><p>Shant also reflects on the unique challenges of being an academic entrepreneur, and why he believes the confusion of having too many career options in front of you is actually a blessing in disguise.</p>]]>
      </itunes:summary>
      <itunes:keywords>Biotech, Organ Transplantation, Regenerative Medicine, Medical Innovation, Startup Journey, Medical Research, Biotech Entrepreneurship, Organ Rescue Technology, Life Sciences, Health Sciences, Entrepreneurship, Startups, Canadian Business, Innovators, Jim Wilson, Life Sciences Summit, Canada, Biotech Innovation, Biopharma, MedTech, Montreal, Cell Therapy, Drug Discovery, Leadership, Medicine, Pharma, Clinical Trials, Health Innovation, Stem Cell Research, Canadian Startups, Life Sciences Community, Next Great Big Ideas, CEOs, Research Hospital, University of Montreal, Organ Donation, Patient Outcomes, Transplant Surgery</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBiPlus S2.E3: SPEC Labs</title>
      <itunes:title>NGBiPlus S2.E3: SPEC Labs</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">1eb79cc4-2c0d-43c9-9529-3cd685551463</guid>
      <link>https://ngbideas.transistor.fm/ngbiplus-spec-labs</link>
      <description>
        <![CDATA[<p>Based in Mississauga, Ontario, SPEC Labs is a not-for-profit organization providing shared, ready-to-use wet lab space for life sciences startups that need room to grow. Their all-inclusive model is designed to remove one of the biggest barriers facing Canadian biotech companies: access to affordable lab infrastructure.</p><p><br></p><p>In this episode, host Jim Wilson speaks with founder and CEO Doris Qamar about how a frustrating gap in the Canadian market sparked an idea that took years to bring to life. What started as a search for scalable lab space for a small biotech company became a 20,000 square foot facility in Sheridan Research Park, now open and welcoming its first clients.</p><p><br></p><p>Doris also makes a passionate case for why keeping innovation and intellectual property in Canada matters now more than ever.</p><p><br></p><p>With the Mississauga location now up and running, SPEC Labs has its sights set on a second location in Toronto in 2028.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Based in Mississauga, Ontario, SPEC Labs is a not-for-profit organization providing shared, ready-to-use wet lab space for life sciences startups that need room to grow. Their all-inclusive model is designed to remove one of the biggest barriers facing Canadian biotech companies: access to affordable lab infrastructure.</p><p><br></p><p>In this episode, host Jim Wilson speaks with founder and CEO Doris Qamar about how a frustrating gap in the Canadian market sparked an idea that took years to bring to life. What started as a search for scalable lab space for a small biotech company became a 20,000 square foot facility in Sheridan Research Park, now open and welcoming its first clients.</p><p><br></p><p>Doris also makes a passionate case for why keeping innovation and intellectual property in Canada matters now more than ever.</p><p><br></p><p>With the Mississauga location now up and running, SPEC Labs has its sights set on a second location in Toronto in 2028.</p>]]>
      </content:encoded>
      <pubDate>Tue, 14 Apr 2026 03:30:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/f139baf8/b9aa01ec.mp3" length="11829934" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/hpGBKM33-1YvS1SDuvPKwUYCyOfIvP-toTTyyYC5rtU/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84NzYz/MmNmMGIxZDI2MTAy/ZDFlZGRiOTViM2Vj/MTk1ZC5wbmc.jpg"/>
      <itunes:duration>1479</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Based in Mississauga, Ontario, SPEC Labs is a not-for-profit organization providing shared, ready-to-use wet lab space for life sciences startups that need room to grow. Their all-inclusive model is designed to remove one of the biggest barriers facing Canadian biotech companies: access to affordable lab infrastructure.</p><p><br></p><p>In this episode, host Jim Wilson speaks with founder and CEO Doris Qamar about how a frustrating gap in the Canadian market sparked an idea that took years to bring to life. What started as a search for scalable lab space for a small biotech company became a 20,000 square foot facility in Sheridan Research Park, now open and welcoming its first clients.</p><p><br></p><p>Doris also makes a passionate case for why keeping innovation and intellectual property in Canada matters now more than ever.</p><p><br></p><p>With the Mississauga location now up and running, SPEC Labs has its sights set on a second location in Toronto in 2028.</p>]]>
      </itunes:summary>
      <itunes:keywords>SPEC Labs, Biotech, Life Sciences, Health Sciences, Entrepreneurship, Startups, Canadian Business, Innovators, Lab Space, Mississauga, Jim Wilson, Life Sciences Summit, Canada, Biotech Innovation, Biopharma, MedTech, Leadership, Wet Lab, Incubator, Intellectual Property</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBideas S4.E3 - Dr. Kullervo Hynynen</title>
      <itunes:title>NGBideas S4.E3 - Dr. Kullervo Hynynen</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">2d9f5840-81c5-482f-b76f-7b9abf8ab383</guid>
      <link>https://ngbideas.transistor.fm/Kullervo-Hynynen</link>
      <description>
        <![CDATA[<p>Based in Toronto, Ontario, Dr. Kullervo Hynynen is Vice President of Research and Innovation at Sunnybrook Health Sciences Centre and a global leader in focused ultrasound technology. His decades of work have helped transform how the medical community approaches treatment for some of the most challenging neurological and oncological conditions.</p><p>In this episode, host Jim Wilson speaks with Dr. Hynynen about a remarkable journey that began on a small farm in rural Finland and led to one of the most significant breakthroughs in modern neuroscience. What started as a rejected NIH grant proposal became the foundation for a technology that can now open the blood-brain barrier non-invasively, potentially unlocking treatment for conditions like Alzheimer's and brain cancer.</p><p>Kullervo also reflects on the personal losses that shaped his commitment to cancer research, and how a series of serendipitous career decisions, from Aberdeen to Arizona to Boston to Toronto, brought him to Sunnybrook.</p><p>This conversation covers the stubbornness required to push through years of failed experiments, the challenge of commercializing science in Canada, and why Kullervo believes the next frontier is a focused ultrasound helmet that patients could one day use at home.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Based in Toronto, Ontario, Dr. Kullervo Hynynen is Vice President of Research and Innovation at Sunnybrook Health Sciences Centre and a global leader in focused ultrasound technology. His decades of work have helped transform how the medical community approaches treatment for some of the most challenging neurological and oncological conditions.</p><p>In this episode, host Jim Wilson speaks with Dr. Hynynen about a remarkable journey that began on a small farm in rural Finland and led to one of the most significant breakthroughs in modern neuroscience. What started as a rejected NIH grant proposal became the foundation for a technology that can now open the blood-brain barrier non-invasively, potentially unlocking treatment for conditions like Alzheimer's and brain cancer.</p><p>Kullervo also reflects on the personal losses that shaped his commitment to cancer research, and how a series of serendipitous career decisions, from Aberdeen to Arizona to Boston to Toronto, brought him to Sunnybrook.</p><p>This conversation covers the stubbornness required to push through years of failed experiments, the challenge of commercializing science in Canada, and why Kullervo believes the next frontier is a focused ultrasound helmet that patients could one day use at home.</p>]]>
      </content:encoded>
      <pubDate>Thu, 09 Apr 2026 03:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/2725d4f7/a14958ec.mp3" length="26018813" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/qUIT6-VvCL9RgfA__wyHPG1gq2vUhUvVsb77A5fgNkQ/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zMzkz/MWY1YTM5NTIzYjU5/ZWZlNzVmOWIzODk0/ZmJkZC5wbmc.jpg"/>
      <itunes:duration>3253</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Based in Toronto, Ontario, Dr. Kullervo Hynynen is Vice President of Research and Innovation at Sunnybrook Health Sciences Centre and a global leader in focused ultrasound technology. His decades of work have helped transform how the medical community approaches treatment for some of the most challenging neurological and oncological conditions.</p><p>In this episode, host Jim Wilson speaks with Dr. Hynynen about a remarkable journey that began on a small farm in rural Finland and led to one of the most significant breakthroughs in modern neuroscience. What started as a rejected NIH grant proposal became the foundation for a technology that can now open the blood-brain barrier non-invasively, potentially unlocking treatment for conditions like Alzheimer's and brain cancer.</p><p>Kullervo also reflects on the personal losses that shaped his commitment to cancer research, and how a series of serendipitous career decisions, from Aberdeen to Arizona to Boston to Toronto, brought him to Sunnybrook.</p><p>This conversation covers the stubbornness required to push through years of failed experiments, the challenge of commercializing science in Canada, and why Kullervo believes the next frontier is a focused ultrasound helmet that patients could one day use at home.</p>]]>
      </itunes:summary>
      <itunes:keywords>Ultrasound, Blood-Brain Barrier, Medical Innovation, Healthcare Technology, Brain Treatment, Cancer Therapy, Medical Devices, Biomedical Physics, Startup Innovation, Canadian Healthcare. life sciences, health sciences, medtech, healthcare, innovators</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBiLab S3.E7: Cove Neurosciences</title>
      <itunes:title>NGBiLab S3.E7: Cove Neurosciences</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">bcccc789-c327-490a-9a35-316f859a2ba7</guid>
      <link>https://ngbideas.transistor.fm/ngbilab-cove-neuro</link>
      <description>
        <![CDATA[<p>Based in Toronto, Ontario, Cove Neurosciences is a precision neuroscience company focused on translating complex brain data into meaningful insights. Their analytics software helps researchers and pharmaceutical companies better understand human brain function without requiring specialized data science expertise.</p><p>In this episode, host Jim Wilson speaks with co-founder and CEO Dr. Nardin Samuel about the company's unexpected beginnings inside a University of Toronto research lab. What started as a grant application to solve a data analysis problem became the foundation for a commercial software platform now targeting pharmaceutical companies and EEG device manufacturers.</p><p>Nardin also opens up about the unique challenge of balancing life as a practicing neurology resident with running a startup, and how the team grew early on through university internship programs.</p><p>This conversation covers the realities of the entrepreneurial rollercoaster, the mentorship that shaped Cove's early growth, and why Nardin believes that filtering signal from noise in brain data and in business is the key to staying focused on what matters most.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Based in Toronto, Ontario, Cove Neurosciences is a precision neuroscience company focused on translating complex brain data into meaningful insights. Their analytics software helps researchers and pharmaceutical companies better understand human brain function without requiring specialized data science expertise.</p><p>In this episode, host Jim Wilson speaks with co-founder and CEO Dr. Nardin Samuel about the company's unexpected beginnings inside a University of Toronto research lab. What started as a grant application to solve a data analysis problem became the foundation for a commercial software platform now targeting pharmaceutical companies and EEG device manufacturers.</p><p>Nardin also opens up about the unique challenge of balancing life as a practicing neurology resident with running a startup, and how the team grew early on through university internship programs.</p><p>This conversation covers the realities of the entrepreneurial rollercoaster, the mentorship that shaped Cove's early growth, and why Nardin believes that filtering signal from noise in brain data and in business is the key to staying focused on what matters most.</p>]]>
      </content:encoded>
      <pubDate>Tue, 07 Apr 2026 04:30:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/e0f45a77/6c91d966.mp3" length="11367880" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/b4QOQioOvCt9RANym1_fdBwX0WBpjJGovEUk3uRLEXI/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mMTMz/ZGE4MzVjYzg0OGFi/Nzk1MTE2ODIwMWRh/NjdmYi5wbmc.jpg"/>
      <itunes:duration>1421</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Based in Toronto, Ontario, Cove Neurosciences is a precision neuroscience company focused on translating complex brain data into meaningful insights. Their analytics software helps researchers and pharmaceutical companies better understand human brain function without requiring specialized data science expertise.</p><p>In this episode, host Jim Wilson speaks with co-founder and CEO Dr. Nardin Samuel about the company's unexpected beginnings inside a University of Toronto research lab. What started as a grant application to solve a data analysis problem became the foundation for a commercial software platform now targeting pharmaceutical companies and EEG device manufacturers.</p><p>Nardin also opens up about the unique challenge of balancing life as a practicing neurology resident with running a startup, and how the team grew early on through university internship programs.</p><p>This conversation covers the realities of the entrepreneurial rollercoaster, the mentorship that shaped Cove's early growth, and why Nardin believes that filtering signal from noise in brain data and in business is the key to staying focused on what matters most.</p>]]>
      </itunes:summary>
      <itunes:keywords>HealthTech, MedTech, AI in Medicine, Health Innovation, Startup Journey, Toronto Tech, Patient Access, Jim Wilson, NGBILab, Life Sciences, Life Sciences Community, Next Great Big Ideas, Startups, Innovators, Canadian Business, Neuroscience, Data Analysis, Startup, Innovation, Medical Technology, Entrepreneurship, Brain Research, Pharma, EEG, Toronto</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBiPlus S2.E2: Innovation Factory</title>
      <itunes:title>NGBiPlus S2.E2: Innovation Factory</itunes:title>
      <itunes:episodeType>bonus</itunes:episodeType>
      <guid isPermaLink="false">5d08c5cb-4119-4ff9-a179-246639ff49f2</guid>
      <link>https://ngbideas.transistor.fm/ngbiplus-innovation-factory</link>
      <description>
        <![CDATA[<p>Based in Hamilton, Ontario, Innovation Factory is one of 17 Regional Innovation Centres across Ontario, providing free advisory services, training, and mentorship to entrepreneurs at every stage - from idea to scale-up. With a particular strength in life sciences, roughly 35% of the 850+ companies Innovation Factory supports each year come from that sector, drawn in part by Hamilton's exceptional ecosystem of hospitals, universities, and research institutions.</p><p>In this episode, host Jim Wilson speaks with Shannon Graszat, Manager of Venture Growth at Innovation Factory, about how the organization helps founders turn ideas into products, access hospital and university networks, and tap into funding programs - all at no cost. Shannon discusses the Synapse Life Sciences Consortium, which brings together key institutional partners to support life sciences companies not just locally, but from across the province and country.</p><p>This conversation highlights why Hamilton has emerged as a hub for life sciences innovation in Canada, and how entrepreneurs anywhere in Ontario can access Innovation Factory's growing suite of resources - remotely or in person.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Based in Hamilton, Ontario, Innovation Factory is one of 17 Regional Innovation Centres across Ontario, providing free advisory services, training, and mentorship to entrepreneurs at every stage - from idea to scale-up. With a particular strength in life sciences, roughly 35% of the 850+ companies Innovation Factory supports each year come from that sector, drawn in part by Hamilton's exceptional ecosystem of hospitals, universities, and research institutions.</p><p>In this episode, host Jim Wilson speaks with Shannon Graszat, Manager of Venture Growth at Innovation Factory, about how the organization helps founders turn ideas into products, access hospital and university networks, and tap into funding programs - all at no cost. Shannon discusses the Synapse Life Sciences Consortium, which brings together key institutional partners to support life sciences companies not just locally, but from across the province and country.</p><p>This conversation highlights why Hamilton has emerged as a hub for life sciences innovation in Canada, and how entrepreneurs anywhere in Ontario can access Innovation Factory's growing suite of resources - remotely or in person.</p>]]>
      </content:encoded>
      <pubDate>Thu, 02 Apr 2026 03:30:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/32d960a3/4a7b3967.mp3" length="8057644" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/1xZyW-qH4oxkG0eX5u16lG7hyhl1LN1_OWvnt27Ii3w/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yZGJi/N2U5NzRmYTRmNDMx/ZDdkNmM5ODdiYTdm/ZTA3ZC5wbmc.jpg"/>
      <itunes:duration>1008</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Based in Hamilton, Ontario, Innovation Factory is one of 17 Regional Innovation Centres across Ontario, providing free advisory services, training, and mentorship to entrepreneurs at every stage - from idea to scale-up. With a particular strength in life sciences, roughly 35% of the 850+ companies Innovation Factory supports each year come from that sector, drawn in part by Hamilton's exceptional ecosystem of hospitals, universities, and research institutions.</p><p>In this episode, host Jim Wilson speaks with Shannon Graszat, Manager of Venture Growth at Innovation Factory, about how the organization helps founders turn ideas into products, access hospital and university networks, and tap into funding programs - all at no cost. Shannon discusses the Synapse Life Sciences Consortium, which brings together key institutional partners to support life sciences companies not just locally, but from across the province and country.</p><p>This conversation highlights why Hamilton has emerged as a hub for life sciences innovation in Canada, and how entrepreneurs anywhere in Ontario can access Innovation Factory's growing suite of resources - remotely or in person.</p>]]>
      </itunes:summary>
      <itunes:keywords>Life Sciences, canadian, innovators, ceos, startups, lab occupier, jim wilson, health, canada, health sciences, entrepreneurship, life sciences summit, innovation, innovation factory </itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBiLab S3.E6: Skinopathy</title>
      <itunes:title>NGBiLab S3.E6: Skinopathy</itunes:title>
      <itunes:episodeType>bonus</itunes:episodeType>
      <guid isPermaLink="false">e5e01304-fa7f-4894-9d8f-387001638028</guid>
      <link>https://ngbideas.transistor.fm/ngbilab-skinopathy</link>
      <description>
        <![CDATA[<p>Based in Toronto, Ontario, Skinopathy is a medical technology company on a mission to provide accessible healthcare on demand. By integrating advanced AI with smartphone technology, Skinopathy allows patients to screen for skin cancer and other conditions from home, bridging the gap between early detection and specialized medical intervention.</p><p>In this episode, host Jim Wilson speaks with co-founder and CEO Keith Loo about the company’s "accidental" beginnings during the COVID-19 pandemic. What started as a conversation between friends about the alarming rise in late-stage skin cancer became a life-saving tool now used globally. Keith discusses the technical challenge of building AI that works on all skin tones, navigating Canadian healthcare bureaucracy, and the emotional weight of building a company that helps patients "cancel their funerals."</p><p>This conversation explores the intersection of high-tech innovation and human-centric care, highlighting how a tool meant to be given away for free evolved into a clinically validated platform that outperforms traditional diagnostic standards.</p>Note: We unfortunately ran into some technology issues with our microphone and apologize for Jim's mic quality. We have added a transcript to this podcast to make Jim's side accessible.]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Based in Toronto, Ontario, Skinopathy is a medical technology company on a mission to provide accessible healthcare on demand. By integrating advanced AI with smartphone technology, Skinopathy allows patients to screen for skin cancer and other conditions from home, bridging the gap between early detection and specialized medical intervention.</p><p>In this episode, host Jim Wilson speaks with co-founder and CEO Keith Loo about the company’s "accidental" beginnings during the COVID-19 pandemic. What started as a conversation between friends about the alarming rise in late-stage skin cancer became a life-saving tool now used globally. Keith discusses the technical challenge of building AI that works on all skin tones, navigating Canadian healthcare bureaucracy, and the emotional weight of building a company that helps patients "cancel their funerals."</p><p>This conversation explores the intersection of high-tech innovation and human-centric care, highlighting how a tool meant to be given away for free evolved into a clinically validated platform that outperforms traditional diagnostic standards.</p>Note: We unfortunately ran into some technology issues with our microphone and apologize for Jim's mic quality. We have added a transcript to this podcast to make Jim's side accessible.]]>
      </content:encoded>
      <pubDate>Tue, 31 Mar 2026 03:30:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/7accc402/6c30033b.mp3" length="16384227" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/ipsqOdsvjOGcuk4fH-XWg5E7eBPOQsdQVfee9EPDz-Q/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yNWM4/OWI5NTAyNzIwNjQy/YjY3NzMzYWZhMjY0/MDYyOS5wbmc.jpg"/>
      <itunes:duration>2048</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Based in Toronto, Ontario, Skinopathy is a medical technology company on a mission to provide accessible healthcare on demand. By integrating advanced AI with smartphone technology, Skinopathy allows patients to screen for skin cancer and other conditions from home, bridging the gap between early detection and specialized medical intervention.</p><p>In this episode, host Jim Wilson speaks with co-founder and CEO Keith Loo about the company’s "accidental" beginnings during the COVID-19 pandemic. What started as a conversation between friends about the alarming rise in late-stage skin cancer became a life-saving tool now used globally. Keith discusses the technical challenge of building AI that works on all skin tones, navigating Canadian healthcare bureaucracy, and the emotional weight of building a company that helps patients "cancel their funerals."</p><p>This conversation explores the intersection of high-tech innovation and human-centric care, highlighting how a tool meant to be given away for free evolved into a clinically validated platform that outperforms traditional diagnostic standards.</p>Note: We unfortunately ran into some technology issues with our microphone and apologize for Jim's mic quality. We have added a transcript to this podcast to make Jim's side accessible.]]>
      </itunes:summary>
      <itunes:keywords>HealthTech, Skin Cancer Screening, Artificial Intelligence, Skinopathy, GetSkinHelp, Digital Health, Dermatology, Canadian Healthcare, MedTech, AI in Medicine, Health Innovation, Startup Journey, Toronto Tech, Health Canada, Burn Assessment, Patient Access, Reconstructive Surgery, Keith Loo, Jim Wilson, NGBILab, Life Sciences, Life Sciences Community, Next Great Big Ideas, Startups, Innovators, Canadian Business</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
      <podcast:transcript url="https://share.transistor.fm/s/7accc402/transcript.txt" type="text/plain"/>
    </item>
    <item>
      <title>NGBiLab S3.E5: Xpan Medical</title>
      <itunes:title>NGBiLab S3.E5: Xpan Medical</itunes:title>
      <itunes:episodeType>bonus</itunes:episodeType>
      <guid isPermaLink="false">bb60656c-f2b2-4136-85b1-a84ee9f7c995</guid>
      <link>https://ngbideas.transistor.fm/ngbilab-xpan</link>
      <description>
        <![CDATA[<p>Join host Jim Wilson for a conversation with Zaid Atto, founder and CEO of Xpan in Vaughan, Ontario.</p><p>Xpan is a medical device company focused on minimally invasive surgery, developing a new approach to surgical trocars used in laparoscopic procedures - tools that haven’t changed much in decades, despite being used in millions of procedures every year.</p><p>Zaid shares how the idea started while he was studying biomedical engineering at the University of Toronto, after hearing firsthand from surgeons frustrated with the limitations of existing devices. He walks through the journey from a university capstone project to building a company, and why he chose to move beyond research and into entrepreneurship to bring real solutions to patients.</p><p>This episode offers a grounded look at what it takes to turn a real clinical problem into a viable medical device.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Join host Jim Wilson for a conversation with Zaid Atto, founder and CEO of Xpan in Vaughan, Ontario.</p><p>Xpan is a medical device company focused on minimally invasive surgery, developing a new approach to surgical trocars used in laparoscopic procedures - tools that haven’t changed much in decades, despite being used in millions of procedures every year.</p><p>Zaid shares how the idea started while he was studying biomedical engineering at the University of Toronto, after hearing firsthand from surgeons frustrated with the limitations of existing devices. He walks through the journey from a university capstone project to building a company, and why he chose to move beyond research and into entrepreneurship to bring real solutions to patients.</p><p>This episode offers a grounded look at what it takes to turn a real clinical problem into a viable medical device.</p>]]>
      </content:encoded>
      <pubDate>Fri, 27 Mar 2026 03:30:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/594895d3/c077869c.mp3" length="20779276" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/T6YtGRHZ0Kon72NCWZVcvl9OaIVfeO3Qw73RjwbpgnQ/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yYjMx/YzkzMmQ5ZDg0Njdj/ODVkYTI3ODdmYzZh/YmI1ZS5wbmc.jpg"/>
      <itunes:duration>2598</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Join host Jim Wilson for a conversation with Zaid Atto, founder and CEO of Xpan in Vaughan, Ontario.</p><p>Xpan is a medical device company focused on minimally invasive surgery, developing a new approach to surgical trocars used in laparoscopic procedures - tools that haven’t changed much in decades, despite being used in millions of procedures every year.</p><p>Zaid shares how the idea started while he was studying biomedical engineering at the University of Toronto, after hearing firsthand from surgeons frustrated with the limitations of existing devices. He walks through the journey from a university capstone project to building a company, and why he chose to move beyond research and into entrepreneurship to bring real solutions to patients.</p><p>This episode offers a grounded look at what it takes to turn a real clinical problem into a viable medical device.</p>]]>
      </itunes:summary>
      <itunes:keywords>Life Sciences, canadian, innovators, ceos, startups, lab occupier, jim wilson, health, canada, health sciences, entrepreneurship, life sciences summit, xpan medical, medical devices, medtech, medical devices, trocar, surgery, business, biomedical engineering</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBideas S4.E2 - NMX Research and Solutions</title>
      <itunes:season>4</itunes:season>
      <podcast:season>4</podcast:season>
      <itunes:episode>2</itunes:episode>
      <podcast:episode>2</podcast:episode>
      <itunes:title>NGBideas S4.E2 - NMX Research and Solutions</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">648c44a5-cbd9-4c53-851d-2f7b868b8ca0</guid>
      <link>https://ngbideas.transistor.fm/nmx-research</link>
      <description>
        <![CDATA[<p>Based in Laval, Quebec, NMX Research and Solutions is a specialized biopharma firm helping scientists find new medicines faster. By using tools like NMR spectroscopy and Fragment-Based Lead Discovery, NMX bridges the gap between lab research and real-world cures while mentoring the next generation of Canadian biotech leaders.</p><p>In this episode, host Jim Wilson sits down with founder Steven LaPlante to trace his journey from a dairy farm in upstate New York to the front lines of drug discovery. Steven discusses the "shoveling manure" work ethic that fueled his move into science, his childhood spent building farm tools with a welder and torch, and why he eventually moved to Montreal to care for his family.</p><p>This conversation explores the role of curiosity in innovation, the shift from big pharma "four walls" to the fast-paced world of startups, and how a background in biophysics became the foundation for a revolution in medicine. From Hepatitis C to COVID-19 research, Steven explains why "building your own tools" is the secret to solving the world's biggest health challenges.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Based in Laval, Quebec, NMX Research and Solutions is a specialized biopharma firm helping scientists find new medicines faster. By using tools like NMR spectroscopy and Fragment-Based Lead Discovery, NMX bridges the gap between lab research and real-world cures while mentoring the next generation of Canadian biotech leaders.</p><p>In this episode, host Jim Wilson sits down with founder Steven LaPlante to trace his journey from a dairy farm in upstate New York to the front lines of drug discovery. Steven discusses the "shoveling manure" work ethic that fueled his move into science, his childhood spent building farm tools with a welder and torch, and why he eventually moved to Montreal to care for his family.</p><p>This conversation explores the role of curiosity in innovation, the shift from big pharma "four walls" to the fast-paced world of startups, and how a background in biophysics became the foundation for a revolution in medicine. From Hepatitis C to COVID-19 research, Steven explains why "building your own tools" is the secret to solving the world's biggest health challenges.</p>]]>
      </content:encoded>
      <pubDate>Tue, 24 Mar 2026 03:30:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/1ff159e7/69bf4632.mp3" length="35211470" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/Z6dgIR4Vdzeynfj2VsKVUyba1BJrSIbowhiteXPRCc0/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83MWFk/NDhjNTFiOTAzMTcz/NDBkZjg1ZGQ1OTM2/MzlmYi5wbmc.jpg"/>
      <itunes:duration>4395</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Based in Laval, Quebec, NMX Research and Solutions is a specialized biopharma firm helping scientists find new medicines faster. By using tools like NMR spectroscopy and Fragment-Based Lead Discovery, NMX bridges the gap between lab research and real-world cures while mentoring the next generation of Canadian biotech leaders.</p><p>In this episode, host Jim Wilson sits down with founder Steven LaPlante to trace his journey from a dairy farm in upstate New York to the front lines of drug discovery. Steven discusses the "shoveling manure" work ethic that fueled his move into science, his childhood spent building farm tools with a welder and torch, and why he eventually moved to Montreal to care for his family.</p><p>This conversation explores the role of curiosity in innovation, the shift from big pharma "four walls" to the fast-paced world of startups, and how a background in biophysics became the foundation for a revolution in medicine. From Hepatitis C to COVID-19 research, Steven explains why "building your own tools" is the secret to solving the world's biggest health challenges.</p>]]>
      </itunes:summary>
      <itunes:keywords>drug discovery, biotech, leadership, creativity, Montreal, entrepreneurship, biophysics, NMR spectroscopy, COVID-19 research, biotech innovation, life sciences, health sciences, jim wilson, life sciences summit, innovators, Canadian business, startups, medicine, biopharma</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBideas S4: Replay - Matthew Miller</title>
      <itunes:title>NGBideas S4: Replay - Matthew Miller</itunes:title>
      <itunes:episodeType>bonus</itunes:episodeType>
      <guid isPermaLink="false">94a975dd-7f09-4e21-815c-94dc7d7db5c0</guid>
      <link>https://ngbideas.transistor.fm/episodes/s4-replay-matthew-miller</link>
      <description>
        <![CDATA[<p>Join us for throwback insightful conversation with Matthew Miller, a distinguished scientist and academic leader, as he shares his journey from a small town in Ontario to becoming a key figure in infectious disease research.</p><p>Discover how serendipity and mentorship shaped his career, the challenges of starting a lab, and the impact of the COVID-19 pandemic on his work.</p><p>Matthew also discusses the importance of basic science funding, the role of serendipity in scientific discovery, and his vision for the future of health sciences in Canada. Tune in to explore the next great big idea on the horizon and how it could transform the health and economy of Canadians.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Join us for throwback insightful conversation with Matthew Miller, a distinguished scientist and academic leader, as he shares his journey from a small town in Ontario to becoming a key figure in infectious disease research.</p><p>Discover how serendipity and mentorship shaped his career, the challenges of starting a lab, and the impact of the COVID-19 pandemic on his work.</p><p>Matthew also discusses the importance of basic science funding, the role of serendipity in scientific discovery, and his vision for the future of health sciences in Canada. Tune in to explore the next great big idea on the horizon and how it could transform the health and economy of Canadians.</p>]]>
      </content:encoded>
      <pubDate>Thu, 19 Mar 2026 19:06:01 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/dbe3133c/2293e20a.mp3" length="59479504" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/YQvmikjUKUxOVE4EnoTNnw_usm6bvnY2OaUgIQn-Zdc/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mMDYz/ZWI0YWQ1MmQ2Njll/ODk4ZDUyNjdhYWM4/MTQwYi5wbmc.jpg"/>
      <itunes:duration>3713</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Join us for throwback insightful conversation with Matthew Miller, a distinguished scientist and academic leader, as he shares his journey from a small town in Ontario to becoming a key figure in infectious disease research.</p><p>Discover how serendipity and mentorship shaped his career, the challenges of starting a lab, and the impact of the COVID-19 pandemic on his work.</p><p>Matthew also discusses the importance of basic science funding, the role of serendipity in scientific discovery, and his vision for the future of health sciences in Canada. Tune in to explore the next great big idea on the horizon and how it could transform the health and economy of Canadians.</p>]]>
      </itunes:summary>
      <itunes:keywords>Drug Formulation, AI in Medicine, Life Sciences Innovation, University of Toronto, Christine Allen, Pharmaceutical Development, Academic Leadership, Biotechnology, Startup Journey, Canadian Life Sciences, biotech, medtech, life sciences, jim wilson, academia, fundraising, health sciences</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBideas S4.E1 - Vive Crop Protection</title>
      <itunes:season>4</itunes:season>
      <podcast:season>4</podcast:season>
      <itunes:episode>1</itunes:episode>
      <podcast:episode>1</podcast:episode>
      <itunes:title>NGBideas S4.E1 - Vive Crop Protection</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">328b719c-e1b0-4152-83d4-134061f00fe0</guid>
      <link>https://ngbideas.transistor.fm/ngbideas-vive-crop-protection</link>
      <description>
        <![CDATA[<p>Based in Mississauga, Ontario, <strong>Vive Crop Protection</strong> is a leading agri-tech company dedicated to helping farmers "do more with less." By focusing on development over discovery, Vive combines synthetic chemistry with bio-based pesticides to create high-performance products that lower costs for growers while reducing the environmental footprint of traditional farming.</p><p><br></p><p>In this episode, host <strong>Jim Wilson</strong> sits down with CEO and co-founder <strong>Darren Anderson</strong> to trace his journey from a chemistry-obsessed high schooler in Sarnia to the head of a major Canadian innovation success story. Darren discusses the "accident of history" that led to his birth in West Virginia, his burnout during undergraduate studies at the University of Toronto, and the pivotal influence of his PhD supervisor, Dr. Cynthia Goh, who saw an entrepreneur in him before he saw it in himself.</p><p>This conversation explores the critical role of humility and luck in business, the transition from a "perfect" academic mindset to the fast-paced world of startups, and how a specialized background in chemical physics became the foundation for a sustainable revolution in agriculture.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Based in Mississauga, Ontario, <strong>Vive Crop Protection</strong> is a leading agri-tech company dedicated to helping farmers "do more with less." By focusing on development over discovery, Vive combines synthetic chemistry with bio-based pesticides to create high-performance products that lower costs for growers while reducing the environmental footprint of traditional farming.</p><p><br></p><p>In this episode, host <strong>Jim Wilson</strong> sits down with CEO and co-founder <strong>Darren Anderson</strong> to trace his journey from a chemistry-obsessed high schooler in Sarnia to the head of a major Canadian innovation success story. Darren discusses the "accident of history" that led to his birth in West Virginia, his burnout during undergraduate studies at the University of Toronto, and the pivotal influence of his PhD supervisor, Dr. Cynthia Goh, who saw an entrepreneur in him before he saw it in himself.</p><p>This conversation explores the critical role of humility and luck in business, the transition from a "perfect" academic mindset to the fast-paced world of startups, and how a specialized background in chemical physics became the foundation for a sustainable revolution in agriculture.</p>]]>
      </content:encoded>
      <pubDate>Tue, 17 Mar 2026 03:30:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/a3ef765f/ce899a12.mp3" length="39917475" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/kKYKZpj4pvY90nGX8pe1l4cRhroqzMfFZIF_rh2D95E/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kZmNh/MjhjNmFkYzMxYTZm/YzY5NzgxOGY5Zjlh/MTc4Ni5wbmc.jpg"/>
      <itunes:duration>4983</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Based in Mississauga, Ontario, <strong>Vive Crop Protection</strong> is a leading agri-tech company dedicated to helping farmers "do more with less." By focusing on development over discovery, Vive combines synthetic chemistry with bio-based pesticides to create high-performance products that lower costs for growers while reducing the environmental footprint of traditional farming.</p><p><br></p><p>In this episode, host <strong>Jim Wilson</strong> sits down with CEO and co-founder <strong>Darren Anderson</strong> to trace his journey from a chemistry-obsessed high schooler in Sarnia to the head of a major Canadian innovation success story. Darren discusses the "accident of history" that led to his birth in West Virginia, his burnout during undergraduate studies at the University of Toronto, and the pivotal influence of his PhD supervisor, Dr. Cynthia Goh, who saw an entrepreneur in him before he saw it in himself.</p><p>This conversation explores the critical role of humility and luck in business, the transition from a "perfect" academic mindset to the fast-paced world of startups, and how a specialized background in chemical physics became the foundation for a sustainable revolution in agriculture.</p>]]>
      </itunes:summary>
      <itunes:keywords>AgriTech, Sustainable Agriculture, Vive Crop Protection, Industrial Chemistry, Chemical Physics, Crop Protection, Bio-based Pesticides, University of Toronto, Toronto, Mississauga, PhD to CEO, Entrepreneurship, Canadian Startups, Innovation, Green Tech, Scaling a Startup, Venture Capital, Science Business, NGBI Ideas, Jim Wilson, Lab Occupier, Life Sciences Summit</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBiLab S3.E4: AxCell Labs</title>
      <itunes:title>NGBiLab S3.E4: AxCell Labs</itunes:title>
      <itunes:episodeType>bonus</itunes:episodeType>
      <guid isPermaLink="false">8483a5cc-3426-4bdd-9a40-f8dbd8188159</guid>
      <link>https://ngbideas.transistor.fm/ngbilab-axcell-labs</link>
      <description>
        <![CDATA[<p>Based in Sherbrooke, Quebec, <strong>AxCell Labs</strong> is a biotech engineering startup developing a new generation of biomaterials designed to help the body heal itself.<br> <br>Their core innovation is a specialized <strong>scaffold made from bacterial cellulose</strong>—originally derived from a local kombucha culture—that provides a physical structure for human cells to colonize and regenerate soft tissue lost to trauma, surgery, or cancer.</p><p>In this episode, host <strong>Jim Wilson</strong> sits down with CEO <strong>Jérémie Chaussé</strong> to share the "accidental" origin story of the company, which began when two university students went door-to-door hunting for kombucha scoby to start their first lab culture.</p><p>Jérémie discusses the grit required to navigate a three-year master’s degree while acting as his own tax accountant, the critical technical pivot they made after a failed animal trial, and how their "scaffold" technology provides a new benchmark for reconstructive surgery.</p><p>This conversation offers a candid look at the reality of student entrepreneurship, the importance of securing intellectual property early, and how a bit of "kombucha luck" turned into a high-stakes medical mission.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Based in Sherbrooke, Quebec, <strong>AxCell Labs</strong> is a biotech engineering startup developing a new generation of biomaterials designed to help the body heal itself.<br> <br>Their core innovation is a specialized <strong>scaffold made from bacterial cellulose</strong>—originally derived from a local kombucha culture—that provides a physical structure for human cells to colonize and regenerate soft tissue lost to trauma, surgery, or cancer.</p><p>In this episode, host <strong>Jim Wilson</strong> sits down with CEO <strong>Jérémie Chaussé</strong> to share the "accidental" origin story of the company, which began when two university students went door-to-door hunting for kombucha scoby to start their first lab culture.</p><p>Jérémie discusses the grit required to navigate a three-year master’s degree while acting as his own tax accountant, the critical technical pivot they made after a failed animal trial, and how their "scaffold" technology provides a new benchmark for reconstructive surgery.</p><p>This conversation offers a candid look at the reality of student entrepreneurship, the importance of securing intellectual property early, and how a bit of "kombucha luck" turned into a high-stakes medical mission.</p>]]>
      </content:encoded>
      <pubDate>Thu, 12 Mar 2026 03:30:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/0259f89e/bc1619f0.mp3" length="14297565" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/GwWUNDihNz0P5wp1kPW3yggK5jlykg8YXEvWkUtcIeE/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kNzBh/MmZiNzE2NjI2ODU0/OWYzNGIxMWIxZGZj/MjlkZi5wbmc.jpg"/>
      <itunes:duration>1788</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Based in Sherbrooke, Quebec, <strong>AxCell Labs</strong> is a biotech engineering startup developing a new generation of biomaterials designed to help the body heal itself.<br> <br>Their core innovation is a specialized <strong>scaffold made from bacterial cellulose</strong>—originally derived from a local kombucha culture—that provides a physical structure for human cells to colonize and regenerate soft tissue lost to trauma, surgery, or cancer.</p><p>In this episode, host <strong>Jim Wilson</strong> sits down with CEO <strong>Jérémie Chaussé</strong> to share the "accidental" origin story of the company, which began when two university students went door-to-door hunting for kombucha scoby to start their first lab culture.</p><p>Jérémie discusses the grit required to navigate a three-year master’s degree while acting as his own tax accountant, the critical technical pivot they made after a failed animal trial, and how their "scaffold" technology provides a new benchmark for reconstructive surgery.</p><p>This conversation offers a candid look at the reality of student entrepreneurship, the importance of securing intellectual property early, and how a bit of "kombucha luck" turned into a high-stakes medical mission.</p>]]>
      </itunes:summary>
      <itunes:keywords>life sciences, startups, life sciences summit, AxCell Labs, biotech, reconstructive surgery, science, healthcare, innovation, entrepreneurship, fundraising, jim wilson, biotechnology, medical industry, bacterial cellulose, surgical reconstruction, soft tissue implants, biomaterials</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBiLab S3.E3:  EncephalX</title>
      <itunes:title>NGBiLab S3.E3:  EncephalX</itunes:title>
      <itunes:episodeType>bonus</itunes:episodeType>
      <guid isPermaLink="false">5524f548-2b6f-45e7-b13d-45106cf18721</guid>
      <link>https://ngbideas.transistor.fm/ngbilab-encephalX</link>
      <description>
        <![CDATA[<p>Join host Jim Wilson for a conversation with <strong>Simon LaPointe</strong>, founder and CEO of <strong>EncephalX</strong> in Sherbrooke, Quebec.</p><p>EncephalX is a medical device company focused on helping people recovering from severe head injuries and strokes. Their main invention, the <strong>Dynamic Cranioplasty System</strong>, aims to turn two dangerous brain surgeries into one by creating a special implant that allows the brain to swell and heal safely without having to leave a piece of the skull out.</p><p>Simon shares how a college internship took him out of the classroom and directly into operating rooms, where seeing the reality of brain trauma changed his career path. He talks about the patience it took to study the problem for months before ever building a prototype, the challenge of starting a business during the pandemic, and how a "moving" skull piece can save patients from a second high-risk surgery.</p><p>This episode offers a clear look at how a young engineer is using simple mechanics to solve a massive healthcare problem and get patients home sooner.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Join host Jim Wilson for a conversation with <strong>Simon LaPointe</strong>, founder and CEO of <strong>EncephalX</strong> in Sherbrooke, Quebec.</p><p>EncephalX is a medical device company focused on helping people recovering from severe head injuries and strokes. Their main invention, the <strong>Dynamic Cranioplasty System</strong>, aims to turn two dangerous brain surgeries into one by creating a special implant that allows the brain to swell and heal safely without having to leave a piece of the skull out.</p><p>Simon shares how a college internship took him out of the classroom and directly into operating rooms, where seeing the reality of brain trauma changed his career path. He talks about the patience it took to study the problem for months before ever building a prototype, the challenge of starting a business during the pandemic, and how a "moving" skull piece can save patients from a second high-risk surgery.</p><p>This episode offers a clear look at how a young engineer is using simple mechanics to solve a massive healthcare problem and get patients home sooner.</p>]]>
      </content:encoded>
      <pubDate>Tue, 10 Mar 2026 03:30:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/bf94759b/4ed379db.mp3" length="10512945" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/Y4YLTDP2hV-_5GghFfkQXC_s2eS0eYGBTBMP4TIvxao/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTE3/ZGViZmQ4MWU3MzNk/NTBmODc2ZjkzMjNh/NTI1Mi5wbmc.jpg"/>
      <itunes:duration>1315</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Join host Jim Wilson for a conversation with <strong>Simon LaPointe</strong>, founder and CEO of <strong>EncephalX</strong> in Sherbrooke, Quebec.</p><p>EncephalX is a medical device company focused on helping people recovering from severe head injuries and strokes. Their main invention, the <strong>Dynamic Cranioplasty System</strong>, aims to turn two dangerous brain surgeries into one by creating a special implant that allows the brain to swell and heal safely without having to leave a piece of the skull out.</p><p>Simon shares how a college internship took him out of the classroom and directly into operating rooms, where seeing the reality of brain trauma changed his career path. He talks about the patience it took to study the problem for months before ever building a prototype, the challenge of starting a business during the pandemic, and how a "moving" skull piece can save patients from a second high-risk surgery.</p><p>This episode offers a clear look at how a young engineer is using simple mechanics to solve a massive healthcare problem and get patients home sooner.</p>]]>
      </itunes:summary>
      <itunes:keywords>life sciences, startups, life sciences summit, encephalX, medtech, brain surgery, science, healthcare, innovation, entrepreneurship, fundraising, jim wilson, life sciences summit, cranioplasty, brain trauma, mechanics, engineering</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBiPlus S2.E1: Cortex Design</title>
      <itunes:title>NGBiPlus S2.E1: Cortex Design</itunes:title>
      <itunes:episodeType>bonus</itunes:episodeType>
      <guid isPermaLink="false">4fd5849a-bf76-4271-a77f-bcdb0a619778</guid>
      <link>https://ngbideas.transistor.fm/ngbiplus-cortex-design</link>
      <description>
        <![CDATA[<p>Join host Jim Wilson for a conversation with Dylan Horvath, founder and principal of Cortex Design in Toronto, Ontario. </p><p>Cortex helps MedTech teams take medical devices from early concept through to commercialization, with a focus on designing for real users and the full set of stakeholders who influence adoption. </p><p>Dylan shares how a childhood obsession with robotics led him into systems design engineering, then into industrial design, and ultimately into building Cortex into a specialized MedTech practice. They talk about the high-stakes Qualcomm Tricorder XPRIZE experience, what it taught the team about focus and execution, and why usability, workflow, and practical realities like cleaning and procurement can determine whether a device succeeds in the market. </p><p>This episode offers a clear look at what it takes to turn complex ideas into viable, commercial medical products. </p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Join host Jim Wilson for a conversation with Dylan Horvath, founder and principal of Cortex Design in Toronto, Ontario. </p><p>Cortex helps MedTech teams take medical devices from early concept through to commercialization, with a focus on designing for real users and the full set of stakeholders who influence adoption. </p><p>Dylan shares how a childhood obsession with robotics led him into systems design engineering, then into industrial design, and ultimately into building Cortex into a specialized MedTech practice. They talk about the high-stakes Qualcomm Tricorder XPRIZE experience, what it taught the team about focus and execution, and why usability, workflow, and practical realities like cleaning and procurement can determine whether a device succeeds in the market. </p><p>This episode offers a clear look at what it takes to turn complex ideas into viable, commercial medical products. </p>]]>
      </content:encoded>
      <pubDate>Thu, 05 Mar 2026 15:43:17 -0500</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/28e5fbea/625dfeba.mp3" length="21224194" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/5_a21pn-1ggi4vmOQ-MBIMwiDZ76aFMVhU_5GSP-ROs/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTRk/MDk2Njk5NTVmN2Vi/MWRiMDJiYmRiNDA2/NmQxNi5qcGVn.jpg"/>
      <itunes:duration>2653</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Join host Jim Wilson for a conversation with Dylan Horvath, founder and principal of Cortex Design in Toronto, Ontario. </p><p>Cortex helps MedTech teams take medical devices from early concept through to commercialization, with a focus on designing for real users and the full set of stakeholders who influence adoption. </p><p>Dylan shares how a childhood obsession with robotics led him into systems design engineering, then into industrial design, and ultimately into building Cortex into a specialized MedTech practice. They talk about the high-stakes Qualcomm Tricorder XPRIZE experience, what it taught the team about focus and execution, and why usability, workflow, and practical realities like cleaning and procurement can determine whether a device succeeds in the market. </p><p>This episode offers a clear look at what it takes to turn complex ideas into viable, commercial medical products. </p>]]>
      </itunes:summary>
      <itunes:keywords>Life Sciences, canadian, innovators, ceos, startups, lab occupier, jim wilson, health, canada, health sciences, entrepreneurship, life sciences summit, cortex design, medical devices, industrial design, medtech, robotics, medical devices</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBiLab S3.E2: Revive Wellness</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:episode>2</itunes:episode>
      <podcast:episode>2</podcast:episode>
      <itunes:title>NGBiLab S3.E2: Revive Wellness</itunes:title>
      <itunes:episodeType>bonus</itunes:episodeType>
      <guid isPermaLink="false">8422a17b-6442-44ef-9526-ebf8f46ba93d</guid>
      <link>https://ngbilab.transistor.fm/episodes/s3-e2-revive-wellness</link>
      <description>
        <![CDATA[<p>In this episode of NGBi Lab, host Jim Wilson welcomes <strong>Loreen Wales</strong>, the Founder and CEO of <strong>Revive Wellness</strong> and <strong>My Viva</strong>.</p><p>Discover the harrowing origin story that fueled Loreen's mission: a near-fatal accident at age 19 that left her with a miracle survival and a relentless drive to transform how we deliver patient care.</p><p>From her early days as a dietitian in Edmonton to realizing that the healthcare system lacked a personalized, scalable plan for patients, Loreen discusses her 18-year journey of building a holistic digital health platform.</p><p>From the grit required to transition from a "bricks and mortar" clinic to a global technology company, to the reality of a "10-year overnight success," this conversation dives into the conviction and risk required to innovate in the health sciences sector.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of NGBi Lab, host Jim Wilson welcomes <strong>Loreen Wales</strong>, the Founder and CEO of <strong>Revive Wellness</strong> and <strong>My Viva</strong>.</p><p>Discover the harrowing origin story that fueled Loreen's mission: a near-fatal accident at age 19 that left her with a miracle survival and a relentless drive to transform how we deliver patient care.</p><p>From her early days as a dietitian in Edmonton to realizing that the healthcare system lacked a personalized, scalable plan for patients, Loreen discusses her 18-year journey of building a holistic digital health platform.</p><p>From the grit required to transition from a "bricks and mortar" clinic to a global technology company, to the reality of a "10-year overnight success," this conversation dives into the conviction and risk required to innovate in the health sciences sector.</p>]]>
      </content:encoded>
      <pubDate>Tue, 03 Mar 2026 03:00:00 -0500</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/42c36661/1b0a9a5f.mp3" length="16502892" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/ZJ_3QkUNj49q9odiu75cpOmphsc1LpraJskIIO52dWk/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83ODYz/NzIzNTU1ZGU3MTZl/MGJmNGJlOTAzNzEw/Y2I3My5wbmc.jpg"/>
      <itunes:duration>2055</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of NGBi Lab, host Jim Wilson welcomes <strong>Loreen Wales</strong>, the Founder and CEO of <strong>Revive Wellness</strong> and <strong>My Viva</strong>.</p><p>Discover the harrowing origin story that fueled Loreen's mission: a near-fatal accident at age 19 that left her with a miracle survival and a relentless drive to transform how we deliver patient care.</p><p>From her early days as a dietitian in Edmonton to realizing that the healthcare system lacked a personalized, scalable plan for patients, Loreen discusses her 18-year journey of building a holistic digital health platform.</p><p>From the grit required to transition from a "bricks and mortar" clinic to a global technology company, to the reality of a "10-year overnight success," this conversation dives into the conviction and risk required to innovate in the health sciences sector.</p>]]>
      </itunes:summary>
      <itunes:keywords>Life sciences, wellness, registered dieticians, canadian, innovators, ceos, startups, lab occupier, jim wilson, health, canada, nutrition, health program, lifestyle medicine, chronic disease, physicians, health sciences, entrepreneurship, life sciences summit</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBiLab S3.E1: Canurta Therapeutics</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:episode>1</itunes:episode>
      <podcast:episode>1</podcast:episode>
      <itunes:title>NGBiLab S3.E1: Canurta Therapeutics</itunes:title>
      <itunes:episodeType>bonus</itunes:episodeType>
      <guid isPermaLink="false">14ba2937-a028-4262-b928-fdfa2ed1ae67</guid>
      <link>https://ngbilab.transistor.fm/episodes/s3-e1-canurta</link>
      <description>
        <![CDATA[<p>In this episode of NGBi Lab, host Jim Wilson welcomes Akeem Gardner, CEO and Founder of Canurta Therapeutics. Discover how Akeem transitioned from law school and farming into the biotech space to build a company developing botanical drug candidates for neurodegenerative diseases, with a lead program targeting ALS.</p><p>From his unconventional entrepreneurial journey and the shift from ingredient supplier to full biotechnology company, to the stark financial realities of funding clinical trials, this conversation dives deep into the conviction and risk required to innovate in the life sciences sector.</p><p>Tune in to learn about his vision for Canurta Therapeutics and what it really takes to run a startup. </p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of NGBi Lab, host Jim Wilson welcomes Akeem Gardner, CEO and Founder of Canurta Therapeutics. Discover how Akeem transitioned from law school and farming into the biotech space to build a company developing botanical drug candidates for neurodegenerative diseases, with a lead program targeting ALS.</p><p>From his unconventional entrepreneurial journey and the shift from ingredient supplier to full biotechnology company, to the stark financial realities of funding clinical trials, this conversation dives deep into the conviction and risk required to innovate in the life sciences sector.</p><p>Tune in to learn about his vision for Canurta Therapeutics and what it really takes to run a startup. </p>]]>
      </content:encoded>
      <pubDate>Tue, 24 Feb 2026 10:52:12 -0500</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/f5161d91/786eb18c.mp3" length="14999716" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/j_qT4JlskAxB3we7lXW82_9djFeA_QIVJhchQwamkAc/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zZWI1/YTJkZWVlZTgxNDY3/MWVmMGE1NDUzYjNk/Mzk0OS5wbmc.jpg"/>
      <itunes:duration>1868</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of NGBi Lab, host Jim Wilson welcomes Akeem Gardner, CEO and Founder of Canurta Therapeutics. Discover how Akeem transitioned from law school and farming into the biotech space to build a company developing botanical drug candidates for neurodegenerative diseases, with a lead program targeting ALS.</p><p>From his unconventional entrepreneurial journey and the shift from ingredient supplier to full biotechnology company, to the stark financial realities of funding clinical trials, this conversation dives deep into the conviction and risk required to innovate in the life sciences sector.</p><p>Tune in to learn about his vision for Canurta Therapeutics and what it really takes to run a startup. </p>]]>
      </itunes:summary>
      <itunes:keywords>life sciences, startups, life sciences summit, canurta therapeutics, botanical therapies, ALS, inflammatory diseases, disease research, science, healthcare, innovation, entrepreneurship, fundraising, jim wilson</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBiPlus S1.E2: mcCallumSather</title>
      <itunes:title>NGBiPlus S1.E2: mcCallumSather</itunes:title>
      <itunes:episodeType>bonus</itunes:episodeType>
      <guid isPermaLink="false">1c7b0b15-7619-42cd-ad9b-0a6230df2d37</guid>
      <link>https://ngbideas.transistor.fm/ngbiplus-s1-e2-mccallumsather</link>
      <description>
        <![CDATA[<p>In this episode, host Jim Wilson sits down with the team at McCallum-Sather Architects to explore their forward-thinking approach to sustainable, integrated design in the life sciences sector. Mary Georgious and Liam Brown share how their architectural and mechanical engineering expertise come together to shape high-performance lab environments. They discuss the importance of collaboration, adaptability, and user-centered planning—especially when transforming aging facilities into modern research spaces. Their work on the University of Waterloo’s Earth Sciences and Chemistry complex offers a compelling look at the opportunities and challenges of renovating existing buildings to meet today’s scientific and environmental standards. </p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode, host Jim Wilson sits down with the team at McCallum-Sather Architects to explore their forward-thinking approach to sustainable, integrated design in the life sciences sector. Mary Georgious and Liam Brown share how their architectural and mechanical engineering expertise come together to shape high-performance lab environments. They discuss the importance of collaboration, adaptability, and user-centered planning—especially when transforming aging facilities into modern research spaces. Their work on the University of Waterloo’s Earth Sciences and Chemistry complex offers a compelling look at the opportunities and challenges of renovating existing buildings to meet today’s scientific and environmental standards. </p>]]>
      </content:encoded>
      <pubDate>Tue, 09 Dec 2025 16:37:26 -0500</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/0a980862/a74ec389.mp3" length="31045215" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/3G2oQWd1xdyv_vK82GXB2SXixF6rT-kgc7MfdvU2BgE/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84MzQw/OWM3ODM3NmQ0YTRk/ZWY1YmUwYTM4ZDBj/NzA2MC5wbmc.jpg"/>
      <itunes:duration>1941</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode, host Jim Wilson sits down with the team at McCallum-Sather Architects to explore their forward-thinking approach to sustainable, integrated design in the life sciences sector. Mary Georgious and Liam Brown share how their architectural and mechanical engineering expertise come together to shape high-performance lab environments. They discuss the importance of collaboration, adaptability, and user-centered planning—especially when transforming aging facilities into modern research spaces. Their work on the University of Waterloo’s Earth Sciences and Chemistry complex offers a compelling look at the opportunities and challenges of renovating existing buildings to meet today’s scientific and environmental standards. </p>]]>
      </itunes:summary>
      <itunes:keywords>McCallum-Sather Architects, sustainability, integrated design, life sciences, architectural engineering, lab spaces, University of Waterloo, Earth Sciences, Chemistry, Renovation</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>S3.E10: Amol Deshpande</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:episode>10</itunes:episode>
      <podcast:episode>10</podcast:episode>
      <itunes:title>S3.E10: Amol Deshpande</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">ec436d70-98b6-4e5d-bc5d-8a9c0d02a5ac</guid>
      <link>https://ngbideas.transistor.fm/episodes/s3-e9-Amol-Deshpande</link>
      <description>
        <![CDATA[<p>Dr. Amol Deshpande shares his journey from a Toronto upbringing to a diverse career spanning chronic pain medicine, emergency and cardiac care, healthcare consulting, and venture support at MaRS. He reflects on key experiences at UHN, WSIB, Toronto Rehab, and AIoT Health, as well as launching his podcast <em>Reboot Health</em>.</p><p>Amol also discusses the state of Canadian life sciences, the need for genuine collaboration, and the importance of clear national vision. He closes with personal reflections on fatherhood and what’s next in his mission to improve healthcare and innovation in Canada.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Dr. Amol Deshpande shares his journey from a Toronto upbringing to a diverse career spanning chronic pain medicine, emergency and cardiac care, healthcare consulting, and venture support at MaRS. He reflects on key experiences at UHN, WSIB, Toronto Rehab, and AIoT Health, as well as launching his podcast <em>Reboot Health</em>.</p><p>Amol also discusses the state of Canadian life sciences, the need for genuine collaboration, and the importance of clear national vision. He closes with personal reflections on fatherhood and what’s next in his mission to improve healthcare and innovation in Canada.</p>]]>
      </content:encoded>
      <pubDate>Thu, 04 Dec 2025 09:38:03 -0500</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/902c0e39/04e0a07d.mp3" length="119087044" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/FHBk6zOHcxwXDqMayTdMr0WDc1GFcqOwUCL0PYtJc70/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iODA2/NjE2ODMyNjUyYjhj/MzVkMDYzNGU0ZTJk/OTliMy5wbmc.jpg"/>
      <itunes:duration>3659</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Dr. Amol Deshpande shares his journey from a Toronto upbringing to a diverse career spanning chronic pain medicine, emergency and cardiac care, healthcare consulting, and venture support at MaRS. He reflects on key experiences at UHN, WSIB, Toronto Rehab, and AIoT Health, as well as launching his podcast <em>Reboot Health</em>.</p><p>Amol also discusses the state of Canadian life sciences, the need for genuine collaboration, and the importance of clear national vision. He closes with personal reflections on fatherhood and what’s next in his mission to improve healthcare and innovation in Canada.</p>]]>
      </itunes:summary>
      <itunes:keywords>Keywords  immigration, India, Canada, Toronto, physician, chemical engineer, education, medical school, fellowship, chronic pain, clinical consultant, University Health Network, cardiac medicine, emergency medicine, family practice, medicine, MBA, healthcare consulting, chronic pain, opioids, WSIB, Toronto Rehabilitation Institute, AIoT Health, Reboot Health, Mars Discovery District, innovation, Mars, innovation, collaboration, Canadian life sciences, challenges, opportunities, raising children, future goals</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBiLab S2.E8: Cobionix</title>
      <itunes:title>NGBiLab S2.E8: Cobionix</itunes:title>
      <itunes:episodeType>bonus</itunes:episodeType>
      <guid isPermaLink="false">d5705562-dccc-4493-8266-b833d361e0eb</guid>
      <link>https://ngbilab.transistor.fm/episodes/s2-e8-CoBionix</link>
      <description>
        <![CDATA[<p>Join us for an engaging conversation with Nima Zamani, co-founder of Cobionix, as he shares the inspiring journey of building a cutting-edge robotics company. Discover how Cobionix is revolutionizing healthcare with its needle-free AI-powered robotic injection technology, addressing labor shortages, and pioneering autonomous medical solutions. Nima also delves into the challenges of entrepreneurship and the critical role of human-robot collaboration in transforming the medical field.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Join us for an engaging conversation with Nima Zamani, co-founder of Cobionix, as he shares the inspiring journey of building a cutting-edge robotics company. Discover how Cobionix is revolutionizing healthcare with its needle-free AI-powered robotic injection technology, addressing labor shortages, and pioneering autonomous medical solutions. Nima also delves into the challenges of entrepreneurship and the critical role of human-robot collaboration in transforming the medical field.</p>]]>
      </content:encoded>
      <pubDate>Thu, 27 Nov 2025 09:43:17 -0500</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/a442594c/749a10b6.mp3" length="44080157" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/J79E1LM9SLqq0zj9CDVp2HnEoG1ijDHIeugJtusSCYk/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yY2Rj/ZGFlMGMwNDU0YWJm/ZjQ5MGQ2MjRmMmFm/Zjg5Zi5wbmc.jpg"/>
      <itunes:duration>1383</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Join us for an engaging conversation with Nima Zamani, co-founder of Cobionix, as he shares the inspiring journey of building a cutting-edge robotics company. Discover how Cobionix is revolutionizing healthcare with its needle-free AI-powered robotic injection technology, addressing labor shortages, and pioneering autonomous medical solutions. Nima also delves into the challenges of entrepreneurship and the critical role of human-robot collaboration in transforming the medical field.</p>]]>
      </itunes:summary>
      <itunes:keywords>Cobionix, robotics, AI, needle-free injection, labor shortages, medical technology, entrepreneurship, human-robot collaboration, innovation, healthcare</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>S3.E9: Jonathan Bramson</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:episode>9</itunes:episode>
      <podcast:episode>9</podcast:episode>
      <itunes:title>S3.E9: Jonathan Bramson</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">9cdd2c62-d06f-496a-a18b-89049553449e</guid>
      <link>https://ngbideas.transistor.fm/episodes/s3-e9-Jonathan-Bramson</link>
      <description>
        <![CDATA[<p>In this episode Jonathan Bramson walks us through his path from childhood in Montreal to pursuing a PhD at McGill and becoming a leading voice in gene and cell therapy. He reflects on early influences, academic anxieties, and the unexpected turns that led him into oncology and biotech. We explore the evolution of gene therapy, the power of mentorship, the realities of building in the life sciences sector, and the creativity behind developing new treatments. Jonathan also shares what he's most proud of—both personally and professionally—and his aspirations for the future of universal cell therapy. </p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode Jonathan Bramson walks us through his path from childhood in Montreal to pursuing a PhD at McGill and becoming a leading voice in gene and cell therapy. He reflects on early influences, academic anxieties, and the unexpected turns that led him into oncology and biotech. We explore the evolution of gene therapy, the power of mentorship, the realities of building in the life sciences sector, and the creativity behind developing new treatments. Jonathan also shares what he's most proud of—both personally and professionally—and his aspirations for the future of universal cell therapy. </p>]]>
      </content:encoded>
      <pubDate>Thu, 27 Nov 2025 00:00:00 -0500</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/229b3354/38b97dbf.mp3" length="117455700" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/vD-MPiE-AC_0tmy_o-ZCNboljkzymCFApSDLb05LV6Y/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hYTQ4/NTUwMTVkNzQ4YWQz/ZDAyNmNhZTVlOTRk/NTRhNC5wbmc.jpg"/>
      <itunes:duration>3618</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode Jonathan Bramson walks us through his path from childhood in Montreal to pursuing a PhD at McGill and becoming a leading voice in gene and cell therapy. He reflects on early influences, academic anxieties, and the unexpected turns that led him into oncology and biotech. We explore the evolution of gene therapy, the power of mentorship, the realities of building in the life sciences sector, and the creativity behind developing new treatments. Jonathan also shares what he's most proud of—both personally and professionally—and his aspirations for the future of universal cell therapy. </p>]]>
      </itunes:summary>
      <itunes:keywords> Montreal, childhood, family, education, biochemistry, PhD, oncology, gene therapy, personal growth, anxiety, gene therapy, oncology, cell therapy, mentorship, creativity, biotechnology, life sciences, McMaster University, cancer treatment, research innovation</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBiLab S2.E7: YellowBird Diagnostic</title>
      <itunes:title>NGBiLab S2.E7: YellowBird Diagnostic</itunes:title>
      <itunes:episodeType>bonus</itunes:episodeType>
      <guid isPermaLink="false">2f937be5-9fa4-45c1-977a-4a69be2ef3a3</guid>
      <link>https://ngbilab.transistor.fm/episodes/s2-e7-yellowbird-diagnostic</link>
      <description>
        <![CDATA[<p>In this episode of NGBiLab, host Jim Wilson welcomes the innovative minds behind YellowBird Diagnostics: Nicholas Calvert, Alexia Kirby, and Adam Shuhendler. Discover how this dynamic team, spun out of the University of Ottawa, is revolutionizing disease diagnosis with cutting-edge chemical technologies. From their entrepreneurial journey to the challenges of bringing molecular imaging to the clinic, this conversation delves into the heart of innovation in the life sciences sector. Tune in to learn about their vision to become leaders in advanced imaging dye innovation and their plans for the future.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of NGBiLab, host Jim Wilson welcomes the innovative minds behind YellowBird Diagnostics: Nicholas Calvert, Alexia Kirby, and Adam Shuhendler. Discover how this dynamic team, spun out of the University of Ottawa, is revolutionizing disease diagnosis with cutting-edge chemical technologies. From their entrepreneurial journey to the challenges of bringing molecular imaging to the clinic, this conversation delves into the heart of innovation in the life sciences sector. Tune in to learn about their vision to become leaders in advanced imaging dye innovation and their plans for the future.</p>]]>
      </content:encoded>
      <pubDate>Thu, 20 Nov 2025 00:00:00 -0500</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/d3e80fb4/6f20032f.mp3" length="36660540" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/Qo6Lu5Ivu3c6N8liDN68oJS4PrCo6p-jrsecKuVjErk/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xNDMx/ODY3Y2MzMWM0Y2U0/Mzg2MzA1MWZlYTMy/OWMzNi5wbmc.jpg"/>
      <itunes:duration>1132</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of NGBiLab, host Jim Wilson welcomes the innovative minds behind YellowBird Diagnostics: Nicholas Calvert, Alexia Kirby, and Adam Shuhendler. Discover how this dynamic team, spun out of the University of Ottawa, is revolutionizing disease diagnosis with cutting-edge chemical technologies. From their entrepreneurial journey to the challenges of bringing molecular imaging to the clinic, this conversation delves into the heart of innovation in the life sciences sector. Tune in to learn about their vision to become leaders in advanced imaging dye innovation and their plans for the future.</p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>S3.E8: Marc Jeschke</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:episode>8</itunes:episode>
      <podcast:episode>8</podcast:episode>
      <itunes:title>S3.E8: Marc Jeschke</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">2c022d85-d6da-4fd6-b436-1c7d870ea794</guid>
      <link>https://ngbideas.transistor.fm/episodes/s3-e8-marc-jeschke</link>
      <description>
        <![CDATA[<p>In this engaging episode, Jim Wilson sits down with Marc Jeschke, a renowned surgeon and researcher, to explore his fascinating journey from Germany to becoming a leading figure in burn care and research. Marc shares insights into his early life, the challenges and triumphs of his career, and his vision for the future of healthcare. Discover how his passion for innovation and dedication to patient care have shaped his path and continue to drive his work at Hamilton Health Sciences.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this engaging episode, Jim Wilson sits down with Marc Jeschke, a renowned surgeon and researcher, to explore his fascinating journey from Germany to becoming a leading figure in burn care and research. Marc shares insights into his early life, the challenges and triumphs of his career, and his vision for the future of healthcare. Discover how his passion for innovation and dedication to patient care have shaped his path and continue to drive his work at Hamilton Health Sciences.</p>]]>
      </content:encoded>
      <pubDate>Wed, 19 Nov 2025 14:25:23 -0500</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/3415f1b4/e3f6308b.mp3" length="64775294" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/w7prvlDkycMbpJgq56U82QT8Auo4d7ld_ElBC9HFtOg/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zY2Qz/YjMyYzUzZWRjY2Iw/YjM5YWRiZjk1YTZi/MTkwYy5wbmc.jpg"/>
      <itunes:duration>4045</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this engaging episode, Jim Wilson sits down with Marc Jeschke, a renowned surgeon and researcher, to explore his fascinating journey from Germany to becoming a leading figure in burn care and research. Marc shares insights into his early life, the challenges and triumphs of his career, and his vision for the future of healthcare. Discover how his passion for innovation and dedication to patient care have shaped his path and continue to drive his work at Hamilton Health Sciences.</p>]]>
      </itunes:summary>
      <itunes:keywords>Marc Jeschke, Jim Wilson, burn care, healthcare innovation, Hamilton Health Sciences, medical research, Germany, career journey, patient care, healthcare future</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBiLab S2: Replay - PragmaClin</title>
      <itunes:title>NGBiLab S2: Replay - PragmaClin</itunes:title>
      <itunes:episodeType>bonus</itunes:episodeType>
      <guid isPermaLink="false">e76f93c9-31cb-479c-a40b-7278e7545577</guid>
      <link>https://ngbilab.transistor.fm/episodes/s2-replay-pragmaclin</link>
      <description>
        <![CDATA[<p>In this archived episode of NGBiLab, host Jim Wilson revisits his conversation with Bronwyn Bridges, CEO and co-founder of PragmaClin, a pioneering startup from St. John's, Newfoundland. PragmaClin's innovative digital tool, Prims, is designed to enhance the assessment of Parkinson's disease, offering more objective and efficient pathways for neurological care. Bronwyn reflects on her journey, the hurdles overcome, and the serendipitous moments that shaped PragmaClin's mission to make healthcare more accessible.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this archived episode of NGBiLab, host Jim Wilson revisits his conversation with Bronwyn Bridges, CEO and co-founder of PragmaClin, a pioneering startup from St. John's, Newfoundland. PragmaClin's innovative digital tool, Prims, is designed to enhance the assessment of Parkinson's disease, offering more objective and efficient pathways for neurological care. Bronwyn reflects on her journey, the hurdles overcome, and the serendipitous moments that shaped PragmaClin's mission to make healthcare more accessible.</p>]]>
      </content:encoded>
      <pubDate>Thu, 06 Nov 2025 12:12:57 -0500</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/a7c2036f/31955b83.mp3" length="24140529" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/FgykFEFxikWw9C4LyxLo7xmDhVaMXqyvNdWGL0nrUTU/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9jZGIz/OGJkNTM0M2MxNDRk/ZjA0OGJhMjc2YzBk/MWMyYS5wbmc.jpg"/>
      <itunes:duration>1509</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this archived episode of NGBiLab, host Jim Wilson revisits his conversation with Bronwyn Bridges, CEO and co-founder of PragmaClin, a pioneering startup from St. John's, Newfoundland. PragmaClin's innovative digital tool, Prims, is designed to enhance the assessment of Parkinson's disease, offering more objective and efficient pathways for neurological care. Bronwyn reflects on her journey, the hurdles overcome, and the serendipitous moments that shaped PragmaClin's mission to make healthcare more accessible.</p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences, Startups, Parkinson's, Disease, PragmaClin, Digital Health Tools. Neurological Care, Remote Assessments, Female Entrepreneurs, Innovation in Healthcare, Clinical Trials</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>S3: Replay - Christine Allen</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>S3: Replay - Christine Allen</itunes:title>
      <itunes:episodeType>bonus</itunes:episodeType>
      <guid isPermaLink="false">7b6f0354-93b4-439f-ab5d-ada59c8df985</guid>
      <link>https://ngbideas.transistor.fm/episodes/s3-replay-christine-allen</link>
      <description>
        <![CDATA[<p>In this archive episode of NGBideas, host Jim Wilson sits down with Professor Christine Allen from the University of Toronto's Leslie Dan Faculty of Pharmacy. Join us as we explore Dr. Allen's remarkable journey from her early days in Ottawa to becoming a globally recognized leader in drug formulation and development. Discover her insights on the integration of AI in drug development, her experiences in academia and industry, and her inspiring personal story of resilience and innovation. Tune in for an engaging conversation that delves into the future of life sciences and the power of formulation to transform medicine.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this archive episode of NGBideas, host Jim Wilson sits down with Professor Christine Allen from the University of Toronto's Leslie Dan Faculty of Pharmacy. Join us as we explore Dr. Allen's remarkable journey from her early days in Ottawa to becoming a globally recognized leader in drug formulation and development. Discover her insights on the integration of AI in drug development, her experiences in academia and industry, and her inspiring personal story of resilience and innovation. Tune in for an engaging conversation that delves into the future of life sciences and the power of formulation to transform medicine.</p>]]>
      </content:encoded>
      <pubDate>Tue, 04 Nov 2025 11:07:34 -0500</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/279f0c80/8cd1704d.mp3" length="66165907" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/2Py_OHv_Dy4vjoGePp6RzmZuRie5x6CBPcf1swVrIak/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83YTU2/MTAzNGM0YjViZjM4/NDg3NzE1YzA3NjZi/YmZhYy5wbmc.jpg"/>
      <itunes:duration>4136</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this archive episode of NGBideas, host Jim Wilson sits down with Professor Christine Allen from the University of Toronto's Leslie Dan Faculty of Pharmacy. Join us as we explore Dr. Allen's remarkable journey from her early days in Ottawa to becoming a globally recognized leader in drug formulation and development. Discover her insights on the integration of AI in drug development, her experiences in academia and industry, and her inspiring personal story of resilience and innovation. Tune in for an engaging conversation that delves into the future of life sciences and the power of formulation to transform medicine.</p>]]>
      </itunes:summary>
      <itunes:keywords>Drug Formulation, AI in Medicine, Life Sciences Innovation, University of Toronto, Christine Allen, Pharmaceutical Development, Academic Leadership, Biotechnology, Startup Journey, Canadian Life Sciences</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBiLab S2: Replay - TATUM Bioscience</title>
      <itunes:title>NGBiLab S2: Replay - TATUM Bioscience</itunes:title>
      <itunes:episodeType>bonus</itunes:episodeType>
      <guid isPermaLink="false">41f0e40b-ad1a-49f2-a65b-631092f19f21</guid>
      <link>https://ngbilab.transistor.fm/episodes/s2-replay-tatum-bioscience</link>
      <description>
        <![CDATA[<p>In this throwback episode of NGBiLab, host Jim Wilson sits down with Kevin Neal and Jean-Francois Mio from Tatum Bioscience in Sherbrooke, Quebec. Discover how they are revolutionizing cancer treatment by programming bacteria to become cancer-fighting drugs. Learn about their journey, the challenges they face, and their vision for the future of immunotherapy. Tune in to explore the cutting-edge innovations in Canada's life sciences sector.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this throwback episode of NGBiLab, host Jim Wilson sits down with Kevin Neal and Jean-Francois Mio from Tatum Bioscience in Sherbrooke, Quebec. Discover how they are revolutionizing cancer treatment by programming bacteria to become cancer-fighting drugs. Learn about their journey, the challenges they face, and their vision for the future of immunotherapy. Tune in to explore the cutting-edge innovations in Canada's life sciences sector.</p>]]>
      </content:encoded>
      <pubDate>Thu, 30 Oct 2025 10:59:31 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/2cf6eb10/536ab194.mp3" length="17780444" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/2-8aLttlxPNWLnSkAraAPp_uj0Wp45WitEgux47kunY/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yOGRm/NTEyMTI5NDBjNmJk/ZTZlYzFlY2NlYWIz/YzlmYi5wbmc.jpg"/>
      <itunes:duration>1112</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this throwback episode of NGBiLab, host Jim Wilson sits down with Kevin Neal and Jean-Francois Mio from Tatum Bioscience in Sherbrooke, Quebec. Discover how they are revolutionizing cancer treatment by programming bacteria to become cancer-fighting drugs. Learn about their journey, the challenges they face, and their vision for the future of immunotherapy. Tune in to explore the cutting-edge innovations in Canada's life sciences sector.</p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>S3: Replay - Brigitte Nolet</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>S3: Replay - Brigitte Nolet</itunes:title>
      <itunes:episodeType>bonus</itunes:episodeType>
      <guid isPermaLink="false">36a2847d-e8bb-4435-af26-4f21ea7524dd</guid>
      <link>https://ngbideas.transistor.fm/episodes/s3-replay-brigitte-nolet</link>
      <description>
        <![CDATA[<p>In this throwback episode of NGBideas, host Jim Wilson sits down with Brigitte Nolet, President and CEO of Roche Canada Pharma. They explore Brigitte's journey as a trisector leader, her personal experiences as a patient, and her insights into Canada's life sciences sector. Discover the importance of honesty in leadership and the potential of healthcare innovation. Tune in for an inspiring conversation about resilience, ambition, and the future of healthcare in Canada.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this throwback episode of NGBideas, host Jim Wilson sits down with Brigitte Nolet, President and CEO of Roche Canada Pharma. They explore Brigitte's journey as a trisector leader, her personal experiences as a patient, and her insights into Canada's life sciences sector. Discover the importance of honesty in leadership and the potential of healthcare innovation. Tune in for an inspiring conversation about resilience, ambition, and the future of healthcare in Canada.</p>]]>
      </content:encoded>
      <pubDate>Tue, 28 Oct 2025 14:13:02 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/a3914c0c/9c300ca3.mp3" length="55484228" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/JyLeB3cw4L6SB844hZFZSskm4Kw0-8xWCMSvk2qBrbI/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iZDQ2/YWI1ZTc2NjI2ZDcz/NGJmYzZjMmI3YzZh/NjI0YS5wbmc.jpg"/>
      <itunes:duration>3464</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this throwback episode of NGBideas, host Jim Wilson sits down with Brigitte Nolet, President and CEO of Roche Canada Pharma. They explore Brigitte's journey as a trisector leader, her personal experiences as a patient, and her insights into Canada's life sciences sector. Discover the importance of honesty in leadership and the potential of healthcare innovation. Tune in for an inspiring conversation about resilience, ambition, and the future of healthcare in Canada.</p>]]>
      </itunes:summary>
      <itunes:keywords>Brigitte Nolet, Roche Canada Pharma, Life Sciences, Healthcare Innovation, Leadership, Trisector Leader, Patient Experience, Canadian Healthcare, Resilience, Ambition</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBiLab S2: Replay - Vessl Prosthetics</title>
      <itunes:title>NGBiLab S2: Replay - Vessl Prosthetics</itunes:title>
      <itunes:episodeType>bonus</itunes:episodeType>
      <guid isPermaLink="false">bba163db-0700-41eb-b762-222c899540a8</guid>
      <link>https://ngbilab.transistor.fm/episodes/s2-replay-vessl-prosthetics</link>
      <description>
        <![CDATA[<p>This week, we’re throwing it back to when Jim connected with Sydney Robinson, CEO and co-founder of Vessl Prosthetics, based in London, Ontario. Sydney and her team are pioneering next-generation prosthetic solutions specifically designed for below-knee amputees. Their innovative technology features automatic adjustments that ensure a consistently comfortable fit—greatly improving quality of life for many.</p><p><br>In 2025, Vessl Prosthetics made significant strides, securing key funding and expanding their impact in the prosthetics field. Their journey perfectly exemplifies the spirit of innovation and collaboration that NGBi is proud to amplify—showcasing real-world breakthroughs happening across Canada’s life sciences ecosystem.</p><p>Tune in to hear their inspiring story, and stay connected for more fresh conversations coming soon!</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>This week, we’re throwing it back to when Jim connected with Sydney Robinson, CEO and co-founder of Vessl Prosthetics, based in London, Ontario. Sydney and her team are pioneering next-generation prosthetic solutions specifically designed for below-knee amputees. Their innovative technology features automatic adjustments that ensure a consistently comfortable fit—greatly improving quality of life for many.</p><p><br>In 2025, Vessl Prosthetics made significant strides, securing key funding and expanding their impact in the prosthetics field. Their journey perfectly exemplifies the spirit of innovation and collaboration that NGBi is proud to amplify—showcasing real-world breakthroughs happening across Canada’s life sciences ecosystem.</p><p>Tune in to hear their inspiring story, and stay connected for more fresh conversations coming soon!</p>]]>
      </content:encoded>
      <pubDate>Thu, 23 Oct 2025 14:30:38 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/db39e1d5/5780f555.mp3" length="33913977" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/rHqKIdUY2F14bNr1d9jptxsygZb5GitPp3LQJESJjZE/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mNjNk/MmE5ODcyMmMzM2Fm/OGUzYjY1NTEzZWYw/OGNjZC5wbmc.jpg"/>
      <itunes:duration>1058</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>This week, we’re throwing it back to when Jim connected with Sydney Robinson, CEO and co-founder of Vessl Prosthetics, based in London, Ontario. Sydney and her team are pioneering next-generation prosthetic solutions specifically designed for below-knee amputees. Their innovative technology features automatic adjustments that ensure a consistently comfortable fit—greatly improving quality of life for many.</p><p><br>In 2025, Vessl Prosthetics made significant strides, securing key funding and expanding their impact in the prosthetics field. Their journey perfectly exemplifies the spirit of innovation and collaboration that NGBi is proud to amplify—showcasing real-world breakthroughs happening across Canada’s life sciences ecosystem.</p><p>Tune in to hear their inspiring story, and stay connected for more fresh conversations coming soon!</p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>S3: Replay - Cate Murray</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>S3: Replay - Cate Murray</itunes:title>
      <itunes:episodeType>bonus</itunes:episodeType>
      <guid isPermaLink="false">72446c7e-efae-4eca-955d-b760a8c63b79</guid>
      <link>https://ngbideas.transistor.fm/episodes/s3-replay-cate-murray</link>
      <description>
        <![CDATA[<p>This week, we’re revisiting an episode with <strong>Cate Murray</strong>, President and CEO of the <strong>Stem Cell Network (SCN)</strong> in Ottawa. SCN is a Canadian not-for-profit supporting three main objectives: advancing stem cell and regenerative medicine research, training the next generation of researchers, and sharing breakthroughs in this incredible field.Founded in 2001 with federal support, SCN has grown from a few dozen labs to over <strong>270 world-class research groups</strong> and dozens of clinical trials.</p><p>Cate will also be joining <strong>NGBi25</strong> to speak about <strong>regenerative medicine</strong>, sharing her insights on the latest innovations and trends in this exciting field.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>This week, we’re revisiting an episode with <strong>Cate Murray</strong>, President and CEO of the <strong>Stem Cell Network (SCN)</strong> in Ottawa. SCN is a Canadian not-for-profit supporting three main objectives: advancing stem cell and regenerative medicine research, training the next generation of researchers, and sharing breakthroughs in this incredible field.Founded in 2001 with federal support, SCN has grown from a few dozen labs to over <strong>270 world-class research groups</strong> and dozens of clinical trials.</p><p>Cate will also be joining <strong>NGBi25</strong> to speak about <strong>regenerative medicine</strong>, sharing her insights on the latest innovations and trends in this exciting field.</p>]]>
      </content:encoded>
      <pubDate>Tue, 21 Oct 2025 00:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/cf5d3790/22a41268.mp3" length="59983873" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/ViQfr4Sk6iHZ-Uo_wpno6QpiZnsmTFt6Fnxg4BeVwsM/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83ZTk0/NTc1MTM3ODU0YWE2/MjVmODNkYTc1ZThi/ZjhmYy5wbmc.jpg"/>
      <itunes:duration>3749</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>This week, we’re revisiting an episode with <strong>Cate Murray</strong>, President and CEO of the <strong>Stem Cell Network (SCN)</strong> in Ottawa. SCN is a Canadian not-for-profit supporting three main objectives: advancing stem cell and regenerative medicine research, training the next generation of researchers, and sharing breakthroughs in this incredible field.Founded in 2001 with federal support, SCN has grown from a few dozen labs to over <strong>270 world-class research groups</strong> and dozens of clinical trials.</p><p>Cate will also be joining <strong>NGBi25</strong> to speak about <strong>regenerative medicine</strong>, sharing her insights on the latest innovations and trends in this exciting field.</p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBiPlus S1.E1: VIDO</title>
      <itunes:title>NGBiPlus S1.E1: VIDO</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">c27caf52-c66b-48e6-983b-5aa4f439ae20</guid>
      <link>https://ngbideas.transistor.fm/ngbiplus-s1-e1-vido</link>
      <description>
        <![CDATA[<p>Join host Jim Wilson as he sits down with Dr. Arinjay Banerjee and Dr. Volker Gerdts from the Vaccine and Infectious Disease Organization (VIDO) in Saskatoon. Discover how VIDO is at the forefront of infectious disease research and vaccine development, bridging human and animal health. Learn about their cutting-edge facilities, global partnerships, and the ambitious plans to make Canada a leader in pandemic preparedness. This episode offers a deep dive into the world of life sciences and the inspiring stories behind the scientists driving innovation. Tune in for insights that could shape the future of global health.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Join host Jim Wilson as he sits down with Dr. Arinjay Banerjee and Dr. Volker Gerdts from the Vaccine and Infectious Disease Organization (VIDO) in Saskatoon. Discover how VIDO is at the forefront of infectious disease research and vaccine development, bridging human and animal health. Learn about their cutting-edge facilities, global partnerships, and the ambitious plans to make Canada a leader in pandemic preparedness. This episode offers a deep dive into the world of life sciences and the inspiring stories behind the scientists driving innovation. Tune in for insights that could shape the future of global health.</p>]]>
      </content:encoded>
      <pubDate>Thu, 16 Oct 2025 10:13:58 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/b9e3bbde/261f6090.mp3" length="72958979" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/eGXYQj0jdEzRBp3JLRBu5f5GZym0Ybhefjl_dhj54pk/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kY2My/M2I1YmZmMTA4ZDIx/Mjc3NWQ2OTNlYWEz/MDZlNS5wbmc.jpg"/>
      <itunes:duration>2238</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Join host Jim Wilson as he sits down with Dr. Arinjay Banerjee and Dr. Volker Gerdts from the Vaccine and Infectious Disease Organization (VIDO) in Saskatoon. Discover how VIDO is at the forefront of infectious disease research and vaccine development, bridging human and animal health. Learn about their cutting-edge facilities, global partnerships, and the ambitious plans to make Canada a leader in pandemic preparedness. This episode offers a deep dive into the world of life sciences and the inspiring stories behind the scientists driving innovation. Tune in for insights that could shape the future of global health.</p>]]>
      </itunes:summary>
      <itunes:keywords>Vaccine Development, Infectious Diseases, VIDO, Pandemic Preparedness,  Saskatoon, Global Health, Life Sciences, Research, Innovation, Canadian Science</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>S3.E7: Shanil Ebrahim</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:episode>7</itunes:episode>
      <podcast:episode>7</podcast:episode>
      <itunes:title>S3.E7: Shanil Ebrahim</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">f8f7059a-f3c4-4c84-ba5f-0863baa911d0</guid>
      <link>https://ngbideas.transistor.fm/episodes/s3-e7-shanil-ebrahim</link>
      <description>
        <![CDATA[<p>Join us for an insightful conversation with Shanil Ebrahim as he shares his journey from Saudi Arabia to Canada, navigating cultural transitions, and building a successful career in healthcare consulting. Discover how his experiences shaped his leadership style and his vision for creating a lasting impact in the healthcare industry. Shanil's story is one of resilience, adaptability, and a commitment to lifelong learning.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Join us for an insightful conversation with Shanil Ebrahim as he shares his journey from Saudi Arabia to Canada, navigating cultural transitions, and building a successful career in healthcare consulting. Discover how his experiences shaped his leadership style and his vision for creating a lasting impact in the healthcare industry. Shanil's story is one of resilience, adaptability, and a commitment to lifelong learning.</p>]]>
      </content:encoded>
      <pubDate>Mon, 13 Oct 2025 23:59:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/2aff39e5/4dffb031.mp3" length="119869759" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/iUhm58fERz7IC0z39oSuin04VhbY2GO2dgUs3nyhYTM/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iY2Nk/N2NlZmEzODJkZTdk/ZjM2YjcwZjUyOTky/MTM2MS5wbmc.jpg"/>
      <itunes:duration>3677</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Join us for an insightful conversation with Shanil Ebrahim as he shares his journey from Saudi Arabia to Canada, navigating cultural transitions, and building a successful career in healthcare consulting. Discover how his experiences shaped his leadership style and his vision for creating a lasting impact in the healthcare industry. Shanil's story is one of resilience, adaptability, and a commitment to lifelong learning.</p>]]>
      </itunes:summary>
      <itunes:keywords>healthcare consulting, cultural transition, leadership, resilience, lifelong learning, Saudi Arabia, Canada, career journey, healthcare industry</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>S3: Replay - Gordon McCauley</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>S3: Replay - Gordon McCauley</itunes:title>
      <itunes:episodeType>bonus</itunes:episodeType>
      <guid isPermaLink="false">842c6906-b76a-419a-a8a9-72c0c403fad7</guid>
      <link>https://ngbideas.transistor.fm/episodes/s3-replay-gordon-mccauley</link>
      <description>
        <![CDATA[<p>This week on <em>NGB Ideas</em>, we’re revisiting a Season 1 conversation with <strong>Gordon McCauley, President &amp; CEO of AdMare BioInnovations</strong>. Gordon has built his career at the intersection of politics, investment, and life sciences — and today, he’s at the center of Canada’s growing biotech ecosystem. In this episode, Gordon shares his journey from political staffer to venture capitalist to leading one of Canada’s most influential life sciences organizations. He reflects on lessons learned from both successes and setbacks, the importance of building domestic anchor companies, and how AdMare is working to transform Canada’s research strength into a globally competitive industry.</p><p>Gordon will also be joining us at <strong>NGBi25 as the moderator of the Investment Panel</strong>, where these very themes will take center stage.</p><p>Tune in for insights on leadership, ecosystem building, and the future of Canadian life sciences.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>This week on <em>NGB Ideas</em>, we’re revisiting a Season 1 conversation with <strong>Gordon McCauley, President &amp; CEO of AdMare BioInnovations</strong>. Gordon has built his career at the intersection of politics, investment, and life sciences — and today, he’s at the center of Canada’s growing biotech ecosystem. In this episode, Gordon shares his journey from political staffer to venture capitalist to leading one of Canada’s most influential life sciences organizations. He reflects on lessons learned from both successes and setbacks, the importance of building domestic anchor companies, and how AdMare is working to transform Canada’s research strength into a globally competitive industry.</p><p>Gordon will also be joining us at <strong>NGBi25 as the moderator of the Investment Panel</strong>, where these very themes will take center stage.</p><p>Tune in for insights on leadership, ecosystem building, and the future of Canadian life sciences.</p>]]>
      </content:encoded>
      <pubDate>Tue, 07 Oct 2025 09:52:57 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/78058913/b2032338.mp3" length="153852173" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/ZQOFCk9WXeLWk8Ekwbd0kE_eBYBKVAmYImIctUXnlII/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84NjE0/ZGE5ODE3YTRhOWRl/ZDYxZjE1ZjdkMDBj/ZDhjOC5wbmc.jpg"/>
      <itunes:duration>3845</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>This week on <em>NGB Ideas</em>, we’re revisiting a Season 1 conversation with <strong>Gordon McCauley, President &amp; CEO of AdMare BioInnovations</strong>. Gordon has built his career at the intersection of politics, investment, and life sciences — and today, he’s at the center of Canada’s growing biotech ecosystem. In this episode, Gordon shares his journey from political staffer to venture capitalist to leading one of Canada’s most influential life sciences organizations. He reflects on lessons learned from both successes and setbacks, the importance of building domestic anchor companies, and how AdMare is working to transform Canada’s research strength into a globally competitive industry.</p><p>Gordon will also be joining us at <strong>NGBi25 as the moderator of the Investment Panel</strong>, where these very themes will take center stage.</p><p>Tune in for insights on leadership, ecosystem building, and the future of Canadian life sciences.</p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences, adMare BioInnovations, Domestic Anchor Companies, Life Sciences Ecosystem, Biotechnology, Venture Capital, RND, Innovation, Leadership, Development, Talent Building</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>S3.E6: Bill Hunter</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:episode>6</itunes:episode>
      <podcast:episode>6</podcast:episode>
      <itunes:title>S3.E6: Bill Hunter</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">916fafac-0895-400c-acf1-8cadfce3ad84</guid>
      <link>https://ngbideas.transistor.fm/s3-e6-bill-hunter/</link>
      <description>
        <![CDATA[<p>Join Jim Wilson as he sits down with Bill Hunter, a pioneering figure in the Canadian life sciences community. From his early days in Mississauga to founding Angiotech Pharmaceuticals, Bill shares his journey of innovation, resilience, and the pursuit of medical breakthroughs. Discover how his passion for science and entrepreneurship led to the development of life-saving technologies and his vision for the future of med-tech. Tune in for an inspiring conversation about leadership, innovation, and the relentless pursuit of progress in healthcare.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Join Jim Wilson as he sits down with Bill Hunter, a pioneering figure in the Canadian life sciences community. From his early days in Mississauga to founding Angiotech Pharmaceuticals, Bill shares his journey of innovation, resilience, and the pursuit of medical breakthroughs. Discover how his passion for science and entrepreneurship led to the development of life-saving technologies and his vision for the future of med-tech. Tune in for an inspiring conversation about leadership, innovation, and the relentless pursuit of progress in healthcare.</p>]]>
      </content:encoded>
      <pubDate>Tue, 30 Sep 2025 10:45:01 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/afa04c42/ad2f7922.mp3" length="65046188" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/ijH4aXJZlSMdLyH0TS1svjDkaR7yr0eenhhVFwgtNvA/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80MzA2/NDYyY2IzMjAyYWVh/NDY4M2I0YTBhYzU2/MGM3NC5wbmc.jpg"/>
      <itunes:duration>4062</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Join Jim Wilson as he sits down with Bill Hunter, a pioneering figure in the Canadian life sciences community. From his early days in Mississauga to founding Angiotech Pharmaceuticals, Bill shares his journey of innovation, resilience, and the pursuit of medical breakthroughs. Discover how his passion for science and entrepreneurship led to the development of life-saving technologies and his vision for the future of med-tech. Tune in for an inspiring conversation about leadership, innovation, and the relentless pursuit of progress in healthcare.</p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>S3.E5: Bharat Srinivasa</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:episode>5</itunes:episode>
      <podcast:episode>5</podcast:episode>
      <itunes:title>S3.E5: Bharat Srinivasa</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">0a27eaad-ecb9-467c-90c9-655a0d727691</guid>
      <link>https://NGBIdeas.transistor.fm/s3/5</link>
      <description>
        <![CDATA[<p>In this episode of NGBideas, we sit down with Bharat Srinivasa, Co-Founder of Amplitude Venture Capital, to trace his journey from Bangalore to Canada and into the world of biotech investing. Bharat shares how curiosity, persistence, and networking shaped his path from biology labs to consulting and venture capital, and reflects on the growth of Canada’s life sciences ecosystem, the challenges of company creation, and the exciting future of AI, new biology, and transformative healthcare innovation. Bharat will also be joining our Investment Panel at NGBi25 — hear his perspective live at the Summit. </p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of NGBideas, we sit down with Bharat Srinivasa, Co-Founder of Amplitude Venture Capital, to trace his journey from Bangalore to Canada and into the world of biotech investing. Bharat shares how curiosity, persistence, and networking shaped his path from biology labs to consulting and venture capital, and reflects on the growth of Canada’s life sciences ecosystem, the challenges of company creation, and the exciting future of AI, new biology, and transformative healthcare innovation. Bharat will also be joining our Investment Panel at NGBi25 — hear his perspective live at the Summit. </p>]]>
      </content:encoded>
      <pubDate>Tue, 23 Sep 2025 00:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/8a27da9f/013563aa.mp3" length="64339844" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/fiEktp_nXTYRF5UMfzo4HqZAW1Z8JZZZNFntD_vPRTY/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84Y2U1/OWM1NjhkYjA4MjBh/MGQ2ZGU3ZGFiMDlj/MGVhNi5wbmc.jpg"/>
      <itunes:duration>4018</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of NGBideas, we sit down with Bharat Srinivasa, Co-Founder of Amplitude Venture Capital, to trace his journey from Bangalore to Canada and into the world of biotech investing. Bharat shares how curiosity, persistence, and networking shaped his path from biology labs to consulting and venture capital, and reflects on the growth of Canada’s life sciences ecosystem, the challenges of company creation, and the exciting future of AI, new biology, and transformative healthcare innovation. Bharat will also be joining our Investment Panel at NGBi25 — hear his perspective live at the Summit. </p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>S3.E4: Matthew Miller</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:episode>4</itunes:episode>
      <podcast:episode>4</podcast:episode>
      <itunes:title>S3.E4: Matthew Miller</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">e269901f-2da7-4085-b3e7-356f8933018b</guid>
      <link>https://NGBIdeas.transistor.fm/s3/4</link>
      <description>
        <![CDATA[<p>Join us for an insightful conversation with Matthew Miller, a distinguished scientist and academic leader, as he shares his journey from a small town in Ontario to becoming a key figure in infectious disease research. Discover how serendipity and mentorship shaped his career, the challenges of starting a lab, and the impact of the COVID-19 pandemic on his work. Matthew also discusses the importance of basic science funding, the role of serendipity in scientific discovery, and his vision for the future of health sciences in Canada. Tune in to explore the next great big idea on the horizon and how it could transform the health and economy of Canadians.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Join us for an insightful conversation with Matthew Miller, a distinguished scientist and academic leader, as he shares his journey from a small town in Ontario to becoming a key figure in infectious disease research. Discover how serendipity and mentorship shaped his career, the challenges of starting a lab, and the impact of the COVID-19 pandemic on his work. Matthew also discusses the importance of basic science funding, the role of serendipity in scientific discovery, and his vision for the future of health sciences in Canada. Tune in to explore the next great big idea on the horizon and how it could transform the health and economy of Canadians.</p>]]>
      </content:encoded>
      <pubDate>Tue, 16 Sep 2025 00:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/51bb06b3/9dd71d70.mp3" length="59479504" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/i-3ogLbSqytiMkraSVJrseJj6831ZRu71Wa07Js1P1s/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83NmM4/NmYzZmMyNjFhYWQ0/ZTVmYmQ1ODZiOTM5/NGZjNi5wbmc.jpg"/>
      <itunes:duration>3713</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Join us for an insightful conversation with Matthew Miller, a distinguished scientist and academic leader, as he shares his journey from a small town in Ontario to becoming a key figure in infectious disease research. Discover how serendipity and mentorship shaped his career, the challenges of starting a lab, and the impact of the COVID-19 pandemic on his work. Matthew also discusses the importance of basic science funding, the role of serendipity in scientific discovery, and his vision for the future of health sciences in Canada. Tune in to explore the next great big idea on the horizon and how it could transform the health and economy of Canadians.</p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>S3.E3: Neil Fraser</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:episode>3</itunes:episode>
      <podcast:episode>3</podcast:episode>
      <itunes:title>S3.E3: Neil Fraser</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">74d28c65-4e5b-4d4e-9675-7205cab11554</guid>
      <link>https://NGBIdeas.transistor.fm/s3/3</link>
      <description>
        <![CDATA[<p>Join us as we delve into the remarkable career of Neil Fraser, a visionary leader in the Canadian medtech sector. From his early days growing up in a nomadic family to becoming the president of Medtronic Canada, Neil's journey is one of innovation and leadership. Discover how he transformed Medtronic into a powerhouse in the industry, his insights on value-based healthcare, and his ongoing influence as a policy advisor. Tune in to explore the pivotal moments and lessons from Neil's 38-year career that continue to shape the future of healthcare in Canada.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Join us as we delve into the remarkable career of Neil Fraser, a visionary leader in the Canadian medtech sector. From his early days growing up in a nomadic family to becoming the president of Medtronic Canada, Neil's journey is one of innovation and leadership. Discover how he transformed Medtronic into a powerhouse in the industry, his insights on value-based healthcare, and his ongoing influence as a policy advisor. Tune in to explore the pivotal moments and lessons from Neil's 38-year career that continue to shape the future of healthcare in Canada.</p>]]>
      </content:encoded>
      <pubDate>Tue, 09 Sep 2025 00:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/86556e93/e532a7ba.mp3" length="59113356" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/N_EtgsqrfffBbSZAFlTeFTdrrBN0tCm8klYR-d_Dfrw/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iOTM3/NGQ2NGYwYTI3YTMz/ZDU1ZGM0YTI1YTdk/MDcwMS5wbmc.jpg"/>
      <itunes:duration>3691</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Join us as we delve into the remarkable career of Neil Fraser, a visionary leader in the Canadian medtech sector. From his early days growing up in a nomadic family to becoming the president of Medtronic Canada, Neil's journey is one of innovation and leadership. Discover how he transformed Medtronic into a powerhouse in the industry, his insights on value-based healthcare, and his ongoing influence as a policy advisor. Tune in to explore the pivotal moments and lessons from Neil's 38-year career that continue to shape the future of healthcare in Canada.</p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>S3.E2: Alison Symington</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:episode>2</itunes:episode>
      <podcast:episode>2</podcast:episode>
      <itunes:title>S3.E2: Alison Symington</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">4b505c87-1eaa-4a1e-8870-5f410a130c99</guid>
      <link>https://NGBIdeas.transistor.fm/s3/2</link>
      <description>
        <![CDATA[<p>In this episode of NGBI Ideas, host Jim Wilson sits down with Alison Symington, a key leader in the Ontario life sciences community. Alison shares her journey from the UK to Canada, her academic pursuits, and her impactful career in life sciences. Discover how she bridges the gap between industry and academia, and her insights on the future of genomics and AI. Tune in for an inspiring conversation about innovation, collaboration, and the power of storytelling in science.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of NGBI Ideas, host Jim Wilson sits down with Alison Symington, a key leader in the Ontario life sciences community. Alison shares her journey from the UK to Canada, her academic pursuits, and her impactful career in life sciences. Discover how she bridges the gap between industry and academia, and her insights on the future of genomics and AI. Tune in for an inspiring conversation about innovation, collaboration, and the power of storytelling in science.</p>]]>
      </content:encoded>
      <pubDate>Wed, 03 Sep 2025 00:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/a144cc40/b6bb82f8.mp3" length="60025823" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/nwfva0WssO7OTsrmbRbts47fkw_GCuHtWQiRqEogZoo/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kNDdl/NGE0YmNmMWJmYzA1/NDdjMjIwNjYwZjU5/ZmIyNC5wbmc.jpg"/>
      <itunes:duration>3749</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of NGBI Ideas, host Jim Wilson sits down with Alison Symington, a key leader in the Ontario life sciences community. Alison shares her journey from the UK to Canada, her academic pursuits, and her impactful career in life sciences. Discover how she bridges the gap between industry and academia, and her insights on the future of genomics and AI. Tune in for an inspiring conversation about innovation, collaboration, and the power of storytelling in science.</p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>S3.E1: Andrew Casey</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:episode>1</itunes:episode>
      <podcast:episode>1</podcast:episode>
      <itunes:title>S3.E1: Andrew Casey</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">e651a010-fc43-4a92-a8cf-9f5053b5a251</guid>
      <link>https://NGBIdeas.transistor.fm/s3/1</link>
      <description>
        <![CDATA[<p>In this episode of NGBideas, host Jim Wilson sits down with Andrew Casey, the outgoing President and former CEO of Biotech Canada. They discuss Andrew's journey from his early days in Montreal to leading one of Canada's most influential biotech organizations. Andrew shares insights on the challenges and triumphs of his career, the future of the biotech industry, and his thoughts on leadership and innovation. Tune in to hear about the pivotal moments that shaped his path and the next big ideas on his horizon.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this episode of NGBideas, host Jim Wilson sits down with Andrew Casey, the outgoing President and former CEO of Biotech Canada. They discuss Andrew's journey from his early days in Montreal to leading one of Canada's most influential biotech organizations. Andrew shares insights on the challenges and triumphs of his career, the future of the biotech industry, and his thoughts on leadership and innovation. Tune in to hear about the pivotal moments that shaped his path and the next big ideas on his horizon.</p>]]>
      </content:encoded>
      <pubDate>Tue, 26 Aug 2025 00:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/4e07cd44/fc917cf5.mp3" length="60738365" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/8PsOTxDjcr7z1FzxyFfIIuI3evuL1NOg1bKqdA6qLo8/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83ZjU0/OTAzZWRmNjNjMWI5/NmRmYWYxYWI2OTdi/YTkzZC5wbmc.jpg"/>
      <itunes:duration>3793</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this episode of NGBideas, host Jim Wilson sits down with Andrew Casey, the outgoing President and former CEO of Biotech Canada. They discuss Andrew's journey from his early days in Montreal to leading one of Canada's most influential biotech organizations. Andrew shares insights on the challenges and triumphs of his career, the future of the biotech industry, and his thoughts on leadership and innovation. Tune in to hear about the pivotal moments that shaped his path and the next big ideas on his horizon.</p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:person role="Host" href="https://www.LabOccupier.com" img="https://img.transistorcdn.com/27nclYGc1DNWQKEJOAl1ChqSrHtwY5ClyU1dr2K3z04/rs:fill:0:0:1/w:800/h:800/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTU1/Njc5YzY0MGE2OGMy/YTM3Yzk0OGE1ZTRh/NjhlZC5qcGc.jpg">Jim Wilson</podcast:person>
    </item>
    <item>
      <title>NGBi25 Podcasts Coming Soon</title>
      <itunes:season>3</itunes:season>
      <podcast:season>3</podcast:season>
      <itunes:title>NGBi25 Podcasts Coming Soon</itunes:title>
      <itunes:episodeType>trailer</itunes:episodeType>
      <guid isPermaLink="false">16651489-6bbb-4e20-a542-2a60f4c633f9</guid>
      <link>https://NGBIdeas.transistor.fm/episodes/ngbi25-podcast-coming-soon</link>
      <description>
        <![CDATA[]]>
      </description>
      <content:encoded>
        <![CDATA[]]>
      </content:encoded>
      <pubDate>Mon, 28 Jul 2025 14:53:49 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/3a6f8b8e/3380c25d.mp3" length="2021783" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:duration>122</itunes:duration>
      <itunes:summary>
        <![CDATA[]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S2.E13: Amol Karnick | KA Imaging</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:episode>13</itunes:episode>
      <podcast:episode>13</podcast:episode>
      <itunes:title>S2.E13: Amol Karnick | KA Imaging</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">142d6a9e-0cdf-46b6-b5ee-8d5e81399952</guid>
      <link>https://NGBIdeas.transistor.fm/s2/13</link>
      <description>
        <![CDATA[<p>July 23rd 2024 – This week we have the privilege of speaking with Amol Karnick, President and CEO of KA Imaging, spun out of the University of Waterloo, Ontario. Amol and his team are developing high dynamic range and lower dose x-ray detectors for the medical, industrial, and veterinary imaging markets. Their portable x-rays provide a high-resolution view of both hard and soft tissues, which Amol hopes will revolutionize medical imaging.</p><p>KA Imaging: <a href="https://kaimaging.com/"><strong>KAimaging.com</strong></a><br>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier:<strong> </strong><a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>July 23rd 2024 – This week we have the privilege of speaking with Amol Karnick, President and CEO of KA Imaging, spun out of the University of Waterloo, Ontario. Amol and his team are developing high dynamic range and lower dose x-ray detectors for the medical, industrial, and veterinary imaging markets. Their portable x-rays provide a high-resolution view of both hard and soft tissues, which Amol hopes will revolutionize medical imaging.</p><p>KA Imaging: <a href="https://kaimaging.com/"><strong>KAimaging.com</strong></a><br>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier:<strong> </strong><a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </content:encoded>
      <pubDate>Wed, 24 Jul 2024 10:51:52 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/5bd52e3a/59f63da8.mp3" length="56360112" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/NFz1chemCIFaoLf4hx9-T0Motc2YIN5c_CPu7-M58xU/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83ODcx/MTlhYjRkMzBiNjQ5/ODM4OTFkNWViYTE2/NTU4Ny5wbmc.jpg"/>
      <itunes:duration>3519</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>July 23rd 2024 – This week we have the privilege of speaking with Amol Karnick, President and CEO of KA Imaging, spun out of the University of Waterloo, Ontario. Amol and his team are developing high dynamic range and lower dose x-ray detectors for the medical, industrial, and veterinary imaging markets. Their portable x-rays provide a high-resolution view of both hard and soft tissues, which Amol hopes will revolutionize medical imaging.</p><p>KA Imaging: <a href="https://kaimaging.com/"><strong>KAimaging.com</strong></a><br>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier:<strong> </strong><a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S2.E12: Karen Mossman | McMaster University</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:episode>12</itunes:episode>
      <podcast:episode>12</podcast:episode>
      <itunes:title>S2.E12: Karen Mossman | McMaster University</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">c8695b57-303d-48f4-9af5-e9a7ed5557f8</guid>
      <link>https://NGBIdeas.transistor.fm/s2/12</link>
      <description>
        <![CDATA[<p>July 2nd 2024 – Join us this week as we have the privilege of speaking with Dr. Karen Mossman, a researcher and innovation leader from McMaster University in Hamilton, Ontario. Karen previously served as the Vice President of Research at McMaster and was part of the team of researchers who first isolated the COVID-19 virus. We discuss her early aspirations, challenges in academia, and the importance of mentorship and support.</p><p>McMaster University: <a href="https://www.mcmaster.ca/"><strong>mcmaster.ca</strong></a><br>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>July 2nd 2024 – Join us this week as we have the privilege of speaking with Dr. Karen Mossman, a researcher and innovation leader from McMaster University in Hamilton, Ontario. Karen previously served as the Vice President of Research at McMaster and was part of the team of researchers who first isolated the COVID-19 virus. We discuss her early aspirations, challenges in academia, and the importance of mentorship and support.</p><p>McMaster University: <a href="https://www.mcmaster.ca/"><strong>mcmaster.ca</strong></a><br>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </content:encoded>
      <pubDate>Tue, 02 Jul 2024 09:12:28 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/fbf1526d/2b5c71af.mp3" length="57925719" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/oBdR5GzY50oUzXyeFL-N8gWCCn3VLtZbm1NZbxhk4U8/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mYzQz/ZTQ5ZWRmNzY2NmVi/NDQ2MGQ4Y2RiOGRl/OWFmNi5qcGc.jpg"/>
      <itunes:duration>3617</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>July 2nd 2024 – Join us this week as we have the privilege of speaking with Dr. Karen Mossman, a researcher and innovation leader from McMaster University in Hamilton, Ontario. Karen previously served as the Vice President of Research at McMaster and was part of the team of researchers who first isolated the COVID-19 virus. We discuss her early aspirations, challenges in academia, and the importance of mentorship and support.</p><p>McMaster University: <a href="https://www.mcmaster.ca/"><strong>mcmaster.ca</strong></a><br>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S2.E11: Penny Walsh-McGuire | CASTL</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:episode>11</itunes:episode>
      <podcast:episode>11</podcast:episode>
      <itunes:title>S2.E11: Penny Walsh-McGuire | CASTL</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">2a7a47e5-b392-4072-8ba0-d9a63b45abf1</guid>
      <link>https://NGBIdeas.transistor.fm/s2/11</link>
      <description>
        <![CDATA[<p>June 25th 2024 – We are thrilled to announce that this week we will be welcoming Penny Walsh-McGuire from the Canadian Alliance for Skills and Training in Life Sciences (CASTL), based in Charlottetown, PEI. Join us as we delve into CASTL's role in the Canadian life sciences ecosystem, how they are fostering the next generation of biopharmaceutical manufacturing professionals, and learn about Penny’s journey from her roots in Savage Harbour, PEI to the boardroom.</p><p>CASTL: <a href="https://www.castlcanada.ca/en/"><strong>castlcanada.ca</strong></a><br>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>June 25th 2024 – We are thrilled to announce that this week we will be welcoming Penny Walsh-McGuire from the Canadian Alliance for Skills and Training in Life Sciences (CASTL), based in Charlottetown, PEI. Join us as we delve into CASTL's role in the Canadian life sciences ecosystem, how they are fostering the next generation of biopharmaceutical manufacturing professionals, and learn about Penny’s journey from her roots in Savage Harbour, PEI to the boardroom.</p><p>CASTL: <a href="https://www.castlcanada.ca/en/"><strong>castlcanada.ca</strong></a><br>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </content:encoded>
      <pubDate>Tue, 25 Jun 2024 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/2bd59a78/351dbc15.mp3" length="59425582" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/zS5DwKooPGUGIlingOm7Z_XDeKk5l6J9e7gMskYH09M/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84OGY0/MGZiZDI4ZWUzNDk0/NjQ4NzRiZDVmNTJj/OGI1Ni5wbmc.jpg"/>
      <itunes:duration>3711</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>June 25th 2024 – We are thrilled to announce that this week we will be welcoming Penny Walsh-McGuire from the Canadian Alliance for Skills and Training in Life Sciences (CASTL), based in Charlottetown, PEI. Join us as we delve into CASTL's role in the Canadian life sciences ecosystem, how they are fostering the next generation of biopharmaceutical manufacturing professionals, and learn about Penny’s journey from her roots in Savage Harbour, PEI to the boardroom.</p><p>CASTL: <a href="https://www.castlcanada.ca/en/"><strong>castlcanada.ca</strong></a><br>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S2.E10: Sarah Howe | St. Joseph's Research Institute</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:episode>10</itunes:episode>
      <podcast:episode>10</podcast:episode>
      <itunes:title>S2.E10: Sarah Howe | St. Joseph's Research Institute</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">d027e334-fb6e-41d9-969c-433844670ccb</guid>
      <link>https://NGBIdeas.transistor.fm/s2/10</link>
      <description>
        <![CDATA[<p>June 18th 2024 – This week, we welcome Sarah Howe, Chief Operating Officer of St. Joseph’s Research Center in Hamilton, Ontario. Join us as we delve into Sarah’s journey, from founding Y-Space at York University to her triumphs and challenges in leading the next generation of mental health, lung and chest, kidney, and genitourinary research in Canada.</p><p>St. Joe's Research Institute: <a href="https://research.stjoes.ca/"><strong>research.stjoes.ca</strong></a><br>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>June 18th 2024 – This week, we welcome Sarah Howe, Chief Operating Officer of St. Joseph’s Research Center in Hamilton, Ontario. Join us as we delve into Sarah’s journey, from founding Y-Space at York University to her triumphs and challenges in leading the next generation of mental health, lung and chest, kidney, and genitourinary research in Canada.</p><p>St. Joe's Research Institute: <a href="https://research.stjoes.ca/"><strong>research.stjoes.ca</strong></a><br>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </content:encoded>
      <pubDate>Tue, 18 Jun 2024 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/430e041e/a23a5dc2.mp3" length="60031803" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/qDMjxUsMgL6JcfCF3j_el_99q8b6T6cRdbhC_YejJ3U/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83ZTZi/N2U1Y2I3ZWNiM2Q4/NjAyNjQ5OTE4MjRl/NTdhZS5qcGc.jpg"/>
      <itunes:duration>3749</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>June 18th 2024 – This week, we welcome Sarah Howe, Chief Operating Officer of St. Joseph’s Research Center in Hamilton, Ontario. Join us as we delve into Sarah’s journey, from founding Y-Space at York University to her triumphs and challenges in leading the next generation of mental health, lung and chest, kidney, and genitourinary research in Canada.</p><p>St. Joe's Research Institute: <a href="https://research.stjoes.ca/"><strong>research.stjoes.ca</strong></a><br>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S2.E9: Ivy Parks | BD Canada</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:episode>9</itunes:episode>
      <podcast:episode>9</podcast:episode>
      <itunes:title>S2.E9: Ivy Parks | BD Canada</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">f6f47e44-88dd-4976-bd30-8a58d8ea67f1</guid>
      <link>https://NGBIdeas.transistor.fm/s2/9</link>
      <description>
        <![CDATA[<p>June 11th 2024 –  This week, we have the pleasure of speaking with Ivy Parks, President of BD Canada. Ivy's  journey began in a customer service role, and over the past 20 years, she has risen through the ranks to lead the company. Join us as we explore her career path, the challenges she has overcome, and her vision for the future of BD Canada. </p><p>BD Canada: <a href="https://www.bd.com/en-ca"><strong>BD.com</strong></a> <br>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>June 11th 2024 –  This week, we have the pleasure of speaking with Ivy Parks, President of BD Canada. Ivy's  journey began in a customer service role, and over the past 20 years, she has risen through the ranks to lead the company. Join us as we explore her career path, the challenges she has overcome, and her vision for the future of BD Canada. </p><p>BD Canada: <a href="https://www.bd.com/en-ca"><strong>BD.com</strong></a> <br>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </content:encoded>
      <pubDate>Tue, 11 Jun 2024 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/83656159/1d96e380.mp3" length="56431801" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/0TOjzCiZKYhTmqyF0yjX6cfr-j9Z-JaBxRo4c5yijms/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wMmRh/ODQzNGE5ZjNkZDU1/NGE5MzI3NjQ1ODU0/NGI4MC5qcGc.jpg"/>
      <itunes:duration>3524</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>June 11th 2024 –  This week, we have the pleasure of speaking with Ivy Parks, President of BD Canada. Ivy's  journey began in a customer service role, and over the past 20 years, she has risen through the ranks to lead the company. Join us as we explore her career path, the challenges she has overcome, and her vision for the future of BD Canada. </p><p>BD Canada: <a href="https://www.bd.com/en-ca"><strong>BD.com</strong></a> <br>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S2.E8: Tom Mikkelsen | Ontario Brain Institute </title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:episode>8</itunes:episode>
      <podcast:episode>8</podcast:episode>
      <itunes:title>S2.E8: Tom Mikkelsen | Ontario Brain Institute </itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">22b493e3-6ab7-4150-8fcb-f8a8dd542b2e</guid>
      <link>https://NGBIdeas.transistor.fm/s2/8</link>
      <description>
        <![CDATA[<p>May 28th 2024 – Join us this week for a conversation with Dr. Tom Mikkelsen, President and Scientific Director of the Ontario Brain Institute in Toronto, Ontario, and Co-Director of the Hermelin Brain Center at Henry Ford Hospital in Detroit, Michigan. Dr. Mikkelsen is recognized as one of the top 0.04% of scholars researching glioblastoma, the most aggressive form of brain cancer, over the past decade.</p><p>Ontario Brain Institute: <a href="https://braininstitute.ca/"><strong>braininstitute.ca</strong></a><br>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>May 28th 2024 – Join us this week for a conversation with Dr. Tom Mikkelsen, President and Scientific Director of the Ontario Brain Institute in Toronto, Ontario, and Co-Director of the Hermelin Brain Center at Henry Ford Hospital in Detroit, Michigan. Dr. Mikkelsen is recognized as one of the top 0.04% of scholars researching glioblastoma, the most aggressive form of brain cancer, over the past decade.</p><p>Ontario Brain Institute: <a href="https://braininstitute.ca/"><strong>braininstitute.ca</strong></a><br>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </content:encoded>
      <pubDate>Tue, 28 May 2024 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/5debf2ef/44fc475c.mp3" length="59115953" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/J_e3ncruoKSpAx57SaFOU2IlFjnrU7hPMGRGpqv1aAw/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zMzE1/ZDA3ZDRkODkzZGRk/YzIzNmI4YzJjZTAy/ZDkyMS5wbmc.jpg"/>
      <itunes:duration>3692</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>May 28th 2024 – Join us this week for a conversation with Dr. Tom Mikkelsen, President and Scientific Director of the Ontario Brain Institute in Toronto, Ontario, and Co-Director of the Hermelin Brain Center at Henry Ford Hospital in Detroit, Michigan. Dr. Mikkelsen is recognized as one of the top 0.04% of scholars researching glioblastoma, the most aggressive form of brain cancer, over the past decade.</p><p>Ontario Brain Institute: <a href="https://braininstitute.ca/"><strong>braininstitute.ca</strong></a><br>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S2.E7: Nicole Dekort | Medtech Canada</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:episode>7</itunes:episode>
      <podcast:episode>7</podcast:episode>
      <itunes:title>S2.E7: Nicole Dekort | Medtech Canada</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">5489375d-3eb1-483b-b9f2-44b7de9f33d0</guid>
      <link>https://NGBIdeas.transistor.fm/s2/7</link>
      <description>
        <![CDATA[<p>May 22nd 2024 – This week we’re thrilled to welcome Nicole Dekort, President &amp; CEO of Medtech Canada. Join us as we dive into Nicole's journey, from her early days with the Ontario Liberal Party to leading Medtech Canada, and the triumphs and losses along the way. </p><p>Medtech Canada: <a href="https://medtechcanada.org/"><strong>medtechcanada.org</strong></a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>May 22nd 2024 – This week we’re thrilled to welcome Nicole Dekort, President &amp; CEO of Medtech Canada. Join us as we dive into Nicole's journey, from her early days with the Ontario Liberal Party to leading Medtech Canada, and the triumphs and losses along the way. </p><p>Medtech Canada: <a href="https://medtechcanada.org/"><strong>medtechcanada.org</strong></a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </content:encoded>
      <pubDate>Wed, 22 May 2024 15:41:03 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/4cb880d9/64301df8.mp3" length="60669664" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/rbH7cImiG2W206_aXkyTthJKNmlkK0YuiSji9Zt7uJ8/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xYWE1/NjljY2QyZTQ4YTYz/NGYyZDA1N2ZhMGM0/NjM5OC5wbmc.jpg"/>
      <itunes:duration>3789</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>May 22nd 2024 – This week we’re thrilled to welcome Nicole Dekort, President &amp; CEO of Medtech Canada. Join us as we dive into Nicole's journey, from her early days with the Ontario Liberal Party to leading Medtech Canada, and the triumphs and losses along the way. </p><p>Medtech Canada: <a href="https://medtechcanada.org/"><strong>medtechcanada.org</strong></a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/"><strong>nextgreatbigideas.com</strong></a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/"><strong>laboccupier.com</strong></a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S2.E6: Raphael Ronen | Sunnybrook Research Institute</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:episode>6</itunes:episode>
      <podcast:episode>6</podcast:episode>
      <itunes:title>S2.E6: Raphael Ronen | Sunnybrook Research Institute</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">0fd1d9aa-f4c8-421a-b4c0-4d0342741ee7</guid>
      <link>https://NGBIdeas.transistor.fm/s2/6</link>
      <description>
        <![CDATA[<p>May 14th 2024 – Our guest this week is Raphael Ronen, Director of Business Development at Sunnybrook Research Institute. Sunnybrook holds the designation of being recognized as a Centre of Excellence by the Focused Ultrasound Foundation—the first in Canada, and one of only seven worldwide. Regarded as one of the most comprehensive and globally successful programs, Raphael helps get their technology from the bench and into the hands of doctors.</p><p>Sunnybrook Research Institute: sunnybrook.ca/research/</p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>May 14th 2024 – Our guest this week is Raphael Ronen, Director of Business Development at Sunnybrook Research Institute. Sunnybrook holds the designation of being recognized as a Centre of Excellence by the Focused Ultrasound Foundation—the first in Canada, and one of only seven worldwide. Regarded as one of the most comprehensive and globally successful programs, Raphael helps get their technology from the bench and into the hands of doctors.</p><p>Sunnybrook Research Institute: sunnybrook.ca/research/</p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 14 May 2024 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/47066fb4/19c902c4.mp3" length="57936316" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/j-upgEmofEZ3ULcIlQaJsI0oeijs0z7K2-Z52qyJ9_8/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS82ZDJj/OTEwZDRhNGMxZjhh/NjUwMGQ0MzEyODQx/M2MxOC5wbmc.jpg"/>
      <itunes:duration>3618</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>May 14th 2024 – Our guest this week is Raphael Ronen, Director of Business Development at Sunnybrook Research Institute. Sunnybrook holds the designation of being recognized as a Centre of Excellence by the Focused Ultrasound Foundation—the first in Canada, and one of only seven worldwide. Regarded as one of the most comprehensive and globally successful programs, Raphael helps get their technology from the bench and into the hands of doctors.</p><p>Sunnybrook Research Institute: sunnybrook.ca/research/</p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S2.E5: Tamara Seales | Seaford Pharmaceuticals </title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:episode>5</itunes:episode>
      <podcast:episode>5</podcast:episode>
      <itunes:title>S2.E5: Tamara Seales | Seaford Pharmaceuticals </itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">08638001-d7c1-4236-a5c5-80f90affd312</guid>
      <link>https://ngbideas.transistor.fm/tamara-seales</link>
      <description>
        <![CDATA[<p>May 7th, 2024 – Join us this week as we welcome Tamara Seales, President of Seaford Pharmaceuticals, a Canadian-made and family-owned business. Founded in 1991 by the Seales family, Seaford Pharmaceuticals boasts a proud legacy. Today, Tamara leads the company, continuing the vision set forth by her father, Ron Seales. Under her guidance, Seaford Pharmaceuticals is dedicated to developing pharmaceutical solutions for both in-hospital and home settings.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>May 7th, 2024 – Join us this week as we welcome Tamara Seales, President of Seaford Pharmaceuticals, a Canadian-made and family-owned business. Founded in 1991 by the Seales family, Seaford Pharmaceuticals boasts a proud legacy. Today, Tamara leads the company, continuing the vision set forth by her father, Ron Seales. Under her guidance, Seaford Pharmaceuticals is dedicated to developing pharmaceutical solutions for both in-hospital and home settings.</p>]]>
      </content:encoded>
      <pubDate>Tue, 07 May 2024 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/31d75f24/48f42391.mp3" length="59476834" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/qh4tekxLYY8fLTJcAraCQ5IMCxTQCtDufkD5T4G4z8g/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iNDNj/YjRmZDlhZmNhMzNh/MzRhMmIwNzRiNjNm/ZWQ4My5wbmc.jpg"/>
      <itunes:duration>3714</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>May 7th, 2024 – Join us this week as we welcome Tamara Seales, President of Seaford Pharmaceuticals, a Canadian-made and family-owned business. Founded in 1991 by the Seales family, Seaford Pharmaceuticals boasts a proud legacy. Today, Tamara leads the company, continuing the vision set forth by her father, Ron Seales. Under her guidance, Seaford Pharmaceuticals is dedicated to developing pharmaceutical solutions for both in-hospital and home settings.</p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S2.E4: Rob Henderson | BioTalent Canada</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:episode>4</itunes:episode>
      <podcast:episode>4</podcast:episode>
      <itunes:title>S2.E4: Rob Henderson | BioTalent Canada</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">c0127472-60b3-4d2d-b48b-7f844cbeb300</guid>
      <link>https://NGBIdeas.transistor.fm/s2/4</link>
      <description>
        <![CDATA[<p>April 16th 2024 – This week we’re speaking with Rob Henderson, the President and CEO of BioTalent Canada, a national not-for-profit organization headquartered in Ottawa. Since Rob assumed leadership in 2011, the organization has expanded from a team of five to now employing 50 staff members and collaborating with over 80 partner organizations. In 2023, BioTalent Canada received accolades, being named a top workplace in healthcare by HRD Canada and recognized as a five-star employer for diversity, equity, and inclusion.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>April 16th 2024 – This week we’re speaking with Rob Henderson, the President and CEO of BioTalent Canada, a national not-for-profit organization headquartered in Ottawa. Since Rob assumed leadership in 2011, the organization has expanded from a team of five to now employing 50 staff members and collaborating with over 80 partner organizations. In 2023, BioTalent Canada received accolades, being named a top workplace in healthcare by HRD Canada and recognized as a five-star employer for diversity, equity, and inclusion.</p>]]>
      </content:encoded>
      <pubDate>Tue, 16 Apr 2024 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/dbd41f07/8dca1eb2.mp3" length="131488279" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/641x8h0IyBOCtgIqH9Kbi9SdbV8Uuf0i1E8cEZLF66A/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83Nzcz/ZWZjZjIyOTQ2ZDhm/M2MxM2QzMWM5Mjcz/ZDlkYS5wbmc.jpg"/>
      <itunes:duration>4109</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>April 16th 2024 – This week we’re speaking with Rob Henderson, the President and CEO of BioTalent Canada, a national not-for-profit organization headquartered in Ottawa. Since Rob assumed leadership in 2011, the organization has expanded from a team of five to now employing 50 staff members and collaborating with over 80 partner organizations. In 2023, BioTalent Canada received accolades, being named a top workplace in healthcare by HRD Canada and recognized as a five-star employer for diversity, equity, and inclusion.</p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S2.E3: Christine Allen | University of Toronto</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:episode>3</itunes:episode>
      <podcast:episode>3</podcast:episode>
      <itunes:title>S2.E3: Christine Allen | University of Toronto</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">feaa99c5-d1d1-4608-9203-635092f13bc4</guid>
      <link>https://NGBIdeas.transistor.fm/s2/3</link>
      <description>
        <![CDATA[<p>April 9th 2024 – We welcome professor Christine Allen from the University of Toronto, a renowned figure in drug formulation and development, and a distinguished researcher, industry leader, and entrepreneur. A co-founder of NanoVista, recognized in its groundbreaking work in high-precision, image-guided cancer therapy, Christine has held key roles in various biotech and pharmaceutical companies. Recently her startup, Intrepid Labs, has just come out of stealth mode. </p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>April 9th 2024 – We welcome professor Christine Allen from the University of Toronto, a renowned figure in drug formulation and development, and a distinguished researcher, industry leader, and entrepreneur. A co-founder of NanoVista, recognized in its groundbreaking work in high-precision, image-guided cancer therapy, Christine has held key roles in various biotech and pharmaceutical companies. Recently her startup, Intrepid Labs, has just come out of stealth mode. </p>]]>
      </content:encoded>
      <pubDate>Tue, 09 Apr 2024 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/6b6659a5/d462144d.mp3" length="132624890" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/xKSaTdmc5GJOO2DiLrDTqqJ15oGpO2eON-QyzeIMI_Y/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81N2Zj/YTIyNWU3MDc0YjEz/MjNjZGI4NzM2YjQy/OGZkNi5wbmc.jpg"/>
      <itunes:duration>4143</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>April 9th 2024 – We welcome professor Christine Allen from the University of Toronto, a renowned figure in drug formulation and development, and a distinguished researcher, industry leader, and entrepreneur. A co-founder of NanoVista, recognized in its groundbreaking work in high-precision, image-guided cancer therapy, Christine has held key roles in various biotech and pharmaceutical companies. Recently her startup, Intrepid Labs, has just come out of stealth mode. </p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S2.E2: Mark Smithyes | Janus Life Sciences Consulting</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:episode>2</itunes:episode>
      <podcast:episode>2</podcast:episode>
      <itunes:title>S2.E2: Mark Smithyes | Janus Life Sciences Consulting</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">d0ea3144-530d-41c8-a35d-027cbd6a73db</guid>
      <link>https://NGBIdeas.transistor.fm/s2/2</link>
      <description>
        <![CDATA[<p>April 2nd 2024 - Join us this week as we welcome Mark Smithyes, President of Janus Life Sciences Consulting and National Director of Life Sciences at Delphic Research. With an extensive background in the industry, including serving as the former chair of Life Sciences Ontario, Mark shares his insights on founding startups, his extensive volunteer work, and his advocacy for Canada's Life Sciences sector. </p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>April 2nd 2024 - Join us this week as we welcome Mark Smithyes, President of Janus Life Sciences Consulting and National Director of Life Sciences at Delphic Research. With an extensive background in the industry, including serving as the former chair of Life Sciences Ontario, Mark shares his insights on founding startups, his extensive volunteer work, and his advocacy for Canada's Life Sciences sector. </p>]]>
      </content:encoded>
      <pubDate>Tue, 02 Apr 2024 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/9789d2e3/a5f84335.mp3" length="163291761" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/2SD_gcqZkosnAE2mKWaNK8PWfCd1OPM4au_J0xV3OKU/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lcGlz/b2RlLzE4MjU2MjUv/MTcxMTk5MjE3MC1h/cnR3b3JrLmpwZw.jpg"/>
      <itunes:duration>5102</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>April 2nd 2024 - Join us this week as we welcome Mark Smithyes, President of Janus Life Sciences Consulting and National Director of Life Sciences at Delphic Research. With an extensive background in the industry, including serving as the former chair of Life Sciences Ontario, Mark shares his insights on founding startups, his extensive volunteer work, and his advocacy for Canada's Life Sciences sector. </p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S2.E1: Brad Wouters | University Health Network</title>
      <itunes:season>2</itunes:season>
      <podcast:season>2</podcast:season>
      <itunes:episode>1</itunes:episode>
      <podcast:episode>1</podcast:episode>
      <itunes:title>S2.E1: Brad Wouters | University Health Network</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">7547ac60-048c-49a7-a6f6-83a5caab6127</guid>
      <link>https://NGBIdeas.transistor.fm/s2/1</link>
      <description>
        <![CDATA[<p>March 26th 2024 - Our guest this week is Brad Wouters, Executive Vice-President of Science and Research at University Health Network.  We appreciate Brad talking about his passion for Medical Biophysics, his post-doctoral work at Stanford, his time in the Netherlands  and what inspired his return to Canada to join UHN.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>March 26th 2024 - Our guest this week is Brad Wouters, Executive Vice-President of Science and Research at University Health Network.  We appreciate Brad talking about his passion for Medical Biophysics, his post-doctoral work at Stanford, his time in the Netherlands  and what inspired his return to Canada to join UHN.</p>]]>
      </content:encoded>
      <pubDate>Tue, 26 Mar 2024 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/277805b4/e96fe1d5.mp3" length="135122288" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/hVXz0Sp_0c5g7vLd0aJctedAw_4oCqUBD3A75-LZNq8/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lcGlz/b2RlLzE3OTkzMTEv/MTcxMTQ1NzM3NS1h/cnR3b3JrLmpwZw.jpg"/>
      <itunes:duration>4222</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>March 26th 2024 - Our guest this week is Brad Wouters, Executive Vice-President of Science and Research at University Health Network.  We appreciate Brad talking about his passion for Medical Biophysics, his post-doctoral work at Stanford, his time in the Netherlands  and what inspired his return to Canada to join UHN.</p>]]>
      </itunes:summary>
      <itunes:keywords>science, life sciences, technology, research, medical biophysics, Canadian Life Sciences, Canadian Science, Toronto</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E29: Dave Smardon | Bioenterprise Canada</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>29</itunes:episode>
      <podcast:episode>29</podcast:episode>
      <itunes:title>S1.E29: Dave Smardon | Bioenterprise Canada</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/faf4ec7c-4076-3f0d-89b1-bd58b4530b4a</guid>
      <link>https://NGBIdeas.transistor.fm/s1/29</link>
      <description>
        <![CDATA[<p>Sep 19, 2023 - Our guest this week is Dave Smardon, who is President and CEO of Bioenterprise, Canada's food and Agri tech engine. We are delighted to have Dave talk about his passion for music, his early years of the insurance sector, how he pivoted into tech, then venture-capital, and eventually into running one of the key Agri tech organizations in Canada's life sciences industry.</p><p> </p><p>Bioenterprise Canada: <a href="https://www.bioenterprise.ca/">bioenterprise.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Sep 19, 2023 - Our guest this week is Dave Smardon, who is President and CEO of Bioenterprise, Canada's food and Agri tech engine. We are delighted to have Dave talk about his passion for music, his early years of the insurance sector, how he pivoted into tech, then venture-capital, and eventually into running one of the key Agri tech organizations in Canada's life sciences industry.</p><p> </p><p>Bioenterprise Canada: <a href="https://www.bioenterprise.ca/">bioenterprise.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 19 Sep 2023 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/cad19ac3/e6990043.mp3" length="58372242" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/0V-nFxi5uHv8V2BnaptfyMDB9pWsqC-bvOALmClQZzU/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hMTk0/NTZmMDE0Y2IxNjlk/MzZiMzZhMTUwYWUx/ZGI1ZC53ZWJw.jpg"/>
      <itunes:duration>3450</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Sep 19, 2023 - Our guest this week is Dave Smardon, who is President and CEO of Bioenterprise, Canada's food and Agri tech engine. We are delighted to have Dave talk about his passion for music, his early years of the insurance sector, how he pivoted into tech, then venture-capital, and eventually into running one of the key Agri tech organizations in Canada's life sciences industry.</p><p> </p><p>Bioenterprise Canada: <a href="https://www.bioenterprise.ca/">bioenterprise.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E28: Gordon McCauley | AdMare Bioinnovations</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>28</itunes:episode>
      <podcast:episode>28</podcast:episode>
      <itunes:title>S1.E28: Gordon McCauley | AdMare Bioinnovations</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/29029d1c-1c4c-3963-a9c6-4b7ecdac935f</guid>
      <link>https://NGBIdeas.transistor.fm/s1/28</link>
      <description>
        <![CDATA[<p>Sep 12, 2023 - Our guest this week is Gordon McCauley, who is President and CEO of AdMare Bioinnovations.</p><p>We talk today about how Gordon navigated from politics to investment banking to becoming one of the key leaders in the Canadian life sciences community. For decades, scaling start ups in Canada's life sciences sector have struggled for funding, facilities, and support. Most cities across Canada with universities that have strong faculties in medicine, business, science and engineering and direct relationships with a research Hospital have had nascent life sciences hubs. The goal of AdMare Bioinnovations is to be a national catalyst for growing these hubs and the community at large.</p><p> </p><p> AdMare Bioinnovations: <a href="https://www.admarebio.com/en/">admarebio.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Sep 12, 2023 - Our guest this week is Gordon McCauley, who is President and CEO of AdMare Bioinnovations.</p><p>We talk today about how Gordon navigated from politics to investment banking to becoming one of the key leaders in the Canadian life sciences community. For decades, scaling start ups in Canada's life sciences sector have struggled for funding, facilities, and support. Most cities across Canada with universities that have strong faculties in medicine, business, science and engineering and direct relationships with a research Hospital have had nascent life sciences hubs. The goal of AdMare Bioinnovations is to be a national catalyst for growing these hubs and the community at large.</p><p> </p><p> AdMare Bioinnovations: <a href="https://www.admarebio.com/en/">admarebio.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 12 Sep 2023 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/1e0370eb/68705e85.mp3" length="63643261" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/SOi-fYwOzSx3olNZJoIJ00rehgEb_zMmpSpZLjHkPi8/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hMTk3/NGViMmEyZjk4ZDVl/ZjA2NDQ5YmU5NjNk/NjQ0ZC53ZWJw.jpg"/>
      <itunes:duration>3853</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Sep 12, 2023 - Our guest this week is Gordon McCauley, who is President and CEO of AdMare Bioinnovations.</p><p>We talk today about how Gordon navigated from politics to investment banking to becoming one of the key leaders in the Canadian life sciences community. For decades, scaling start ups in Canada's life sciences sector have struggled for funding, facilities, and support. Most cities across Canada with universities that have strong faculties in medicine, business, science and engineering and direct relationships with a research Hospital have had nascent life sciences hubs. The goal of AdMare Bioinnovations is to be a national catalyst for growing these hubs and the community at large.</p><p> </p><p> AdMare Bioinnovations: <a href="https://www.admarebio.com/en/">admarebio.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E27: Cate Murray | Stem Cell Network</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>27</itunes:episode>
      <podcast:episode>27</podcast:episode>
      <itunes:title>S1.E27: Cate Murray | Stem Cell Network</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/269149d7-0b82-3314-83f0-a4b11ca26b45</guid>
      <link>https://ngbideas.transistor.fm/episodes/s1-e27-cate-murray-stem-cell-network</link>
      <description>
        <![CDATA[<p>Aug 29, 2023 - Our guest this week is Cate Murray, who is President and CEO of the Stem Cell Network (SCN) in Ottawa. This organization is a Canadian not-for-profit that supports three main objectives. First, stem cell and regenerative medicine research secondly, training the next generation of researchers and lastly supporting and sharing research in this incredible field. SCN was created in 2001 with support from the federal government and the network has grown from a few dozen labs to include more than 270 world-class research groups and dozens of clinical trials. </p><p> </p><p>Stem Cell Network: <a href="https://stemcellnetwork.ca/">stemcellnetwork.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Aug 29, 2023 - Our guest this week is Cate Murray, who is President and CEO of the Stem Cell Network (SCN) in Ottawa. This organization is a Canadian not-for-profit that supports three main objectives. First, stem cell and regenerative medicine research secondly, training the next generation of researchers and lastly supporting and sharing research in this incredible field. SCN was created in 2001 with support from the federal government and the network has grown from a few dozen labs to include more than 270 world-class research groups and dozens of clinical trials. </p><p> </p><p>Stem Cell Network: <a href="https://stemcellnetwork.ca/">stemcellnetwork.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 29 Aug 2023 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/0eb6fda3/dfc721db.mp3" length="58859575" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/HXbWrF6taL8vJ1gIZ57Mf5kVo3W7XAC1i7crmSQ6R_Q/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iZThm/ZWIzYTdhNTI4NzM0/NTkzMDY4NGYxZjEw/Y2VmMy53ZWJw.jpg"/>
      <itunes:duration>3750</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Aug 29, 2023 - Our guest this week is Cate Murray, who is President and CEO of the Stem Cell Network (SCN) in Ottawa. This organization is a Canadian not-for-profit that supports three main objectives. First, stem cell and regenerative medicine research secondly, training the next generation of researchers and lastly supporting and sharing research in this incredible field. SCN was created in 2001 with support from the federal government and the network has grown from a few dozen labs to include more than 270 world-class research groups and dozens of clinical trials. </p><p> </p><p>Stem Cell Network: <a href="https://stemcellnetwork.ca/">stemcellnetwork.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E26: Ella Korets-Smith | Virica Biotech</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>26</itunes:episode>
      <podcast:episode>26</podcast:episode>
      <itunes:title>S1.E26: Ella Korets-Smith | Virica Biotech</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/9a1a970a-79a1-38e3-af50-f716891d4ebc</guid>
      <link>https://NGBIdeas.transistor.fm/s1/26</link>
      <description>
        <![CDATA[<p>Aug 22, 2023 - Our guest this week is Ella Korets-Smith, who is Co-Founder and Chief Strategy Officer of Virica Biotech in Ottawa, Ontario. Virica Biotech has developed unique viral sensitizers to turn off antiviral responses in cells. The work they're doing is exciting and another example of the groundbreaking research being done in Canadian life sciences. Ella and her family immigrated to Canada from eastern Ukraine in 1990 and hard work, resilience, recognizing when to pivot, knowing what to do with the door opens, and how to overcome imposter syndrome are some of the topics Ella and  I touch on today. </p><p> </p><p>Virica Biotech: <a href="https://www.viricabiotech.com/">viricabiotech.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Aug 22, 2023 - Our guest this week is Ella Korets-Smith, who is Co-Founder and Chief Strategy Officer of Virica Biotech in Ottawa, Ontario. Virica Biotech has developed unique viral sensitizers to turn off antiviral responses in cells. The work they're doing is exciting and another example of the groundbreaking research being done in Canadian life sciences. Ella and her family immigrated to Canada from eastern Ukraine in 1990 and hard work, resilience, recognizing when to pivot, knowing what to do with the door opens, and how to overcome imposter syndrome are some of the topics Ella and  I touch on today. </p><p> </p><p>Virica Biotech: <a href="https://www.viricabiotech.com/">viricabiotech.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 22 Aug 2023 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/67e2f7ea/6d6246ab.mp3" length="59013680" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/iYG-IqjLa4mBzICrvNRpt6uY1hrhyrssfefP4QzXzTE/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjZi/MzVlYWY2ZWMzY2Zi/OTY3ZjIwOGFlNTE4/OTMzZi53ZWJw.jpg"/>
      <itunes:duration>3736</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Aug 22, 2023 - Our guest this week is Ella Korets-Smith, who is Co-Founder and Chief Strategy Officer of Virica Biotech in Ottawa, Ontario. Virica Biotech has developed unique viral sensitizers to turn off antiviral responses in cells. The work they're doing is exciting and another example of the groundbreaking research being done in Canadian life sciences. Ella and her family immigrated to Canada from eastern Ukraine in 1990 and hard work, resilience, recognizing when to pivot, knowing what to do with the door opens, and how to overcome imposter syndrome are some of the topics Ella and  I touch on today. </p><p> </p><p>Virica Biotech: <a href="https://www.viricabiotech.com/">viricabiotech.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E25: Bruce Squires | McMaster Children’s Hospital</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>25</itunes:episode>
      <podcast:episode>25</podcast:episode>
      <itunes:title>S1.E25: Bruce Squires | McMaster Children’s Hospital</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/6e379eb7-8ecb-3426-9acd-1d33484b8d87</guid>
      <link>https://NGBIdeas.transistor.fm/s1/25</link>
      <description>
        <![CDATA[<p>Aug 15, 2023 - Our guest this week is Bruce Squires, who is President of McMaster Children's Hospital in Hamilton Ontario. Today's show is a bit of a departure from our regular format. We touch on Bruce's journey but our focus today is about the hospital he now leads which is the organization that the NGBIdeas podcast was created to support. McMaster Children's Hospital is one of the top critical care paediatric hospitals in Canada and it provides support to families in need from Niagara Falls to Waterloo in the north to Owen Sound and Grey County. Like many impressive organizations, the team at MCH focuses on their work rather than telling people about it. So our goal today is to give our listeners a glimpse into the great work being done by the great team at this organization.</p><p> </p><p>McMaster Children's Hospital: <a href="https://www.hamiltonhealthsciences.ca/mcmaster-childrens-hospital/">McMaster Children's Hospital</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Aug 15, 2023 - Our guest this week is Bruce Squires, who is President of McMaster Children's Hospital in Hamilton Ontario. Today's show is a bit of a departure from our regular format. We touch on Bruce's journey but our focus today is about the hospital he now leads which is the organization that the NGBIdeas podcast was created to support. McMaster Children's Hospital is one of the top critical care paediatric hospitals in Canada and it provides support to families in need from Niagara Falls to Waterloo in the north to Owen Sound and Grey County. Like many impressive organizations, the team at MCH focuses on their work rather than telling people about it. So our goal today is to give our listeners a glimpse into the great work being done by the great team at this organization.</p><p> </p><p>McMaster Children's Hospital: <a href="https://www.hamiltonhealthsciences.ca/mcmaster-childrens-hospital/">McMaster Children's Hospital</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 15 Aug 2023 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/b6d893fc/09332879.mp3" length="33788935" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/m1TI77E9oEieQ7j67r7MgZV-2-n7ShpiCMPwKByGUlo/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yNGFl/Y2FjOWMzM2IxODg2/MGJiNzVlN2M2MjE5/MGM5OC53ZWJw.jpg"/>
      <itunes:duration>1990</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Aug 15, 2023 - Our guest this week is Bruce Squires, who is President of McMaster Children's Hospital in Hamilton Ontario. Today's show is a bit of a departure from our regular format. We touch on Bruce's journey but our focus today is about the hospital he now leads which is the organization that the NGBIdeas podcast was created to support. McMaster Children's Hospital is one of the top critical care paediatric hospitals in Canada and it provides support to families in need from Niagara Falls to Waterloo in the north to Owen Sound and Grey County. Like many impressive organizations, the team at MCH focuses on their work rather than telling people about it. So our goal today is to give our listeners a glimpse into the great work being done by the great team at this organization.</p><p> </p><p>McMaster Children's Hospital: <a href="https://www.hamiltonhealthsciences.ca/mcmaster-childrens-hospital/">McMaster Children's Hospital</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E24: Bettina Hamelin | Ontario Genomics</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>24</itunes:episode>
      <podcast:episode>24</podcast:episode>
      <itunes:title>S1.E24: Bettina Hamelin | Ontario Genomics</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/4c049530-f03e-3498-8e68-e7235db6640f</guid>
      <link>https://NGBIdeas.transistor.fm/s1/24</link>
      <description>
        <![CDATA[<p>Aug 8, 2023 - The Canadian life-sciences community has a long and growing list of leaders who are personable, incredibly talented, and driven to succeed. Our guest today is on top of that list. Bettina Hamelin is President and CEO of Ontario Genomics and her story is inspiring on many levels. Bettina leads by example, helps whenever called upon, and steers the ship at one of the key organizations in Canada.</p><p> </p><p>Ontario Genomics: <a href="https://www.ontariogenomics.ca/">ontariogenomics.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Aug 8, 2023 - The Canadian life-sciences community has a long and growing list of leaders who are personable, incredibly talented, and driven to succeed. Our guest today is on top of that list. Bettina Hamelin is President and CEO of Ontario Genomics and her story is inspiring on many levels. Bettina leads by example, helps whenever called upon, and steers the ship at one of the key organizations in Canada.</p><p> </p><p>Ontario Genomics: <a href="https://www.ontariogenomics.ca/">ontariogenomics.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 08 Aug 2023 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/f8d1a302/bbbcb380.mp3" length="58004720" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/vmr8FpH6w6NVUodO_AHtAYVKAvmEk6wdQN26LXGhWdQ/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9jZDIw/NWUzNmQ5NjAwNjVh/NDc3ZDkyODNkNGVm/NDdhYy53ZWJw.jpg"/>
      <itunes:duration>3784</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Aug 8, 2023 - The Canadian life-sciences community has a long and growing list of leaders who are personable, incredibly talented, and driven to succeed. Our guest today is on top of that list. Bettina Hamelin is President and CEO of Ontario Genomics and her story is inspiring on many levels. Bettina leads by example, helps whenever called upon, and steers the ship at one of the key organizations in Canada.</p><p> </p><p>Ontario Genomics: <a href="https://www.ontariogenomics.ca/">ontariogenomics.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E23: Parimal Nathwani | Toronto Innovation Acceleration Partners</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>23</itunes:episode>
      <podcast:episode>23</podcast:episode>
      <itunes:title>S1.E23: Parimal Nathwani | Toronto Innovation Acceleration Partners</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/26c87d08-baca-371a-b70b-63cd3df9c51d</guid>
      <link>https://NGBIdeas.transistor.fm/s1/23</link>
      <description>
        <![CDATA[<p>Aug 1, 2023 - Our guest today is Parimal Nathwani, President and CEO of the Toronto Innovation Acceleration Partners. Parimal grew up in Calgary, Vancouver, and had his sights set on a career in medicine, but circumstance, timing, and a serendipitous transition from research to business development led to a pivot and a very interesting career path in Canada's life sciences sector. Parimal is one of a handful of people who has a front-row seat at the intersection of innovation and commercialization in Canada's life sciences community that provides a unique perspective on where we are and where we're heading. </p><p> </p><p>Toronto Innovation Acceleration Partners: <a href="https://tiap.ca/">tiap.ca</a></p><p>Members: <a href="https://www.camh.ca/">camh.ca</a> , <a href="https://hollandbloorview.ca/">hollandbloorview.ca</a> , <a href="https://www.marsdd.com/">marsdd.com</a> , <a href="https://www.sinaihealth.ca/">sinaihealth.ca ,</a> <a href="https://oicr.on.ca/">oicr.on.ca</a> , <a href="https://unityhealth.to/">unityhealth.to</a> , <a href="https://www.sickkids.ca/">sickkids.ca</a> , <a href="https://sunnybrook.ca/">sunnybrook.ca</a> , <a href="https://www.uhn.ca/">uhn.ca</a> , <a href="https://www.utoronto.ca/">utoronto.ca</a> </p><p>Simon Fraser University: <a href="https://www.sfu.ca">sfu.ca</a></p><p>University of Calgary: <a href="https://www.ucalgary.ca">ucalgary.ca</a></p><p>The University of British Columbia: <a href="https://www.ubc.ca">ubc.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Aug 1, 2023 - Our guest today is Parimal Nathwani, President and CEO of the Toronto Innovation Acceleration Partners. Parimal grew up in Calgary, Vancouver, and had his sights set on a career in medicine, but circumstance, timing, and a serendipitous transition from research to business development led to a pivot and a very interesting career path in Canada's life sciences sector. Parimal is one of a handful of people who has a front-row seat at the intersection of innovation and commercialization in Canada's life sciences community that provides a unique perspective on where we are and where we're heading. </p><p> </p><p>Toronto Innovation Acceleration Partners: <a href="https://tiap.ca/">tiap.ca</a></p><p>Members: <a href="https://www.camh.ca/">camh.ca</a> , <a href="https://hollandbloorview.ca/">hollandbloorview.ca</a> , <a href="https://www.marsdd.com/">marsdd.com</a> , <a href="https://www.sinaihealth.ca/">sinaihealth.ca ,</a> <a href="https://oicr.on.ca/">oicr.on.ca</a> , <a href="https://unityhealth.to/">unityhealth.to</a> , <a href="https://www.sickkids.ca/">sickkids.ca</a> , <a href="https://sunnybrook.ca/">sunnybrook.ca</a> , <a href="https://www.uhn.ca/">uhn.ca</a> , <a href="https://www.utoronto.ca/">utoronto.ca</a> </p><p>Simon Fraser University: <a href="https://www.sfu.ca">sfu.ca</a></p><p>University of Calgary: <a href="https://www.ucalgary.ca">ucalgary.ca</a></p><p>The University of British Columbia: <a href="https://www.ubc.ca">ubc.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </content:encoded>
      <pubDate>Fri, 04 Aug 2023 15:55:56 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/13a3792e/5a5f7764.mp3" length="60521367" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/I_M7mkF5PkPUBHPzT9GYNixRIMZihb_GlhL0IawKk-M/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81ODIz/NjA1MDE1ZmYxMDRh/YTcwMWE3NDQ3ODQ3/OTE0ZS53ZWJw.jpg"/>
      <itunes:duration>3520</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Aug 1, 2023 - Our guest today is Parimal Nathwani, President and CEO of the Toronto Innovation Acceleration Partners. Parimal grew up in Calgary, Vancouver, and had his sights set on a career in medicine, but circumstance, timing, and a serendipitous transition from research to business development led to a pivot and a very interesting career path in Canada's life sciences sector. Parimal is one of a handful of people who has a front-row seat at the intersection of innovation and commercialization in Canada's life sciences community that provides a unique perspective on where we are and where we're heading. </p><p> </p><p>Toronto Innovation Acceleration Partners: <a href="https://tiap.ca/">tiap.ca</a></p><p>Members: <a href="https://www.camh.ca/">camh.ca</a> , <a href="https://hollandbloorview.ca/">hollandbloorview.ca</a> , <a href="https://www.marsdd.com/">marsdd.com</a> , <a href="https://www.sinaihealth.ca/">sinaihealth.ca ,</a> <a href="https://oicr.on.ca/">oicr.on.ca</a> , <a href="https://unityhealth.to/">unityhealth.to</a> , <a href="https://www.sickkids.ca/">sickkids.ca</a> , <a href="https://sunnybrook.ca/">sunnybrook.ca</a> , <a href="https://www.uhn.ca/">uhn.ca</a> , <a href="https://www.utoronto.ca/">utoronto.ca</a> </p><p>Simon Fraser University: <a href="https://www.sfu.ca">sfu.ca</a></p><p>University of Calgary: <a href="https://www.ucalgary.ca">ucalgary.ca</a></p><p>The University of British Columbia: <a href="https://www.ubc.ca">ubc.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E22: Chris Bryson | New School Foods</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>22</itunes:episode>
      <podcast:episode>22</podcast:episode>
      <itunes:title>S1.E22: Chris Bryson | New School Foods</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/2bdf3f5a-34f3-38d6-a65a-8e0b59f39139</guid>
      <link>https://NGBIdeas.transistor.fm/s1/22</link>
      <description>
        <![CDATA[<p>July 25, 2023 - Our guest today is Chris Bryson, Founder and CEO of New School Foods in Toronto. Chris grew up in Montreal and his story is similar to many of our guests, that its about learning to trust your inner voice, learning that mistakes are lessons and that failures are just problems that are yet to be solved. Before Chris started New School Foods, he was CEO of a software company he founded in 2011 that is a great Canadian success story. He and his partners eventually sold that company for reported $65 million which was a life-changing event and it provided Chris with an opportunity to look at a global issue he is very passionate about helping change. And that issue is factory farming if you're not aware, many of today's farming techniques account for a significant part of our carbon footprint, and his team are focused on creating the next generation of plant-based meat alternatives that will help create a new and sustainable climate strategy. </p><p> </p><p>New School Foods: <a href="https://www.newschoolfoods.co/">www.newschoolfoods.co</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>July 25, 2023 - Our guest today is Chris Bryson, Founder and CEO of New School Foods in Toronto. Chris grew up in Montreal and his story is similar to many of our guests, that its about learning to trust your inner voice, learning that mistakes are lessons and that failures are just problems that are yet to be solved. Before Chris started New School Foods, he was CEO of a software company he founded in 2011 that is a great Canadian success story. He and his partners eventually sold that company for reported $65 million which was a life-changing event and it provided Chris with an opportunity to look at a global issue he is very passionate about helping change. And that issue is factory farming if you're not aware, many of today's farming techniques account for a significant part of our carbon footprint, and his team are focused on creating the next generation of plant-based meat alternatives that will help create a new and sustainable climate strategy. </p><p> </p><p>New School Foods: <a href="https://www.newschoolfoods.co/">www.newschoolfoods.co</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </content:encoded>
      <pubDate>Mon, 31 Jul 2023 12:36:09 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/f4c58e22/8831641d.mp3" length="65123623" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/J5O2DQuEd46MOzIDzz4qVEUy7bsHJw4wxy0P_DDJXmQ/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80MTVi/NThiMTA1MThkMjQ4/ZjQzNWJjN2NjMjlh/ZTgyZC53ZWJw.jpg"/>
      <itunes:duration>3721</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>July 25, 2023 - Our guest today is Chris Bryson, Founder and CEO of New School Foods in Toronto. Chris grew up in Montreal and his story is similar to many of our guests, that its about learning to trust your inner voice, learning that mistakes are lessons and that failures are just problems that are yet to be solved. Before Chris started New School Foods, he was CEO of a software company he founded in 2011 that is a great Canadian success story. He and his partners eventually sold that company for reported $65 million which was a life-changing event and it provided Chris with an opportunity to look at a global issue he is very passionate about helping change. And that issue is factory farming if you're not aware, many of today's farming techniques account for a significant part of our carbon footprint, and his team are focused on creating the next generation of plant-based meat alternatives that will help create a new and sustainable climate strategy. </p><p> </p><p>New School Foods: <a href="https://www.newschoolfoods.co/">www.newschoolfoods.co</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E21: Michael May | CCRM</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>21</itunes:episode>
      <podcast:episode>21</podcast:episode>
      <itunes:title>S1.E21: Michael May | CCRM</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/79e32184-9265-3088-9d71-86f0d3b54567</guid>
      <link>https://NGBIdeas.transistor.fm/s1/21</link>
      <description>
        <![CDATA[<p>July 18, 2023 - Our guest today is Michael May, President and CEO of the Centre for Commercialization of Regenerative Medicine. Michael is someone I've had the pleasure of meeting on a number of occasions and he's one of those people you just know you're going to like. He's focused, incredibly generous with his time, and one of the true national leaders in Canada's life sciences community. Michael's story is similar to many of the guests we've had on our show in that it's not a linear path nor was it planned. You'll hear that his success is based on hard work, being open to opportunity when it presents itself, and sometimes learning life lessons from family pets.</p><p> </p><p>CCRM:<a href="https://www.ccrm.ca/"> ccrm.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>July 18, 2023 - Our guest today is Michael May, President and CEO of the Centre for Commercialization of Regenerative Medicine. Michael is someone I've had the pleasure of meeting on a number of occasions and he's one of those people you just know you're going to like. He's focused, incredibly generous with his time, and one of the true national leaders in Canada's life sciences community. Michael's story is similar to many of the guests we've had on our show in that it's not a linear path nor was it planned. You'll hear that his success is based on hard work, being open to opportunity when it presents itself, and sometimes learning life lessons from family pets.</p><p> </p><p>CCRM:<a href="https://www.ccrm.ca/"> ccrm.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 18 Jul 2023 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/1197fe31/070039ff.mp3" length="56146240" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/TEof8-52vKCRtHPJVJfVS48ZL2ceoJEPDd11sZX1x6o/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84ZWQw/YmZjZTFlYjNjYmIy/ZDI2NWY5MDA5M2Ez/ZjJiYS53ZWJw.jpg"/>
      <itunes:duration>3418</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>July 18, 2023 - Our guest today is Michael May, President and CEO of the Centre for Commercialization of Regenerative Medicine. Michael is someone I've had the pleasure of meeting on a number of occasions and he's one of those people you just know you're going to like. He's focused, incredibly generous with his time, and one of the true national leaders in Canada's life sciences community. Michael's story is similar to many of the guests we've had on our show in that it's not a linear path nor was it planned. You'll hear that his success is based on hard work, being open to opportunity when it presents itself, and sometimes learning life lessons from family pets.</p><p> </p><p>CCRM:<a href="https://www.ccrm.ca/"> ccrm.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E20: Geoff Evans | Eurofins</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>20</itunes:episode>
      <podcast:episode>20</podcast:episode>
      <itunes:title>S1.E20: Geoff Evans | Eurofins</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/0d1a080c-3c08-35a6-a600-a3b07761a014</guid>
      <link>https://NGBIdeas.transistor.fm/s1/20</link>
      <description>
        <![CDATA[<p>July 11, 2023 - Our guest today is Geoff Evans, who is President of Eurofins CDMO Alphora Inc. in Mississauga Ontario. Geoff started his career in the life sciences sector, but he moved to industrial products and then rebounded back to a small research lab that eventually grow into one of Canada's foremost contract development and manufacturing organizations.</p><p> </p><p>Eurofins: <a href="https://www.eurofins.com/">eurofins.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>July 11, 2023 - Our guest today is Geoff Evans, who is President of Eurofins CDMO Alphora Inc. in Mississauga Ontario. Geoff started his career in the life sciences sector, but he moved to industrial products and then rebounded back to a small research lab that eventually grow into one of Canada's foremost contract development and manufacturing organizations.</p><p> </p><p>Eurofins: <a href="https://www.eurofins.com/">eurofins.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 11 Jul 2023 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/2d965c47/3f599634.mp3" length="52818156" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/SCSrWRGGiMzh55U8i-0fc-pdipKZFhSCRhxOSb9LL9A/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wMTJl/MjQ5NWYxODYyMzI2/MTMzMTg1OWQzZmE2/Y2FmNy53ZWJw.jpg"/>
      <itunes:duration>3014</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>July 11, 2023 - Our guest today is Geoff Evans, who is President of Eurofins CDMO Alphora Inc. in Mississauga Ontario. Geoff started his career in the life sciences sector, but he moved to industrial products and then rebounded back to a small research lab that eventually grow into one of Canada's foremost contract development and manufacturing organizations.</p><p> </p><p>Eurofins: <a href="https://www.eurofins.com/">eurofins.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E19: Ryan Wiley | Shift Health</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>19</itunes:episode>
      <podcast:episode>19</podcast:episode>
      <itunes:title>S1.E19: Ryan Wiley | Shift Health</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/88637c5f-3de4-320a-944a-b2f06adc2f1b</guid>
      <link>https://NGBIdeas.transistor.fm/s1/19</link>
      <description>
        <![CDATA[<p>July, 4 2023 - Our guest today is Ryan Wiley, President of Shift Health in Toronto. Ryan grew up in Oshawa, Ontario and his original plan was to attend medical school, but like many of our guests, he pivoted in university and now runs one of Canada's premier life sciences consulting firms. His personal journey is one to which many people in Canada will relate, and I'm very thankful Ryan has kindly shared it with us today.</p><p>Shift Health: <a href="https://www.shifthealth.com/">shifthealth.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>July, 4 2023 - Our guest today is Ryan Wiley, President of Shift Health in Toronto. Ryan grew up in Oshawa, Ontario and his original plan was to attend medical school, but like many of our guests, he pivoted in university and now runs one of Canada's premier life sciences consulting firms. His personal journey is one to which many people in Canada will relate, and I'm very thankful Ryan has kindly shared it with us today.</p><p>Shift Health: <a href="https://www.shifthealth.com/">shifthealth.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 04 Jul 2023 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/901d0865/802695e3.mp3" length="54600388" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/cE_5oqbKskZ2E_kCRLBEIXCrxqjeKkz3ETBK_XXmhlo/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xZGFi/YTA0YzMyNGUxYjNl/YWRiNTVkMTVhMWJk/NjVkZi53ZWJw.jpg"/>
      <itunes:duration>3393</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>July, 4 2023 - Our guest today is Ryan Wiley, President of Shift Health in Toronto. Ryan grew up in Oshawa, Ontario and his original plan was to attend medical school, but like many of our guests, he pivoted in university and now runs one of Canada's premier life sciences consulting firms. His personal journey is one to which many people in Canada will relate, and I'm very thankful Ryan has kindly shared it with us today.</p><p>Shift Health: <a href="https://www.shifthealth.com/">shifthealth.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E18: Mitch Sivilotti | OmniaBio</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>18</itunes:episode>
      <podcast:episode>18</podcast:episode>
      <itunes:title>S1.E18: Mitch Sivilotti | OmniaBio</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/566d96ed-de77-349f-9db9-3433f298fb37</guid>
      <link>https://NGBIdeas.transistor.fm/s1/18</link>
      <description>
        <![CDATA[<p>June 27, 2023 - Our guest today is Mitch Sivilotti, CEO of OmniaBio Inc. Mitch grew up in London, Ontario, and his journey has taken him to Quebec City, Los Angeles, Asia, Kingston, Toronto, and finally to Hamilton where he and his team are building what will be one of the next generation of cell and gene therapy manufacturing facilities in Canada. OmniaBio is a subsidiary of CCRM and it’s a contract development in and manufacturing organization (CDMO) that is producing gene-modified cells and  viral vectors that are compliant with current GMP standards. OmniaBio is in the midst of building a 400,000 square-foot facility, which will be the largest CDMO exclusively manufacturing for cell and gene therapies in Canada, Mitch and the team are creating jobs and supporting global therapeutics developers who are advancing pioneering medicine that has the potential to cure many forms of cancer, cardiovascular diseases, Parkinson’s, and diabetes. </p><p> </p><p>OmniaBio: <a href="https://omniabio.com/">OmniaBio.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>June 27, 2023 - Our guest today is Mitch Sivilotti, CEO of OmniaBio Inc. Mitch grew up in London, Ontario, and his journey has taken him to Quebec City, Los Angeles, Asia, Kingston, Toronto, and finally to Hamilton where he and his team are building what will be one of the next generation of cell and gene therapy manufacturing facilities in Canada. OmniaBio is a subsidiary of CCRM and it’s a contract development in and manufacturing organization (CDMO) that is producing gene-modified cells and  viral vectors that are compliant with current GMP standards. OmniaBio is in the midst of building a 400,000 square-foot facility, which will be the largest CDMO exclusively manufacturing for cell and gene therapies in Canada, Mitch and the team are creating jobs and supporting global therapeutics developers who are advancing pioneering medicine that has the potential to cure many forms of cancer, cardiovascular diseases, Parkinson’s, and diabetes. </p><p> </p><p>OmniaBio: <a href="https://omniabio.com/">OmniaBio.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 27 Jun 2023 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/ce09f1a3/855a8b16.mp3" length="62352362" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/jQw41qB_u2HYjJdGuxHmaK2W8Z5Gg0cFpn5pg0rgx9s/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iZjI1/NDg1MTM3OTVmZmZi/ZjA1N2NmYTgxZTBj/NDMwMi53ZWJw.jpg"/>
      <itunes:duration>3600</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>June 27, 2023 - Our guest today is Mitch Sivilotti, CEO of OmniaBio Inc. Mitch grew up in London, Ontario, and his journey has taken him to Quebec City, Los Angeles, Asia, Kingston, Toronto, and finally to Hamilton where he and his team are building what will be one of the next generation of cell and gene therapy manufacturing facilities in Canada. OmniaBio is a subsidiary of CCRM and it’s a contract development in and manufacturing organization (CDMO) that is producing gene-modified cells and  viral vectors that are compliant with current GMP standards. OmniaBio is in the midst of building a 400,000 square-foot facility, which will be the largest CDMO exclusively manufacturing for cell and gene therapies in Canada, Mitch and the team are creating jobs and supporting global therapeutics developers who are advancing pioneering medicine that has the potential to cure many forms of cancer, cardiovascular diseases, Parkinson’s, and diabetes. </p><p> </p><p>OmniaBio: <a href="https://omniabio.com/">OmniaBio.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E17: Drew Marquardt | University Of Windsor</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>17</itunes:episode>
      <podcast:episode>17</podcast:episode>
      <itunes:title>S1.E17: Drew Marquardt | University Of Windsor</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/bf2513c3-bacf-3f05-a838-86c95a6ff826</guid>
      <link>https://NGBIdeas.transistor.fm/s1/17</link>
      <description>
        <![CDATA[<p>June 20, 2023 - Our guest today is Drew Marquardt, an Associate Professor in the department of chemistry and bio chemistry at the University Windsor. His team are developing applying neutron scattering strategies to study membrane structures, and processes. More than 3000 Canadians are diagnosed with brain cancers like glioblastoma multiforme or recurrent head and neck cancer, which is very difficult to treat. One of the most promising treatments for these cancers is boron neutron capture therapy.</p><p> </p><p>Drew: <a href="https://dmarquardt.ca/">dmarquardt.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>June 20, 2023 - Our guest today is Drew Marquardt, an Associate Professor in the department of chemistry and bio chemistry at the University Windsor. His team are developing applying neutron scattering strategies to study membrane structures, and processes. More than 3000 Canadians are diagnosed with brain cancers like glioblastoma multiforme or recurrent head and neck cancer, which is very difficult to treat. One of the most promising treatments for these cancers is boron neutron capture therapy.</p><p> </p><p>Drew: <a href="https://dmarquardt.ca/">dmarquardt.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 20 Jun 2023 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/8947a732/0f14dafe.mp3" length="49108076" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/olGWMFzZc50d4LOaRfXjoWFln3slGpI6u5ZSbCzQSz4/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kNzJi/OWFkNTFmZDg0MGFj/ZWI1Y2E5ZDM1YWVk/ZDM4OC53ZWJw.jpg"/>
      <itunes:duration>2840</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>June 20, 2023 - Our guest today is Drew Marquardt, an Associate Professor in the department of chemistry and bio chemistry at the University Windsor. His team are developing applying neutron scattering strategies to study membrane structures, and processes. More than 3000 Canadians are diagnosed with brain cancers like glioblastoma multiforme or recurrent head and neck cancer, which is very difficult to treat. One of the most promising treatments for these cancers is boron neutron capture therapy.</p><p> </p><p>Drew: <a href="https://dmarquardt.ca/">dmarquardt.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E16: Maura Campbell | Ontario Bioscience Innovation Organization</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>16</itunes:episode>
      <podcast:episode>16</podcast:episode>
      <itunes:title>S1.E16: Maura Campbell | Ontario Bioscience Innovation Organization</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/ec632e55-7303-3ca8-b89a-e189bd4e88a5</guid>
      <link>https://NGBIdeas.transistor.fm/s1/16</link>
      <description>
        <![CDATA[<p>June 13, 2023 - Our guest today is Maura Campbell CEO of the Ontario Bioscience Innovation Organization (OBIO). Listen as Maura shares her thoughts on surviving a severe car accident, some of the obstacles faced as a woman working in life sciences, the disappointment of doing everything right, but still having a company fail, and how keeping an open mind is important to success.</p><p> </p><p>OBIO: <a href="https://www.obio.ca/">obio.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>June 13, 2023 - Our guest today is Maura Campbell CEO of the Ontario Bioscience Innovation Organization (OBIO). Listen as Maura shares her thoughts on surviving a severe car accident, some of the obstacles faced as a woman working in life sciences, the disappointment of doing everything right, but still having a company fail, and how keeping an open mind is important to success.</p><p> </p><p>OBIO: <a href="https://www.obio.ca/">obio.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 13 Jun 2023 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/2aad8609/0b52955d.mp3" length="52119366" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/XwXdndLrIvemu92Iq18_9egQ62nIoNqtdqXGknc2Avg/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lMzlm/NTY3OTZkZTM3M2Nm/Mzg2NTM4OWE4Y2Vj/M2U2YS53ZWJw.jpg"/>
      <itunes:duration>3459</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>June 13, 2023 - Our guest today is Maura Campbell CEO of the Ontario Bioscience Innovation Organization (OBIO). Listen as Maura shares her thoughts on surviving a severe car accident, some of the obstacles faced as a woman working in life sciences, the disappointment of doing everything right, but still having a company fail, and how keeping an open mind is important to success.</p><p> </p><p>OBIO: <a href="https://www.obio.ca/">obio.ca</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E15: Bruno Paquin | AtomVie Global Radio Pharma</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>15</itunes:episode>
      <podcast:episode>15</podcast:episode>
      <itunes:title>S1.E15: Bruno Paquin | AtomVie Global Radio Pharma</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/8ad4d0be-d847-3f89-ac52-afce1b18cdab</guid>
      <link>https://NGBIdeas.transistor.fm/s1/15</link>
      <description>
        <![CDATA[<p>June 6, 2023 - On todays episode is Bruno Paquin from AtomVie Global Radio Pharma. Listen in as Bruno shares behind the scenes details of his professional and personal journey to becoming CEO of one of North America’s leading CDMOs in the radiopharmaceuticals sector. </p><p> </p><p>AtomVie: <a href="https://www.atomvie.com/">atomvie.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>June 6, 2023 - On todays episode is Bruno Paquin from AtomVie Global Radio Pharma. Listen in as Bruno shares behind the scenes details of his professional and personal journey to becoming CEO of one of North America’s leading CDMOs in the radiopharmaceuticals sector. </p><p> </p><p>AtomVie: <a href="https://www.atomvie.com/">atomvie.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 06 Jun 2023 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/881b01e0/caf56047.mp3" length="53051025" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/ZzEzrafHmgBUTVzZTZbuAl4PAJLKbw35ptWCfHfqoHk/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wNjcy/YjRhZDdhYTVkMTYw/NTliZmVlZWE3ZmVk/MzhjMy53ZWJw.jpg"/>
      <itunes:duration>3443</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>June 6, 2023 - On todays episode is Bruno Paquin from AtomVie Global Radio Pharma. Listen in as Bruno shares behind the scenes details of his professional and personal journey to becoming CEO of one of North America’s leading CDMOs in the radiopharmaceuticals sector. </p><p> </p><p>AtomVie: <a href="https://www.atomvie.com/">atomvie.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E14: John Lewis | Entos Pharmaceuticals</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>14</itunes:episode>
      <podcast:episode>14</podcast:episode>
      <itunes:title>S1.E14: John Lewis | Entos Pharmaceuticals</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/9204bd22-96d6-3585-a87c-0cc6258f54e5</guid>
      <link>https://NGBIdeas.transistor.fm/s1/14</link>
      <description>
        <![CDATA[<p>April 25, 2023 - Our guest for our final show this season is John Lewis, who is the Bird Dogs Chair in Translational Oncology at the University of Alberta, and founder and CEO of Entos Pharma in Edmonton. We're delighted to have John on the show today because he fits into every one of our categories. He's an academic scientist who leads one of the top oncology research organizations in Canada. He's a serial entrepreneur who commercializes innovative research, and he and his team are doing a great job of chipping away at the Canadian Life Sciences status quo.</p><p> </p><p>Entos - <a href="https://www.entospharma.com/">entospharma.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>April 25, 2023 - Our guest for our final show this season is John Lewis, who is the Bird Dogs Chair in Translational Oncology at the University of Alberta, and founder and CEO of Entos Pharma in Edmonton. We're delighted to have John on the show today because he fits into every one of our categories. He's an academic scientist who leads one of the top oncology research organizations in Canada. He's a serial entrepreneur who commercializes innovative research, and he and his team are doing a great job of chipping away at the Canadian Life Sciences status quo.</p><p> </p><p>Entos - <a href="https://www.entospharma.com/">entospharma.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 25 Apr 2023 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/116ed793/052c4434.mp3" length="48373120" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/ojRlzOArVqbLVBZZ9Hc4_whZLuYzQRY_qBfeALPiuME/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMTJk/NGMzM2I5YmUzZWRm/NjI1YzdiNzRmYzZl/MGZlYy53ZWJw.jpg"/>
      <itunes:duration>3660</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>April 25, 2023 - Our guest for our final show this season is John Lewis, who is the Bird Dogs Chair in Translational Oncology at the University of Alberta, and founder and CEO of Entos Pharma in Edmonton. We're delighted to have John on the show today because he fits into every one of our categories. He's an academic scientist who leads one of the top oncology research organizations in Canada. He's a serial entrepreneur who commercializes innovative research, and he and his team are doing a great job of chipping away at the Canadian Life Sciences status quo.</p><p> </p><p>Entos - <a href="https://www.entospharma.com/">entospharma.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E13: Darby McGrath | Vineland Research &amp; Innovation Centre</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>13</itunes:episode>
      <podcast:episode>13</podcast:episode>
      <itunes:title>S1.E13: Darby McGrath | Vineland Research &amp; Innovation Centre</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/fe59a791-9e1c-31f2-bec4-61aa96534e8f</guid>
      <link>https://NGBIdeas.transistor.fm/s1/13</link>
      <description>
        <![CDATA[<p>April 11, 2023 - The Canadian Life Sciences community contains a broad spectrum of sectors and some of our listeners may be surprised to learn that spectrum includes agriculture and horticulture. The Vineland Research and Innovation Center in Vineland, Ontario is one of the leading organizations in this area and our guest today is Darby McGrath, who is Vice President Research and Development at the center. </p><p> </p><p>Vineland Research &amp; Innovation Centre: <a href="https://www.vinelandresearch.com/">vinelandresearch.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>April 11, 2023 - The Canadian Life Sciences community contains a broad spectrum of sectors and some of our listeners may be surprised to learn that spectrum includes agriculture and horticulture. The Vineland Research and Innovation Center in Vineland, Ontario is one of the leading organizations in this area and our guest today is Darby McGrath, who is Vice President Research and Development at the center. </p><p> </p><p>Vineland Research &amp; Innovation Centre: <a href="https://www.vinelandresearch.com/">vinelandresearch.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 11 Apr 2023 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/a341a215/96b0f562.mp3" length="24556263" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/phiJ63hdJFWMY-rgt4wH75YOZUV76GtA9xOGuKK74pI/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zNzVj/ZWQ1NzFjNWExMjFm/OTAwOGFkZjA5OWQz/NmRiMi53ZWJw.jpg"/>
      <itunes:duration>1964</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>April 11, 2023 - The Canadian Life Sciences community contains a broad spectrum of sectors and some of our listeners may be surprised to learn that spectrum includes agriculture and horticulture. The Vineland Research and Innovation Center in Vineland, Ontario is one of the leading organizations in this area and our guest today is Darby McGrath, who is Vice President Research and Development at the center. </p><p> </p><p>Vineland Research &amp; Innovation Centre: <a href="https://www.vinelandresearch.com/">vinelandresearch.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E12: Lisa Porter | University Of Windsor</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>12</itunes:episode>
      <podcast:episode>12</podcast:episode>
      <itunes:title>S1.E12: Lisa Porter | University Of Windsor</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/1df06ddf-60de-35bf-adea-6ecd0182487a</guid>
      <link>https://NGBIdeas.transistor.fm/s1/12</link>
      <description>
        <![CDATA[<p>April 4, 2023 - Today we're joined by Dr. Lisa Porter from the University of Windsor, who shares her perspective on the growing life sciences sector in Windsor Essex. As Dr. Porter points out, if you're part of Canada's life sciences sector and you do not have Windsor on your radar, you should.</p><p> </p><p>University of Windsor: <a href="https://www.uwindsor.ca/">www.uwindsor.ca</a></p><p>Porter Lab: <a href="https://porterlab.com/">porterlab.com</a></p><p>We Spark: <a href="https://www.wesparkhealth.com/">www.wesparkhealth.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p><p> </p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>April 4, 2023 - Today we're joined by Dr. Lisa Porter from the University of Windsor, who shares her perspective on the growing life sciences sector in Windsor Essex. As Dr. Porter points out, if you're part of Canada's life sciences sector and you do not have Windsor on your radar, you should.</p><p> </p><p>University of Windsor: <a href="https://www.uwindsor.ca/">www.uwindsor.ca</a></p><p>Porter Lab: <a href="https://porterlab.com/">porterlab.com</a></p><p>We Spark: <a href="https://www.wesparkhealth.com/">www.wesparkhealth.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p><p> </p>]]>
      </content:encoded>
      <pubDate>Tue, 04 Apr 2023 14:18:13 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/2f589171/c242ced0.mp3" length="42529038" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/VEAldMy3Bz3aHjOTU3EQf0q_lKgszIaAHH1NAXT-ZFg/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS82NzY1/OTBmNGMyODczY2Fh/OGE4NmEzZDBjMzVm/YTliYy53ZWJw.jpg"/>
      <itunes:duration>3344</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>April 4, 2023 - Today we're joined by Dr. Lisa Porter from the University of Windsor, who shares her perspective on the growing life sciences sector in Windsor Essex. As Dr. Porter points out, if you're part of Canada's life sciences sector and you do not have Windsor on your radar, you should.</p><p> </p><p>University of Windsor: <a href="https://www.uwindsor.ca/">www.uwindsor.ca</a></p><p>Porter Lab: <a href="https://porterlab.com/">porterlab.com</a></p><p>We Spark: <a href="https://www.wesparkhealth.com/">www.wesparkhealth.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p><p> </p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E11: Glenn McCarthy | Labworks International Inc.</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>11</itunes:episode>
      <podcast:episode>11</podcast:episode>
      <itunes:title>S1.E11: Glenn McCarthy | Labworks International Inc.</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/96ef59fd-def5-3579-953c-c815a877020e</guid>
      <link>https://NGBIdeas.transistor.fm/s1/11</link>
      <description>
        <![CDATA[<p>March 28, 2023 - On the show today we're speaking with Glenn McCarthy, president and CEO of Labworks International Inc.<br> </p><p>Lab Works:<a href="https://labworksinternational.com"> labworksinternational.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>March 28, 2023 - On the show today we're speaking with Glenn McCarthy, president and CEO of Labworks International Inc.<br> </p><p>Lab Works:<a href="https://labworksinternational.com"> labworksinternational.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 28 Mar 2023 13:48:08 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/9e5ce609/e62b34cd.mp3" length="22613282" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/WBVxXVxkK6SP95v-sjrmg2-r8QoPKNE5uADaj_bvI2k/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81NmJi/MTUyZmU4N2Y5ZDFi/ZTk0ZjdhZTQ5Mjg5/ZjlkYy53ZWJw.jpg"/>
      <itunes:duration>1832</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>March 28, 2023 - On the show today we're speaking with Glenn McCarthy, president and CEO of Labworks International Inc.<br> </p><p>Lab Works:<a href="https://labworksinternational.com"> labworksinternational.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E10: Alex Muggah | Synapse Consortium</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>10</itunes:episode>
      <podcast:episode>10</podcast:episode>
      <itunes:title>S1.E10: Alex Muggah | Synapse Consortium</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/f9c9ef3c-73d1-32a8-bbd8-203bc303636a</guid>
      <link>https://NGBIdeas.transistor.fm/s1/10</link>
      <description>
        <![CDATA[<p>March 20, 2023 - On todays show today we're joined by Alex Muggah, whose serendipitous journey took him from Hamilton to Boston, not once, but twice. Alex's Executive Director of the Synapse Consortium in Hamilton, Ontario, and he not only accepted the position he occupies when it was offered, he helped create it.</p><p> </p><p>Synapse: <a href="https://synapseconsortium.com/">synapseconsortium.com</a></p><p>Synapse Twitter: @<a href="https://twitter.com/SynapseLifeSci">SynapseLifeSci</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>March 20, 2023 - On todays show today we're joined by Alex Muggah, whose serendipitous journey took him from Hamilton to Boston, not once, but twice. Alex's Executive Director of the Synapse Consortium in Hamilton, Ontario, and he not only accepted the position he occupies when it was offered, he helped create it.</p><p> </p><p>Synapse: <a href="https://synapseconsortium.com/">synapseconsortium.com</a></p><p>Synapse Twitter: @<a href="https://twitter.com/SynapseLifeSci">SynapseLifeSci</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 21 Mar 2023 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/1f646f48/a18db63b.mp3" length="46201319" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/gbkmfFRxbnVG1nrzQJ1ybshAorpg33GssGD97DzKe8E/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iYjk4/NTIzOGM0MmYxYzEx/YThkOTczMTZkNDgw/NGUwNS53ZWJw.jpg"/>
      <itunes:duration>3321</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>March 20, 2023 - On todays show today we're joined by Alex Muggah, whose serendipitous journey took him from Hamilton to Boston, not once, but twice. Alex's Executive Director of the Synapse Consortium in Hamilton, Ontario, and he not only accepted the position he occupies when it was offered, he helped create it.</p><p> </p><p>Synapse: <a href="https://synapseconsortium.com/">synapseconsortium.com</a></p><p>Synapse Twitter: @<a href="https://twitter.com/SynapseLifeSci">SynapseLifeSci</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E9: Sabrina Fiorellino | Fero International</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>9</itunes:episode>
      <podcast:episode>9</podcast:episode>
      <itunes:title>S1.E9: Sabrina Fiorellino | Fero International</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/991c7bb9-27d8-3ef7-86d8-333b7d98755c</guid>
      <link>https://NGBIdeas.transistor.fm/s1/9</link>
      <description>
        <![CDATA[<p>March 14, 2023 - One of the major obstacles for many biotech companies in Canada at the moment is simply finding lab space in which to grow. It's not a regional problem, it's a national problem, and our guest today, Sabrina Fiorellino, CEO of Ferro International, is leading a team that is helping solve that problem. </p><p> </p><p>Fero: <a href="https://ferointl.com/">ferointl.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>March 14, 2023 - One of the major obstacles for many biotech companies in Canada at the moment is simply finding lab space in which to grow. It's not a regional problem, it's a national problem, and our guest today, Sabrina Fiorellino, CEO of Ferro International, is leading a team that is helping solve that problem. </p><p> </p><p>Fero: <a href="https://ferointl.com/">ferointl.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 14 Mar 2023 05:00:00 -0400</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/5d749333/82fb1b7a.mp3" length="27563205" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/y3iaWw7rBkpCnTcRcbYwB5sh9sdFTBPkW9Ti91DwQsU/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yY2Zl/ODU5ZmFiNTFiMGFk/NzE1YjA1MmNmY2Q1/MTNiNi53ZWJw.jpg"/>
      <itunes:duration>2152</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>March 14, 2023 - One of the major obstacles for many biotech companies in Canada at the moment is simply finding lab space in which to grow. It's not a regional problem, it's a national problem, and our guest today, Sabrina Fiorellino, CEO of Ferro International, is leading a team that is helping solve that problem. </p><p> </p><p>Fero: <a href="https://ferointl.com/">ferointl.com</a></p><p>Get Your Tickets to The NGBI Summit: <a href="https://www.nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p>Lab Occupier: <a href="https://www.laboccupier.com/">laboccupier.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E8: Jason Field | Life Sciences Ontario</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>8</itunes:episode>
      <podcast:episode>8</podcast:episode>
      <itunes:title>S1.E8: Jason Field | Life Sciences Ontario</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/db9e9153-2902-363d-a6e8-b3aa3690aa19</guid>
      <link>https://NGBIdeas.transistor.fm/s1/8</link>
      <description>
        <![CDATA[<p>March 8, 2023 - There are life sciences organizations across Canada and more than a few hit far above their weight class. The influence of these groups is due in no small part to their membership, but also because of their leadership, and life sciences Ontario is on that list. LSO is a member funded, not-for-profit organization focused on advancing life sciences through advocacy, policy work, educational and networking events, and support services, and our guest today is the president and CEO of Life Sciences Ontario, Jason Field.</p><p> </p><p>LSO: <a href="https://lifesciencesontario.ca/">lifesciencesontario.ca</a></p><p>LabOccupier: <a href="https://laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>March 8, 2023 - There are life sciences organizations across Canada and more than a few hit far above their weight class. The influence of these groups is due in no small part to their membership, but also because of their leadership, and life sciences Ontario is on that list. LSO is a member funded, not-for-profit organization focused on advancing life sciences through advocacy, policy work, educational and networking events, and support services, and our guest today is the president and CEO of Life Sciences Ontario, Jason Field.</p><p> </p><p>LSO: <a href="https://lifesciencesontario.ca/">lifesciencesontario.ca</a></p><p>LabOccupier: <a href="https://laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </content:encoded>
      <pubDate>Wed, 08 Mar 2023 09:15:59 -0500</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/de164bc0/fbbd887a.mp3" length="48819089" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/bqV4-q47JLsaA4WAbbntrPoPvITHb3BXfa1SX9aQcPU/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iMzgx/NjljNGJjNjAzZWQy/Njc0YTgzZjdlNjMz/MjU1NC53ZWJw.jpg"/>
      <itunes:duration>3563</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>March 8, 2023 - There are life sciences organizations across Canada and more than a few hit far above their weight class. The influence of these groups is due in no small part to their membership, but also because of their leadership, and life sciences Ontario is on that list. LSO is a member funded, not-for-profit organization focused on advancing life sciences through advocacy, policy work, educational and networking events, and support services, and our guest today is the president and CEO of Life Sciences Ontario, Jason Field.</p><p> </p><p>LSO: <a href="https://lifesciencesontario.ca/">lifesciencesontario.ca</a></p><p>LabOccupier: <a href="https://laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E7: Brigitte Nolet | Roche Canada Pharma</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>7</itunes:episode>
      <podcast:episode>7</podcast:episode>
      <itunes:title>S1.E7: Brigitte Nolet | Roche Canada Pharma</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/e66ff6f2-f41b-3cbf-be8f-8e17dd5aaef5</guid>
      <link>https://ngbideas.transistor.fm/episode/s1-e7-brigitte-nolet-roche-canada-pharma</link>
      <description>
        <![CDATA[<p>Feb 27, 2023 - On todays show we speak with Brigitte Nolet, CEO of Roche Canada Pharma. We talk about her professional experience as a tri-sector leader, her personal experience as a patient, the potential of Canada health sciences and life sciences sectors and the importance of being honest with everyone on your team, including yourself.</p><p> </p><p>Roche: <a href="https://www.roche.com/">www.roche.com</a></p><p>LabOccupier: <a href="https://www.roche.com/">www.laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Feb 27, 2023 - On todays show we speak with Brigitte Nolet, CEO of Roche Canada Pharma. We talk about her professional experience as a tri-sector leader, her personal experience as a patient, the potential of Canada health sciences and life sciences sectors and the importance of being honest with everyone on your team, including yourself.</p><p> </p><p>Roche: <a href="https://www.roche.com/">www.roche.com</a></p><p>LabOccupier: <a href="https://www.roche.com/">www.laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 28 Feb 2023 05:00:00 -0500</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/4b0ef293/8d768bff.mp3" length="44175593" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/x1H8R4pMTHKbwPbjuRpcawpMZT8uDXIPT_7WQcIh6UM/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lMTc4/NmMxNTA1OWQ0M2My/YzZkNmY5Y2E1MWMz/ZDRkNS53ZWJw.jpg"/>
      <itunes:duration>3468</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Feb 27, 2023 - On todays show we speak with Brigitte Nolet, CEO of Roche Canada Pharma. We talk about her professional experience as a tri-sector leader, her personal experience as a patient, the potential of Canada health sciences and life sciences sectors and the importance of being honest with everyone on your team, including yourself.</p><p> </p><p>Roche: <a href="https://www.roche.com/">www.roche.com</a></p><p>LabOccupier: <a href="https://www.roche.com/">www.laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E6: Derek Newton | University of Toronto</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>6</itunes:episode>
      <podcast:episode>6</podcast:episode>
      <itunes:title>S1.E6: Derek Newton | University of Toronto</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/0143c69c-0126-370f-ae72-ba56b1f3da6a</guid>
      <link>https://NGBIdeas.transistor.fm/s1/6</link>
      <description>
        <![CDATA[<p>Febuary 21, 2023 - Derek Newton is the Assistant Vice-President, Innovation, Partnerships and Entrepreneurship at The University of Toronto. Listen in as we learn about Derek's journey and how in his position he often gets a glimpse of the future path of life sciences before we do.</p><p> </p><p>University of Toronto: <a href="https://www.utoronto.ca/">www.utoronto.ca</a></p><p>LabOccupier: <a href="https://laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Febuary 21, 2023 - Derek Newton is the Assistant Vice-President, Innovation, Partnerships and Entrepreneurship at The University of Toronto. Listen in as we learn about Derek's journey and how in his position he often gets a glimpse of the future path of life sciences before we do.</p><p> </p><p>University of Toronto: <a href="https://www.utoronto.ca/">www.utoronto.ca</a></p><p>LabOccupier: <a href="https://laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 21 Feb 2023 05:00:00 -0500</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/2691f1ce/d04cd616.mp3" length="42642473" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/BtqCj4EIbgk1WL5KLNgBqPYvmwrQxe_LnQDqgmZrmwM/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hMTI5/NmZiYjg3MDU5ZTdk/MmQ5ODI0Zjg1ZDhh/ZjkxZS53ZWJw.jpg"/>
      <itunes:duration>2879</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Febuary 21, 2023 - Derek Newton is the Assistant Vice-President, Innovation, Partnerships and Entrepreneurship at The University of Toronto. Listen in as we learn about Derek's journey and how in his position he often gets a glimpse of the future path of life sciences before we do.</p><p> </p><p>University of Toronto: <a href="https://www.utoronto.ca/">www.utoronto.ca</a></p><p>LabOccupier: <a href="https://laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E5: Scott Phillips | StarFish Medical</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>5</itunes:episode>
      <podcast:episode>5</podcast:episode>
      <itunes:title>S1.E5: Scott Phillips | StarFish Medical</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/68513146-7de0-37aa-86ac-fca3344f6096</guid>
      <link>https://NGBIdeas.transistor.fm/s1/5</link>
      <description>
        <![CDATA[<p>Feb 14, 2023 - Based in Victoria, BC and founded by Scott Phillips, Starfish Medical has grown into one of the largest medical device design and manufacturing companies in North America. Listen in as Scott shares stories about growing up in the Vancouver area, his adventures in travel and business, how goodwill can sometimes backfire and why the Next Great Big Idea on his horizon is about diversification.</p><p> </p><p>StarFish Medical: <a href="https://starfishmedical.com/">starfishmedical.com</a></p><p>LabOccupier: <a href="https://laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Feb 14, 2023 - Based in Victoria, BC and founded by Scott Phillips, Starfish Medical has grown into one of the largest medical device design and manufacturing companies in North America. Listen in as Scott shares stories about growing up in the Vancouver area, his adventures in travel and business, how goodwill can sometimes backfire and why the Next Great Big Idea on his horizon is about diversification.</p><p> </p><p>StarFish Medical: <a href="https://starfishmedical.com/">starfishmedical.com</a></p><p>LabOccupier: <a href="https://laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 14 Feb 2023 05:00:00 -0500</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/09bfcd3c/270316ad.mp3" length="31616666" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/R67NIH0gG1lPtcTIKQKS5KJBUu0zXoNnkwVyYEe0vV8/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yNTYx/YTUzMTc3MDEwZDBj/MDkyOGRlMGM0M2M3/NTQ3Mi53ZWJw.jpg"/>
      <itunes:duration>1975</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Feb 14, 2023 - Based in Victoria, BC and founded by Scott Phillips, Starfish Medical has grown into one of the largest medical device design and manufacturing companies in North America. Listen in as Scott shares stories about growing up in the Vancouver area, his adventures in travel and business, how goodwill can sometimes backfire and why the Next Great Big Idea on his horizon is about diversification.</p><p> </p><p>StarFish Medical: <a href="https://starfishmedical.com/">starfishmedical.com</a></p><p>LabOccupier: <a href="https://laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E4: Ty Shattuck | McMaster Innovation Park</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>4</itunes:episode>
      <podcast:episode>4</podcast:episode>
      <itunes:title>S1.E4: Ty Shattuck | McMaster Innovation Park</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/d57119b1-3378-39b0-a405-1602576b6058</guid>
      <link>https://NGBIdeas.transistor.fm/s1/4</link>
      <description>
        <![CDATA[<p>February 7, 2023 - The land at the corner of Longwood and Aberdeen in Hamilton has been an industrial manufacturing park for over 100 years. Now the home of McMaster Innovation Park (MIP), manufacturing remains a significant focus here - but it is not the kind of manufacturing most people expect. Our guest today is Ty Shattuck, CEO of MIP, who shares his journey from Calgary to Baker Lake, to RMC in Kingston and ultimately to Hamilton – and he suggests the Next Great Big Idea just might involve small modular reactors.</p><p> </p><p>MIP: <a href="https://mcmasterinnovationpark.ca">mcmasterinnovationpark.ca</a></p><p>LabOccupier: <a href="https://laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>February 7, 2023 - The land at the corner of Longwood and Aberdeen in Hamilton has been an industrial manufacturing park for over 100 years. Now the home of McMaster Innovation Park (MIP), manufacturing remains a significant focus here - but it is not the kind of manufacturing most people expect. Our guest today is Ty Shattuck, CEO of MIP, who shares his journey from Calgary to Baker Lake, to RMC in Kingston and ultimately to Hamilton – and he suggests the Next Great Big Idea just might involve small modular reactors.</p><p> </p><p>MIP: <a href="https://mcmasterinnovationpark.ca">mcmasterinnovationpark.ca</a></p><p>LabOccupier: <a href="https://laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 07 Feb 2023 05:00:00 -0500</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/e5171eed/8414781e.mp3" length="38744700" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/Pk9LFcdCyDtuzd0weWH9DsIydkz1wUxzfvjfiXIx_xo/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hYmVj/MTZlZmZmOWVhNmQz/YWIxNWUzOTA3ZjJh/ZGZmNC53ZWJw.jpg"/>
      <itunes:duration>3003</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>February 7, 2023 - The land at the corner of Longwood and Aberdeen in Hamilton has been an industrial manufacturing park for over 100 years. Now the home of McMaster Innovation Park (MIP), manufacturing remains a significant focus here - but it is not the kind of manufacturing most people expect. Our guest today is Ty Shattuck, CEO of MIP, who shares his journey from Calgary to Baker Lake, to RMC in Kingston and ultimately to Hamilton – and he suggests the Next Great Big Idea just might involve small modular reactors.</p><p> </p><p>MIP: <a href="https://mcmasterinnovationpark.ca">mcmasterinnovationpark.ca</a></p><p>LabOccupier: <a href="https://laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E3: Ian McDermott | UHN</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>3</itunes:episode>
      <podcast:episode>3</podcast:episode>
      <itunes:title>S1.E3: Ian McDermott | UHN</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/203518c2-0fca-318b-8da3-d818e2856d7b</guid>
      <link>https://NGBIdeas.transistor.fm/s1/3</link>
      <description>
        <![CDATA[<p>January 31, 2023 - This week our guest is Ian McDermott, Executive Director of Planning and Integration at University Health Network (UHN) in Toronto. We discuss Ian's journey from Ireland to Toronto via northern Ontario, his years at the University of Toronto, the history of UHN, how lab design has changed over the years and why wet lab space is (again) difficult to find in Toronto.</p><p> </p><p>UHN: <a href="https://www.uhn.ca/">www.uhn.ca</a></p><p>LabOccupier: <a href="https://laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>January 31, 2023 - This week our guest is Ian McDermott, Executive Director of Planning and Integration at University Health Network (UHN) in Toronto. We discuss Ian's journey from Ireland to Toronto via northern Ontario, his years at the University of Toronto, the history of UHN, how lab design has changed over the years and why wet lab space is (again) difficult to find in Toronto.</p><p> </p><p>UHN: <a href="https://www.uhn.ca/">www.uhn.ca</a></p><p>LabOccupier: <a href="https://laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 31 Jan 2023 05:00:00 -0500</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/319dcd11/fbd2751c.mp3" length="35148684" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/JGvGx9Wp5jEMg76a77Oi-5iafwwCJdMW2kjUMb5Zfe4/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS85YWMx/MTFjOTcyZTczNGQx/ZmExMWMwNWFiN2Mz/MjkzYS53ZWJw.jpg"/>
      <itunes:duration>2702</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>January 31, 2023 - This week our guest is Ian McDermott, Executive Director of Planning and Integration at University Health Network (UHN) in Toronto. We discuss Ian's journey from Ireland to Toronto via northern Ontario, his years at the University of Toronto, the history of UHN, how lab design has changed over the years and why wet lab space is (again) difficult to find in Toronto.</p><p> </p><p>UHN: <a href="https://www.uhn.ca/">www.uhn.ca</a></p><p>LabOccupier: <a href="https://laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E2: Josh Pottel | Molecular Forecaster Inc</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>2</itunes:episode>
      <podcast:episode>2</podcast:episode>
      <itunes:title>S1.E2: Josh Pottel | Molecular Forecaster Inc</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBIdeas.podbean.com/ed6bcbd1-3169-38e3-9096-5cf09a2b7224</guid>
      <link>https://NGBIdeas.transistor.fm/s1/2</link>
      <description>
        <![CDATA[<p>January 24, 2023 - Molecular Forecaster is a research-as-a-service company providing computer-aided drug discovery technology to biotechs and pharma companies around the world. CEO Josh Pottel talks about growing up in Montreal, sleeping in class, the importance of being open to advice and where the Next Great Big Idea will likely come from.</p><p> </p><p>Molecular Forecaster: <a href="https://molecularforecaster.com/">molecularforecaster.com</a></p><p>LabOccupier: <a href="https://laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p> </p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>January 24, 2023 - Molecular Forecaster is a research-as-a-service company providing computer-aided drug discovery technology to biotechs and pharma companies around the world. CEO Josh Pottel talks about growing up in Montreal, sleeping in class, the importance of being open to advice and where the Next Great Big Idea will likely come from.</p><p> </p><p>Molecular Forecaster: <a href="https://molecularforecaster.com/">molecularforecaster.com</a></p><p>LabOccupier: <a href="https://laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p> </p>]]>
      </content:encoded>
      <pubDate>Tue, 24 Jan 2023 12:38:33 -0500</pubDate>
      <author>Jim Wilson</author>
      <enclosure url="https://media.transistor.fm/07c99dc7/f5ea315f.mp3" length="18721327" type="audio/mpeg"/>
      <itunes:author>Jim Wilson</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/r2lipjr1KcJpY51fnRwf-vSxNXQvdQ5ZCvhmVMQOIC8/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wMDVj/M2Y2ODc5MjBjNzg5/NWY5OTgxMDkzNjUy/YjQxOC53ZWJw.jpg"/>
      <itunes:duration>1365</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>January 24, 2023 - Molecular Forecaster is a research-as-a-service company providing computer-aided drug discovery technology to biotechs and pharma companies around the world. CEO Josh Pottel talks about growing up in Montreal, sleeping in class, the importance of being open to advice and where the Next Great Big Idea will likely come from.</p><p> </p><p>Molecular Forecaster: <a href="https://molecularforecaster.com/">molecularforecaster.com</a></p><p>LabOccupier: <a href="https://laboccupier.com/">laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p><p> </p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1.E1: Jay Levine | Dialog</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:episode>1</itunes:episode>
      <podcast:episode>1</podcast:episode>
      <itunes:title>S1.E1: Jay Levine | Dialog</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">NGBI.podbean.com/febedaf1-a7f1-37f6-b3ab-0b441dabaae5</guid>
      <link>https://NGBIdeas.transistor.fm/s1/1</link>
      <description>
        <![CDATA[<p>January 17, 2023 - This week on the NGBI podcast we speak with Jay Levine from Dialog in Toronto. Learn about Jay's journey, some of the obstacles he has faced and why he believes one of the Next Great Big Ideas in life sciences architecture is focused on clean air.</p><p> </p><p>LabOccupier: <a href="http://laboccupier.com">laboccupier.com</a></p><p>Dialog: <a href="https://dialogdesign.ca/">dialogdesign.ca</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>January 17, 2023 - This week on the NGBI podcast we speak with Jay Levine from Dialog in Toronto. Learn about Jay's journey, some of the obstacles he has faced and why he believes one of the Next Great Big Ideas in life sciences architecture is focused on clean air.</p><p> </p><p>LabOccupier: <a href="http://laboccupier.com">laboccupier.com</a></p><p>Dialog: <a href="https://dialogdesign.ca/">dialogdesign.ca</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 17 Jan 2023 05:00:00 -0500</pubDate>
      <author>LabOccupier.com</author>
      <enclosure url="https://media.transistor.fm/01f8028e/0d99b7e2.mp3" length="25104208" type="audio/mpeg"/>
      <itunes:author>LabOccupier.com</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/PIkGMhpi3XTACK91WCLnFY1_VwuvIwrBQCLoyelChG0/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS82NDdm/M2IxMjk1M2E3NDli/MDg4ZWNhZGU4NDJk/MjRmZi53ZWJw.jpg"/>
      <itunes:duration>1752</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>January 17, 2023 - This week on the NGBI podcast we speak with Jay Levine from Dialog in Toronto. Learn about Jay's journey, some of the obstacles he has faced and why he believes one of the Next Great Big Ideas in life sciences architecture is focused on clean air.</p><p> </p><p>LabOccupier: <a href="http://laboccupier.com">laboccupier.com</a></p><p>Dialog: <a href="https://dialogdesign.ca/">dialogdesign.ca</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>S1: NGBideas Trailer</title>
      <itunes:season>1</itunes:season>
      <podcast:season>1</podcast:season>
      <itunes:title>S1: NGBideas Trailer</itunes:title>
      <itunes:episodeType>trailer</itunes:episodeType>
      <guid isPermaLink="false">NGBI.podbean.com/d0fc0100-60ac-3f08-87df-e90966c3d897</guid>
      <link>https://NGBIdeas.transistor.fm/episodes/s1-ngbideas-trailer</link>
      <description>
        <![CDATA[<p>Who are today’s visionaries and tomorrow’s disrupters, innovators and leaders in Canada’s Life Sciences sector? What are they doing and how did they get there? Join Jim Wilson as he sits down with notable leaders, innovators and disruptors who are working on the Next Great Big Ideas in Biotech, Medtech and Life Sciences across Canada.</p><p> </p><p>LabOccupier: <a href="https://laboccupier.com/">Laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Who are today’s visionaries and tomorrow’s disrupters, innovators and leaders in Canada’s Life Sciences sector? What are they doing and how did they get there? Join Jim Wilson as he sits down with notable leaders, innovators and disruptors who are working on the Next Great Big Ideas in Biotech, Medtech and Life Sciences across Canada.</p><p> </p><p>LabOccupier: <a href="https://laboccupier.com/">Laboccupier.com</a></p><p>Summit: <a href="https://nextgreatbigideas.com/">nextgreatbigideas.com</a></p>]]>
      </content:encoded>
      <pubDate>Fri, 23 Dec 2022 10:10:33 -0500</pubDate>
      <author>LabOccupier.com</author>
      <enclosure url="https://media.transistor.fm/254a96b9/24ce2615.mp3" length="594510" type="audio/mpeg"/>
      <itunes:author>LabOccupier.com</itunes:author>
      <itunes:duration>68</itunes:duration>
      <itunes:summary>Who are today’s visionaries and tomorrow’s disrupters, innovators and leaders in Canada’s Life Sciences sector? What are they doing and how did they get there? Join Jim Wilson as he sits down with notable leaders, innovators and disruptors who are working on the Next Great Big Ideas in Biotech, Medtech and Life Sciences across Canada.
 
LabOccupier: Laboccupier.com
Summit: nextgreatbigideas.com</itunes:summary>
      <itunes:subtitle>Who are today’s visionaries and tomorrow’s disrupters, innovators and leaders in Canada’s Life Sciences sector? What are they doing and how did they get there? Join Jim Wilson as he sits down with notable leaders, innovators and disruptors who are working</itunes:subtitle>
      <itunes:keywords>Canadian Life Sciences Podcast</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
  </channel>
</rss>
